<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vaccines for preventing influenza in healthy children - Jefferson, T - 2018 | Cochrane Library</title> <meta content="Vaccines for preventing influenza in healthy children - Jefferson, T - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004879.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vaccines for preventing influenza in healthy children - Jefferson, T - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004879.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004879.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Vaccines for preventing influenza in healthy children" name="citation_title"/> <meta content="Tom Jefferson" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="jefferson.tom@gmail.com" name="citation_author_email"/> <meta content="Alessandro Rivetti" name="citation_author"/> <meta content="ASL CN2 Alba Bra" name="citation_author_institution"/> <meta content="Carlo Di Pietrantonj" name="citation_author"/> <meta content="Local Health Unit Alessandria‐ ASL AL" name="citation_author_institution"/> <meta content="Vittorio Demicheli" name="citation_author"/> <meta content="Azienda Sanitaria Locale ASL AL" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD004879.pub5" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/02/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004879.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004879.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004879.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Case‐Control Studies; Cohort Studies; Conflict of Interest; Influenza Vaccines [*therapeutic use]; Influenza, Human [*prevention &amp; control]; Numbers Needed To Treat; Otitis Media [diagnosis, epidemiology]; Randomized Controlled Trials as Topic; Research Support as Topic; Vaccines, Attenuated [therapeutic use]; Vaccines, Inactivated [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004879.pub5&amp;doi=10.1002/14651858.CD004879.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="XwNPMGod";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004879\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004879\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","th","ms","ja","fr","hr","fa","pl","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004879.pub5",title:"Vaccines for preventing influenza in healthy children",firstPublishedDate:"Feb 1, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004879.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004879.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004879.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004879.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004879.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004879.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004879.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004879.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004879.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004879.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>23235 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004879.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-sec-0120"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-sec-0084"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-sec-0114"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/appendices#CD004879-sec-0125"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/table_n/CD004879StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/table_n/CD004879StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vaccines for preventing influenza in healthy children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information#CD004879-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Tom Jefferson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information#CD004879-cr-0003">Alessandro Rivetti</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information#CD004879-cr-0004">Carlo Di Pietrantonj</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information#CD004879-cr-0005">Vittorio Demicheli</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information/en#CD004879-sec-0153">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 February 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004879.pub5">https://doi.org/10.1002/14651858.CD004879.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004879-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004879-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004879-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004879-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004879-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD004879-abs-0003">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004879-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004879-abs-0001" lang="en"> <section id="CD004879-sec-0001"> <h3 class="title" id="CD004879-sec-0001">Background</h3> <p>The consequences of influenza in children and adults are mainly absenteeism from school and work. However, the risk of complications is greatest in children and people over 65 years of age. This is an update of a review published in 2011. Future updates of this review will be made only when new trials or vaccines become available. Observational data included in previous versions of the review have been retained for historical reasons but have not been updated because of their lack of influence on the review conclusions. </p> </section> <section id="CD004879-sec-0002"> <h3 class="title" id="CD004879-sec-0002">Objectives</h3> <p>To assess the effects (efficacy, effectiveness, and harm) of vaccines against influenza in healthy children. </p> </section> <section id="CD004879-sec-0003"> <h3 class="title" id="CD004879-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library 2016, Issue 12), which includes the Cochrane Acute Respiratory Infections Group Specialised Register, MEDLINE (1966 to 31 December 2016), Embase (1974 to 31 December 2016), WHO International Clinical Trials Registry Platform (ICTRP; 1 July 2017), and ClinicalTrials.gov (1 July 2017). </p> </section> <section id="CD004879-sec-0004"> <h3 class="title" id="CD004879-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing influenza vaccines with placebo or no intervention in naturally occurring influenza in healthy children under 16 years. Previous versions of this review included 19 cohort and 11 case‐control studies. We are no longer updating the searches for these study designs but have retained the observational studies for historical purposes. </p> </section> <section id="CD004879-sec-0005"> <h3 class="title" id="CD004879-sec-0005">Data collection and analysis</h3> <p>Review authors independently assessed risk of bias and extracted data. We used GRADE to rate the certainty of evidence for the key outcomes of influenza, influenza‐like illness (ILI), complications (hospitalisation, ear infection), and adverse events. Due to variation in control group risks for influenza and ILI, absolute effects are reported as the median control group risk, and numbers needed to vaccinate (NNVs) are reported accordingly. For other outcomes aggregate control group risks are used. </p> </section> <section id="CD004879-sec-0006"> <h3 class="title" id="CD004879-sec-0006">Main results</h3> <p>We included 41 clinical trials (&gt; 200,000 children). Most of the studies were conducted in children over the age of two and compared live attenuated or inactivated vaccines with placebo or no vaccine. Studies were conducted over single influenza seasons in the USA, Western Europe, Russia, and Bangladesh between 1984 and 2013. Restricting analyses to studies at low risk of bias showed that influenza and otitis media were the only outcomes where the impact of bias was negligible. Variability in study design and reporting impeded meta‐analysis of harms outcomes. </p> <p><b>Live attenuated vaccines</b> </p> <p>Compared with placebo or do nothing, live attenuated influenza vaccines probably reduce the risk of influenza infection in children aged 3 to 16 years from 18% to 4% (risk ratio (RR) 0.22, 95% confidence interval (CI) 0.11 to 0.41; 7718 children; moderate‐certainty evidence), and they may reduce ILI by a smaller degree, from 17% to 12% (RR 0.69, 95% CI 0.60 to 0.80; 124,606 children; low‐certainty evidence). Seven children would need to be vaccinated to prevent one case of influenza, and 20 children would need to be vaccinated to prevent one child experiencing an ILI. Acute otitis media is probably similar following vaccine or placebo during seasonal influenza, but this result comes from a single study with particularly high rates of acute otitis media (RR 0.98, 95% CI 0.95 to 1.01; moderate‐certainty evidence). There was insufficient information available to determine the effect of vaccines on school absenteeism due to very low‐certainty evidence from one study. Vaccinating children may lead to fewer parents taking time off work, although the CI includes no effect (RR 0.69, 95% CI 0.46 to 1.03; low‐certainty evidence). Data on the most serious consequences of influenza complications leading to hospitalisation were not available. Data from four studies measuring fever following vaccination varied considerably, from 0.16% to 15% in children who had live vaccines, while in the placebo groups the proportions ranged from 0.71% to 22% (very low‐certainty evidence). Data on nausea were not reported. </p> <p><b>Inactivated vaccines</b> </p> <p>Compared with placebo or no vaccination, inactivated vaccines reduce the risk of influenza in children aged 2 to 16 years from 30% to 11% (RR 0.36, 95% CI 0.28 to 0.48; 1628 children; high‐certainty evidence), and they probably reduce ILI from 28% to 20% (RR 0.72, 95% CI 0.65 to 0.79; 19,044 children; moderate‐certainty evidence). Five children would need to be vaccinated to prevent one case of influenza, and 12 children would need to be vaccinated to avoid one case of ILI. The risk of otitis media is probably similar between vaccinated children and unvaccinated children (31% versus 27%), although the CI does not exclude a meaningful increase in otitis media following vaccination (RR 1.15, 95% CI 0.95 to 1.40; 884 participants; moderate‐certainty evidence). There was insufficient information available to determine the effect of vaccines on school absenteeism due to very low‐certainty evidence from one study. We identified no data on parental working time lost, hospitalisation, fever, or nausea. </p> <p>We found limited evidence on secondary cases, requirement for treatment of lower respiratory tract disease, and drug prescriptions. One brand of monovalent pandemic vaccine was associated with a sudden loss of muscle tone triggered by the experience of an intense emotion (cataplexy) and a sleep disorder (narcolepsy) in children. Evidence of serious harms (such as febrile fits) was sparse. </p> </section> <section id="CD004879-sec-0007"> <h3 class="title" id="CD004879-sec-0007">Authors' conclusions</h3> <p>In children aged between 3 and 16 years, live influenza vaccines probably reduce influenza (moderate‐certainty evidence) and may reduce ILI (low‐certainty evidence) over a single influenza season. In this population inactivated vaccines also reduce influenza (high‐certainty evidence) and may reduce ILI (low‐certainty evidence). For both vaccine types, the absolute reduction in influenza and ILI varied considerably across the study populations, making it difficult to predict how these findings translate to different settings. We found very few randomised controlled trials in children under two years of age. Adverse event data were not well described in the available studies. Standardised approaches to the definition, ascertainment, and reporting of adverse events are needed. Identification of all global cases of potential harms is beyond the scope of this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004879-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004879-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004879-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004879-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004879-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004879-abs-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004879-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004879-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD004879-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004879-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD004879-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004879-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004879-abs-0018">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004879-abs-0005" lang="en"> <h3>Vaccines for preventing influenza in healthy children</h3> <p><b>Review aim</b> </p> <p>The aim of this Cochrane Review, first published in 2007, was to summarise research on immunising healthy children up to the age of 16 with influenza vaccines during influenza seasons. We used randomised trials comparing either one of two types of vaccines with dummy vaccines or nothing. One type of vaccine is based on live but weakened influenza viruses (live attenuated influenza vaccines) and is given via the nose. The other is prepared by killing the influenza viruses with a chemical (inactivated virus) and is given by injection through the skin. We analysed the number of children with confirmed influenza and those who had influenza‐like illness (ILI) (headache, high temperature, cough, and muscle pain) and harms from vaccination. Future updates of this review will be made only when new trials or vaccines become available. Data from 33 observational studies included in previous versions of the review have been retained for historical reasons but have not been updated due to their lack of influence on the review conclusions. </p> <p><b>Key messages</b> </p> <p>Live attenuated and inactivated vaccines can reduce the proportion of children who have influenza and ILI. Variation in the results of studies means that we are uncertain about the effects of these vaccines across different seasons. </p> <p><b>What was studied in this review?</b> </p> <p>Over 200 viruses cause ILI and produce the same symptoms (fever, headache, aches, pains, cough, and runny nose) as influenza. Doctors cannot distinguish between them without laboratory tests because both last for days and rarely cause serious illness or death. </p> <p>The types of virus contained in the vaccines are usually those that are expected to circulate in the following influenza seasons, according to recommendations of the World Health Organization (seasonal vaccine). Pandemic vaccine contains only the virus strain that is responsible for the pandemic (e.g. the type A H1N1 for the 2009 to 2010 pandemic). </p> <p><b>Main results</b> </p> <p>We found 41 randomised studies. Most studies included children older than two years of age and were conducted in the USA, Western Europe, Russia, and Bangladesh. </p> <p>Compared with placebo or do nothing, live attenuated vaccines probably reduced the proportion of children who had confirmed influenza from 18% to 4% (moderate‐certainty evidence), and may reduce ILI from 17% to 12% (low‐certainty evidence). Seven children would need to be vaccinated for one child to avoid influenza, and 20 children would need to prevent one child from experiencing an ILI. We found data from one study that showed similar risk of ear infection in the two groups. There was insufficient information available to assess school absence and parents needing to take time off work. We found no data on hospitalisation, and harms were not consistently reported. </p> <p>Compared with placebo or no vaccination, inactivated vaccines reduce the risk of influenza from 30% to 11% (high‐certainty evidence), and they probably reduce ILI from 28% to 20% (moderate‐certainty evidence). Five children would need to be vaccinated for one child to avoid influenza, and 12 children would need to be vaccinated to prevent one case of ILI. The risk of otitis media is probably similar between vaccinated children and unvaccinated children (31% versus 27%, moderate‐certainty evidence). There was insufficient information available to assess school absenteeism due to very low‐certainty evidence from one study. We identified no data on parental working time lost, hospitalisation, fever, or nausea. </p> <p>One brand of monovalent pandemic vaccine was associated with a sudden loss of muscle tone triggered by the experience of an intense emotion (cataplexy) and a sleep disorder (narcolepsy) in children. </p> <p>Only a few studies were well designed and conducted, and the impact of studies at high risk of bias varied across the outcomes evaluated. Influenza and otitis media were the only outcomes where our confidence in the results was not affected by bias. </p> <p><b>How up to date is this review?</b> </p> <p>The evidence is current to 31 December 2016.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004879-sec-0120" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004879-sec-0120"></div> <h3 class="title" id="CD004879-sec-0121">Implications for practice</h3> <section id="CD004879-sec-0121"> <p>In children under the age of 16 years, live influenza vaccines probably reduce influenza (moderate‐certainty evidence) and may reduce influenza‐like illness (ILI) (low‐certainty evidence) over a single influenza season. In this population, inactivated vaccines also reduce influenza (high‐certainty evidence) and may reduce ILI (low‐certainty evidence). For both vaccine types, the size of effect when expressed in absolute terms varied considerably across the study populations. In addition to the variable certainty of the evidence, decision‐makers looking to inform local or national policies with evidence summarised in this review should be aware of the wide variation in absolute effects for protection against influenza and ILl. We did not find evidence that either vaccine reduces otitis media. </p> <p>To date no studies have adequately measured or reported hospitalisation. Few randomised studies have measured school absenteeism and parental leave following vaccination, and effects on these outcomes are uncertain. We found few studies assessing vaccination during seasonal influenza on children younger than two years of age. Findings from single studies are consistent with estimates of vaccine efficacy from our own analyses, but do not currently provide clear evidence of equivalent effects. Adverse event data and effects on nausea are not well described in the available studies. Standardised approaches to the definition, ascertainment, and reporting of adverse events are needed. We found only one old study of the harms of inactivated vaccine in children younger than two years, despite current recommendations to vaccinate healthy children from six months of age. Identification of all global cases of potential harms is beyond the scope of this review. </p> </section> <h3 class="title" id="CD004879-sec-0122">Implications for research</h3> <section id="CD004879-sec-0122"> <p>When a new vaccination or preventive technology becomes available, an adequately powered, publicly funded, high‐quality placebo‐controlled trial run over several seasons should be undertaken. New insights into the role of viruses and other agents in the genesis of influenza and ILI are also needed. This is especially important for the investigation of the non‐influenza causes of ILI, which could explain the findings of the study by <a href="./references#CD004879-bbs2-0208" title="CowlingB , FangV , NishiuraH , ChanK‐H , NgS , IpDKM , et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clinical Infectious Diseases2012;54(12):1778‐83. ">Cowling 2012</a>. </p> <p>Further data on the safety of vaccines in children should also be collected or made available, particularly on inactivated vaccines in younger children. There is an immediate need to standardise safety outcome data according to Brighton Collaboration guidelines. Honest and full disclosure of all safety data to researchers is also a priority. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004879-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004879-sec-0043"></div> <div class="table" id="CD004879-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Live attenuated influenza vaccine compared to placebo or do nothing for preventing influenza in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Influenza vaccine compared to placebo or do nothing for preventing influenza in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> healthy, community‐dwelling children younger than 16 years of age<br/> <b>Setting:</b> influenza seasons in the USA, Western Europe, Russia, and Bangladesh<br/> <b>Intervention:</b> live attenuated influenza vaccine<br/> <b>Comparison:</b> placebo or do nothing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or do nothing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with influenza vaccine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza assessed by laboratory confirmation</p> <p>Follow‐up over 1 or 2 influenza seasons</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.22<br/> (0.11 to 0.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>7718<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>130 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (14 to 53) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (20 to 74) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>480 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000<br/> (53 to 197) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza‐like illness assessed by subjective report</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.69<br/> (0.60 to 0.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>124,606<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>121 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000<br/> (73 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>172 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000<br/> (103 to 138) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>341 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>235 per 1000<br/> (205 to 273) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media assessed by clinical confirmation (inspection of ear and symptoms)</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>915 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>897 per 1000</p> <p>(869 to 924)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.98 (0.95 to 1.01)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1784</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with time off from school during follow‐up</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.51<br/> (0.22 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>296<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>7 8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (22 to 119) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of parents having to take off work during follow‐up</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69<br/> (0.46 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2874<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>9 1 0</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>262 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>181 per 1000<br/> (121 to 270) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospitalisation ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fever assessed as reported increase in temperature</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Temperature rise as an outcome was presented in most of the RCTs, with large differences among trials. Considering only studies reporting raw data for this outcome, the proportion of vaccinated children with fever ranged from 0.16% to 15%, while the proportion of children in the placebo groups with fever ranged from 0.71% to 22%. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20,561</p> <p>(4 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>11 12</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Control group risks stratified for low‐, moderate‐, and high‐risk groups due to wide variation in event rates across the studies.<br/> <sup>2</sup>Sensitivity analysis by risk of bias did not change the size or direction of effect.<br/> <sup>3</sup>Downgraded one level due to serious inconsistency. Although direction of effect across the studies is consistent, there is variation in the magnitude of effect (I<sup>2</sup> 94%). Statistical variation could not be explained by age or dose. The reasons for wide variation in control group risk could be due to variable viral circulation, but this is uncertain.<br/> <sup>4</sup>Downgraded one level due to serious risk of bias. Analysis dominated by studies at high or unclear risk of bias for multiple domains. We considered only one study as at low risk of bias.<br/> <sup>5</sup>Downgraded one level due to serious inconsistency. Direction and magnitude of effect varies between the studies, and there is a high level of statistical heterogeneity (96%).<br/> <sup>6</sup>Downgraded one level due to serious indirectness. Single study following children over a single influenza season with particularly high rates of otitis media. It is uncertain whether a rate of 92% would be expected over a similar time frame in other settings.<br/> <sup>7</sup>Downgraded one level due to serious risk of bias. Single study at unclear or high risk of bias for most domains.<br/> <sup>8</sup>Downgraded two levels due to serious imprecision. The number of events is low, and the confidence interval for the absolute effect is consistent with a small increase and small reduction in school absenteeism.<br/> <sup>9</sup>Downgraded one level due to serious risk of bias. Of two data sets used from the eligible study, we judged one to be at high risk of bias.<br/> <sup>10</sup>Downgraded due to serious inconsistency. Study results are discordant in terms of size of reduction in parental working days lost.<br/> <sup>11</sup>Downgraded due to very serious inconsistency. Proportion of children with fever differed substantially between studies.<br/> <sup>12</sup>Downgraded due to serious risk of bias. Studies at high or unclear risk of bias across several domains. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004879-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inactivated influenza vaccine compared to placebo or do nothing for preventing influenza in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Inactivated influenza vaccine compared to placebo or do nothing for preventing influenza in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> healthy, community‐dwelling children older than 2 years of age<br/> <b>Setting:</b> influenza seasons in the USA<br/> <b>Intervention:</b> inactivated influenza vaccine<br/> <b>Comparison:</b> placebo or do nothing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or do nothing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with influenza vaccine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza assessed by laboratory confirmation</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.36<br/> (0.28 to 0.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1628<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (1 to 2) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>298 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000<br/> (83 to 143) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>481 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>173 per 1000<br/> (135 to 231) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza‐like illness assessed by subjective report</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.72<br/> (0.65 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>19,044<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>134 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000<br/> (87 to 106) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>282 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<br/> (183 to 223) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>328 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000<br/> (213 to 259) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media assessed by clinical confirmation (inspection of ear and symptoms)</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>271 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>312 per 1000</p> <p>(257 to 379)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.15</p> <p>(0.95 to 1.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>884</p> <p>(3 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absence from school</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1000</p> <p>(16 to 112)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.46</p> <p>(0.17 to 1.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of parents having to take off work during follow‐up ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospitalisations ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fever ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Control group risks stratified by low, moderate, and high due to wide variation in event rates.<br/> <sup>2</sup>Downgraded one level due to serious risk of bias. Analysis based on studies at high or unclear risk of bias for multiple domains.<br/> <sup>3</sup>Downgraded one level due to serious imprecision. Confidence interval includes meaningful increase in otitis media with vaccination.<br/> <sup>4</sup>Downgraded one level due to serious risk of bias. Study contributing data had multiple domains at unclear risk of bias.<br/> <sup>5</sup>Downgraded two levels due to very serious imprecision. Low number of events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004879-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004879-sec-0044"></div> <section id="CD004879-sec-0045"> <h3 class="title" id="CD004879-sec-0045">Description of the condition</h3> <p>Viral respiratory disease imposes a heavy burden on society. The majority of viral respiratory disease (influenza‐like illness (ILI)) is caused by many different agents that are not clinically distinguishable from one another. A variable proportion of ILI (7% to 15% on average) is caused by influenza viruses and is known as influenza (<a href="./references#CD004879-bbs2-0252" title="JeffersonT , SmithS , DemicheliV , HarndenA , RivettiA , DiPietrantonjC . Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet2005;365(9461):773‐80. ">Jefferson 2005b</a>). </p> <p>Influenza is an acute respiratory infection caused by a virus of the <i>Orthomyxoviridae</i> family. Three serotypes are known (A, B, and C). Influenza causes an acute febrile illness with myalgia, headache, and cough. Although the median duration of the acute illness is three days, cough and malaise can persist for weeks. Complications of influenza include otitis media, pneumonia, secondary bacterial pneumonia, exacerbations of chronic respiratory disease, and bronchiolitis in children. Additionally, influenza can cause a range of non‐respiratory complications including febrile convulsions, Reye's syndrome, and myocarditis (<a href="./references#CD004879-bbs2-0246" title="TreanorJJ . Influenza vaccination. New England Journal of Medicine2016;375(13):1261‐8. [DOI: 10.1056/NEJMcp1512870] ">Treanor 2016</a>; <a href="./references#CD004879-bbs2-0250" title="WiselkaM . Influenza: diagnosis, management and prophylaxis. BMJ1994;308(6940):1341‐5. ">Wiselka 1994</a>). Efforts to prevent or minimise the impact of seasonal influenza in the second part of the 20th century centred on the use of vaccines. Due to the yearly changes in viral antigenic configuration and the lack of carry‐over protection from year to year, a new vaccination campaign needs to be organised annually, with a huge scientific and logistic effort to ensure production and delivery of the vaccines. </p> </section> <section id="CD004879-sec-0046"> <h3 class="title" id="CD004879-sec-0046">Description of the intervention</h3> <p>There are four types of influenza vaccines currently available worldwide.</p> <p> <ol id="CD004879-list-0001"> <li> <p>Whole‐virion inactivated vaccines, which consist of complete viruses that have been 'killed' or inactivated, so that they are not infectious but retain their strain‐specific antigenic properties. </p> </li> <li> <p>Subunit inactivated vaccines, which are made of influenza surface antigens (H and N) only. </p> </li> <li> <p>Split‐virion inactivated vaccines in which the viral structure is broken up by a disrupting agent. These vaccines contain both surface and internal antigens. </p> </li> <li> <p>Live attenuated, cold‐adapted vaccines in which the live virus in the vaccine can only multiply in the cooler nasal passages and which are administered intranasally. </p> </li> </ol> </p> <p>Periodic antigenic drifts and shifts pose problems for vaccine production and procurement. New vaccines closely matching the antigenic configuration of circulating strains must be produced and procured for the beginning of each new influenza 'season'. To achieve this, the World Health Organization (WHO) has established a worldwide surveillance system allowing early identification and isolation of viral strains circulating in the different parts of the world. </p> </section> <section id="CD004879-sec-0047"> <h3 class="title" id="CD004879-sec-0047">How the intervention might work</h3> <p>Vaccines work by simulating an infection and stimulating the body to produce antibodies against the threat and activate other defence mechanisms. </p> <p>Efforts to prevent the spread of influenza have been shown to be unsuccessful due to the infectiousness of the condition, and public health interventions rely on vaccination to mitigate the worst consequences of the disease (death and hospitalisation). </p> <p>Most high‐income countries have vaccination programmes covering the elderly and so‐called at‐risk groups (e.g. people with pre‐existing conditions likely to be made worse by influenza infection). However, for the influenza season 2004 to 2005, the American Academy of Pediatrics and the US Centers for Disease Control and Prevention (CDC) recommended that immunisation of healthy children between the ages of 6 and 23 months be instituted as a public health measure (<a href="./references#CD004879-bbs2-0198" title="American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza immunization of children. Pediatrics2004;113:1441‐7. ">AAPCID 2004</a>). This was later extended to cover children aged 6 to 59 months (i.e. 6 months to 5 years) (<a href="./references#CD004879-bbs2-0205" title="FioreAE , ShayDK , HaberP , IskanderJK , UyekiTM , MootreyG , et al. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. Morbidity and Mortality Weekly Report2007;56(RR‐6):1‐54. ">CDC 2007</a>), and to healthy household contacts (including children) and caregivers of children aged under 5 years (<a href="./references#CD004879-bbs2-0199" title="GrohskopfLA , SokolowLZ , BroderKR , OlsenSJ , KarronRA , JerniganDB , et al. Prevention and control of seasonal influenza with vaccines. Morbidity and Mortality Weekly Report2016;65(5):1‐54. ">ACIP 2016</a>; <a href="./references#CD004879-bbs2-0205" title="FioreAE , ShayDK , HaberP , IskanderJK , UyekiTM , MootreyG , et al. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. Morbidity and Mortality Weekly Report2007;56(RR‐6):1‐54. ">CDC 2007</a>). In February 2004, the Canadian National Advisory Committee on Immunization followed the US authorities in recommending immunisation for the 6‐to‐23‐months age group (<a href="./references#CD004879-bbs2-0236" title="OrrP . Statement on influenza vaccination for the 2004‐2005 season. Canada Communicable Disease Report2004;30:1‐32. ">Orr 2004</a>). </p> <p>Finland is the only European country to have introduced routine vaccination of children aged six months to three years (from the beginning of the 2007 to 2008 influenza season). Other countries have also recommended childhood vaccination but have not included it in the routine childhood programmes. Slovenia and Latvia recommended vaccination of children aged six months to two years. Slovakia, Estonia, and Austria recommended it for children and adolescents aged six months to 18 years (<a href="./references#CD004879-bbs2-0231" title="MereckieneJ , CotterS , D’AnconaF , GiambiC , NicollA , Levy‐BruhlD , et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008‐2009. Eurosurveillance2010;15(44):1‐10. ">Mereckiene 2010</a>). </p> <p>The European Medicines Agency (EMA) has made recent changes to the registration of seasonal, pre‐pandemic, and pandemic influenza vaccines (<a href="./references#CD004879-bbs2-0212" title="European Medicines Agency. EMA/CHMP/VWP/457259/2014. Committee for Medicinal Products for Human Use. Guideline on influenza vaccines. Non‐clinical and clinical module. www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500211324 (accessed prior to 23 January 2018). ">EMA 2014</a>; <a href="./references#CD004879-bbs2-0249" title="WijnansL , VoordouwB . A review of the changes to the licensing of influenza vaccines in Europe. Influenza and Other Respiratory Viruses2016;10(1):2‐8. ">Wijnans 2016</a>). </p> <p>The changes were introduced in 2014, triggered by the realisation that antibody responses are not sufficient predictors of field protection, as our reviews have consistently shown over the years. Most of the data for influenza vaccines included in our reviews are from registered vaccines, and yet the field protection afforded is modest or negligible. In addition, the methods of standardisation of antibody titres were lacking. The new rules for adults and elderly require demonstration of non‐inferiority of antibody response (immunogenicity) by a candidate seasonal influenza vaccine compared to an established one. In addition, whenever a demonstration of clinical efficacy is necessary, the EMA encourages the minimisation of the use of placebo and encourages the use of active controls (such a non‐influenza vaccine) with ILI (and relevant polymerase chain reaction results) as a primary endpoint. Clinical effectiveness should be tested by carrying out (preferably prospective) cohort studies or nested so‐called test‐negative case‐control studies following the European Centre for Disease Prevention and Control protocol (<a href="./references#CD004879-bbs2-0211" title="European Centre for Disease Prevention and Control. Protocol for case‐control studies to measure pandemic and seasonal influenza vaccine effectiveness in the European Union and European Economic Area Member States ‐ Technical Document. ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf (accessed prior to 23 January 2018). ">ECDC 2009</a>). </p> <p>Harms surveillance is now required with a follow‐up of at least six months’ duration and in the general elderly population a database of at least 3000 people exposed to the vaccine. Enhanced vaccine vigilance data should be collected as soon as possible at the beginning of the vaccination campaign each year. </p> </section> <section id="CD004879-sec-0048"> <h3 class="title" id="CD004879-sec-0048">Why it is important to do this review</h3> <p>The main arguments for immunising young children and those attending school include (<a href="./references#CD004879-bbs2-0220" title="IzurietaHS , ThompsonWW , KramarzP , ShayDK , DavisRL , DeStefanoF , et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. New England Journal of Medicine2000;342:232‐9. ">Izurieta 2000</a>; <a href="./references#CD004879-bbs2-0234" title="NeuzilKM , MellenBG , WrightPF , MitchelEFJr , GriffinMR . The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. New England Journal of Medicine2000;342:225‐31. ">Neuzil 2000</a>; <a href="./references#CD004879-bbs2-0240" title="PrincipiN , EspositoS . Are we ready for universal influenza vaccination in paediatrics?. Lancet2004;4:75‐83. ">Principi 2004</a>; <a href="./references#CD004879-bbs2-0241" title="ReichertTA , SugayaN , FedsonDS , GlezenWP , SimonsenL , TashiroM . The Japanese experience with vaccinating schoolchildren against influenza. New England Journal of Medicine2001;344:889‐96. ">Reichert 2001</a>): </p> <p> <ol id="CD004879-list-0002"> <li> <p>reduction of the number of people with influenza;</p> </li> <li> <p>reduction in the number of admissions to hospital;</p> </li> <li> <p>reduction in mortality of the elderly in families with children;</p> </li> <li> <p>reduction in illness in healthcare workers; and</p> </li> <li> <p>reduction in the number of antibiotic prescriptions and reduction in absenteeism of children from school and their parents or carers or household contacts from work. </p> </li> </ol> </p> <p>Rational decision‐making about the prevention of influenza is complicated by the absence of reliable forecasts, uncertainty about the effects of the vaccine in different age groups, and the vaccines efficacy versus effectiveness issue. Cochrane Reviews on the effects of the use of vaccines to prevent influenza in other age and risk groups show a striking difference between the vaccine efficacy (reduction in number of laboratory‐confirmed cases of influenza) and vaccine effectiveness against ILI (reduction in symptomatic cases), which can include illness caused by influenza viruses that is not laboratory confirmed or illness caused by other viruses, such as respiratory syncytial virus. To allow a reasoned choice between alternative prevention strategies, accurate assessment of both the efficacy and effectiveness of influenza vaccines is essential. The aim of this review was to identify, assess, and compare studies of vaccine efficacy and vaccine effectiveness in healthy children under 16 years of age, and to review the safety of vaccines in children up to 16 years of age. </p> <p>Due to the unique production cycle of influenza vaccines (they are tested using surrogate outcomes ‐ antibody stimulation ‐ ahead of each influenza 'season'), past performance is probably the only reliable way to predict future performance. An accurate assessment of the effects (efficacy, effectiveness, and safety profile) of influenza vaccines is essential to allow rational choice between alternative strategies. This review, with its two companion reviews (<a href="./references#CD004879-bbs2-0209" title="DemicheliV , JeffersonT , DiPietrantonjC , Al‐AnsaryLA , FerroniE , ThorningS , et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews2010, Issue 2. [DOI: 10.1002/14651858.CD004876.pub3] ">Demicheli 2010</a>; <a href="./references#CD004879-bbs2-0224" title="JeffersonT , RivettiA , DiPietrantonjC , DemicheliV , FerroniE . Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD004879.pub4] ">Jefferson 2012a</a>), are long‐running reviews. They are among the most consistently accessed in the whole Cochrane Database of Systematic Reviews, confirming the importance of the topic and interest in it. Periodic updates, some stretching back almost two decades, have allowed us to include an increasing number of studies on the effects of influenza vaccines and monitor their impact on our reviews (<a href="#CD004879-tbl-0003">Table 1</a>). </p> <div class="table" id="CD004879-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Synthesis of results and conclusions from the previous versions of the present review</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Review version (searches date)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of included trials (RCT/CCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of included observational studies</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Estimates of effect (RCTs/CCTs only)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Conclusions from the Abstract</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 1</p> <p>(15 November 2005)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> <p>(12 cohorts and 1 case‐control study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = 33% (95% CI 28% to 38%)</p> <p>TIV = 36% (95% CI 24% to 46%)</p> <p><b>Influenza</b> </p> <p>LAIV = 79% (95% CI 48% to 92%)</p> <p>TIV = 59% (95% CI 41% to 71%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vaccines are efficacious in children older than two years, but little</p> <p>evidence is available for children under two. There was a marked difference between vaccine efficacy and effectiveness. That no safety comparisons could be carried out emphasises the need for standardisation of methods and presentation of vaccine </p> <p>safety data in future studies. It was surprising to find only one study of inactivated</p> <p>vaccine in children under two years, given recent recommendations to vaccinate</p> <p>healthy children from six months old in the USA and Canada. If immunisation in children is to be recommended as public health policy, large‐scale studies assessing important outcomes and directly comparing vaccine types are urgently required. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 2</p> <p>(20 February 2008)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> <p>(18 cohorts and 3 case‐control studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = 33% (95% CI 28% to 38%)</p> <p>TIV = 36% (95% CI 24% to 46%)</p> <p><b>Influenza</b> </p> <p>LAIV = 82% (95% CI 71% to 89%)</p> <p>TIV = 59% (95% CI 41% to 71%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vaccines are efficacious in children older than two, but little evidence is </p> <p>available for children under two. There was a marked difference between vaccine</p> <p>efficacy and effectiveness. No safety comparisons could be carried out, emphasising</p> <p>the need for standardisation of methods and presentation of vaccine safety data</p> <p>in future studies. It was surprising to find only one study of inactivated vaccine in </p> <p>children under two years, given current recommendations to vaccinate healthy children from six months old in the USA and Canada. If immunisation in children is to be recommended as a public health policy, large‐scale studies assessing important outcomes and directly comparing vaccine types are urgently required. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 3</p> <p>(9 July 2012)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(21 cohorts and 12 case‐control studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = 33% (95% CI 28% to 38%)</p> <p>TIV = 36% (95% CI 24% to 46%)</p> <p><b>Influenza</b> </p> <p>LAIV = 80% (95% CI 68% to 87%)</p> <p>TIV = 59% (95% CI 41% to 71%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vaccines are efficacious in preventing cases of influenza in children older</p> <p>than two years of age, but little evidence is available for children younger than two </p> <p>years of age. There was a difference between vaccine efficacy and effectiveness,</p> <p>partly due to differing data sets, settings, and viral circulation patterns. No safety</p> <p>comparisons could be carried out, emphasising the need for standardisation of</p> <p>methods and presentation of vaccine safety data in future studies. In specific cases,</p> <p>influenza vaccines were associated with serious harms such as narcolepsy and febrile</p> <p>convulsions. It was surprising to find only one study of inactivated vaccine in children</p> <p>under two years, given current recommendations to vaccinate healthy children from</p> <p>six months of age in the USA, Canada, parts of Europe, and Australia. If immunisation</p> <p>in children is to be recommended as a public health policy, large‐scale studies</p> <p>assessing important outcomes and directly comparing vaccine types are urgently required.</p> <p>The degree of scrutiny needed to identify all global cases of potential harms is beyond the resources of this review. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CCT: comparative controlled trial<br/> LAIV: live attenuated influenza vaccine<br/> RCT: randomised controlled trial<br/> TIV: trivalent inactivated influenza vaccine </p> </div> </div> <p>The reviews are not methodologically homogeneous, as their methods reflect the history and development of Cochrane Reviews. In particular the inclusion of observational studies which was initially favoured for the assessment of harms, has been a source of discussion. In this review randomised evidence represents 55% of studies considered. To enhance the relevance of the review to decision‐makers, in the <a href="./references#CD004879-bbs2-0252" title="JeffersonT , SmithS , DemicheliV , HarndenA , RivettiA , DiPietrantonjC . Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet2005;365(9461):773‐80. ">Jefferson 2005b</a> update, we included comparative non‐randomised studies reporting evidence of serious or rare harms (or both). </p> <p>Historically observational studies have been of poor methodological quality, often reporting conflicting or paradoxical results, preventing the drawing of firm conclusions. However, inclusion of particular study types and increasing size of the data sets has not led to a change in the conclusion of the reviews, while leading to a greatly increased workload. This is the main reason why the authors, the review group and the Cochrane editors have decided to stabilise all three reviews, that is not to carry out routine updates of the observational data set and update the randomised data set if certain conditions are fulfilled in the future. </p> <p>For the same reason we have retained the observational content of this review and its companions as historical evidence of the life cycle of the reviews. </p> <p>We plan to update the randomised evidence in this review if any or all of the following conditions are fulfilled in the future. </p> <p> <ul id="CD004879-list-0003"> <li> <p>a trial assessing the clinical effects of the evolution of current technologies becomes available; </p> </li> <li> <p>a new type of vaccine is developed; or</p> </li> <li> <p>a new credible causal paradigm for influenza is put forward.</p> </li> </ul> </p> <p>For an overview of the three reviews, see the covering editorial at <a href="https://community.cochrane.org/news/why-have-three-long-running-cochrane-reviews-influenza-vaccines-been-stabilised" target="_blank">https://community.cochrane.org/news/why‐have‐three‐long‐running‐cochrane‐reviews‐influenza‐vaccines‐been‐stabilised</a>. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004879-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004879-sec-0049"></div> <p>To assess the effects (efficacy, effectiveness, and harm) of vaccines against influenza in healthy children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004879-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004879-sec-0050"></div> <section id="CD004879-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004879-sec-0052"> <h4 class="title">Types of studies</h4> <p>We considered randomised controlled trials (RCTs), quasi‐RCTs, comparative controlled trials (CCTs), and cohort and case‐control studies. See <a href="./appendices#CD004879-sec-0126">Appendix 1</a> for study design definitions. We decided to include evidence from comparative non‐randomised studies to enhance the relevance of the review. The searches for cohort and case‐control studies are no longer being updated but the observational studies have been retained for historical purposes. </p> </section> <section id="CD004879-sec-0053"> <h4 class="title">Types of participants</h4> <p>Healthy children under 16 years of age in any geographical location. All participants were classified as healthy unless otherwise stated. We excluded studies that documented the inclusion of participants with chronic illnesses/conditions or immunodeficiency. </p> </section> <section id="CD004879-sec-0054"> <h4 class="title">Types of interventions</h4> <p>Vaccination with any influenza vaccine given independently, in any dose, preparation, or time schedule (intervention), compared with placebo, or with no intervention (control). </p> <p>We also considered newer, or as yet unlicensed types of vaccines (e.g. live attenuated and DNA vaccines). </p> </section> <section id="CD004879-sec-0055"> <h4 class="title">Types of outcome measures</h4> <section id="CD004879-sec-0056"> <h5 class="title">Primary outcomes</h5> <section id="CD004879-sec-0057"> <h6 class="title">Primary outcome measures for treatment efficacy and effectiveness</h6> <p> <ol id="CD004879-list-0004"> <li> <p>Influenza: symptoms of influenza accompanied by a positive laboratory diagnosis (measure of vaccine efficacy). </p> </li> <li> <p>Influenza‐like illness (ILI): symptoms of influenza only (measure of vaccine effectiveness).</p> </li> <li> <p>Otitis media.</p> </li> <li> <p>Lower respiratory tract diseases.</p> </li> <li> <p>Cases admitted to hospital:</p> <ol id="CD004879-list-0005"> <li> <p>hospitalisation due to otitis media</p> </li> </ol> </li> <li> <p>Deaths of study participants (either from influenza or other causes).</p> </li> </ol> </p> </section> <section id="CD004879-sec-0058"> <h6 class="title">Primary outcome measures for adverse events</h6> <p> <ol id="CD004879-list-0006"> <li> <p>All types of systemic and severe adverse events.</p> </li> </ol> </p> </section> </section> <section id="CD004879-sec-0059"> <h5 class="title">Secondary outcomes</h5> <section id="CD004879-sec-0060"> <h6 class="title">Secondary outcome measures for treatment efficacy and effectiveness</h6> <p> <ol id="CD004879-list-0007"> <li> <p>Direct or indirect indicator of disease impact:</p> <ol id="CD004879-list-0008"> <li> <p>working days lost for influenza;</p> </li> <li> <p>school absenteeism for influenza;</p> </li> <li> <p>drug prescriptions; and</p> </li> <li> <p>outpatients attendances.</p> </li> </ol> </li> </ol> </p> </section> <section id="CD004879-sec-0061"> <h6 class="title">Secondary outcome measures for adverse events</h6> <p> <ol id="CD004879-list-0009"> <li> <p>All types of local adverse events.</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD004879-sec-0062"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004879-sec-0063"> <h4 class="title">Electronic searches</h4> <p>For this update we searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 12, searched 31 December 2016 via the Cochrane Library), which contains the Cochrane Acute Respiratory Infections Group Specialised Register, MEDLINE (PubMed) (1966 to 31 December 2016), Embase (Elsevier) (1974 to 31 December 2016), World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; <a href="http://www.who.int/ictrp/en" target="_blank">www.who.int/ictrp/en</a>, 1 July 2017), and ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, 1 July 2017). </p> <p>We used the search strategy in <a href="./appendices#CD004879-sec-0127">Appendix 2</a> to search MEDLINE. We adapted the search terms to search CENTRAL (<a href="./appendices#CD004879-sec-0128">Appendix 3</a>), Embase (<a href="./appendices#CD004879-sec-0129">Appendix 4</a>), WHO ICTRP (<a href="./appendices#CD004879-sec-0130">Appendix 5</a>), and ClinicalTrials.gov (<a href="./appendices#CD004879-sec-0131">Appendix 6</a>). </p> <p>We did not impose any language or publication restrictions.</p> <p>See <a href="./appendices#CD004879-sec-0132">Appendix 7</a> for details of previous searches. </p> </section> <section id="CD004879-sec-0064"> <h4 class="title">Searching other resources</h4> <p>To identify additional published and unpublished studies, we searched the Vaccine Adverse Event Reporting System website (<a href="https://vaers.hhs.gov/index.html" target="_blank">vaers.hhs.gov/index.html</a>). For past versions, we contacted vaccine manufacturers and first or corresponding authors of relevant studies to identify further published or unpublished trials. </p> </section> </section> <section id="CD004879-sec-0065"> <h3 class="title" id="CD004879-sec-0065">Data collection and analysis</h3> <section id="CD004879-sec-0066"> <h4 class="title">Selection of studies</h4> <p>Two review authors (TOJ, AR) independently excluded all studies not fulfilling the inclusion criteria of initially identified and retrieved articles. In the case of disagreement, VD carried out arbitration. </p> </section> <section id="CD004879-sec-0067"> <h4 class="title">Data extraction and management</h4> <p>Four review authors (AR, TOJ, CDP, EF) performed data extraction using a data extraction form (<a href="./appendices#CD004879-sec-0133">Appendix 8</a>). We checked the data and entered it into Review Manager 5 software (<a href="./references#CD004879-bbs2-0242" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We extracted data on the following: </p> <p> <ul id="CD004879-list-0010"> <li> <p>methodological quality of studies;</p> </li> <li> <p>study design (<a href="./appendices#CD004879-sec-0126">Appendix 1</a>); </p> </li> <li> <p>description of setting;</p> </li> <li> <p>characteristics of participants;</p> </li> <li> <p>description of vaccines (content and antigenic match);</p> </li> <li> <p>description of outcomes;</p> </li> <li> <p>publication status;</p> </li> <li> <p>date of study; and</p> </li> <li> <p>location of study.</p> </li> </ul> </p> <p>One review author (CDP) carried out statistical analyses.</p> </section> <section id="CD004879-sec-0068"> <h4 class="title">Assessment of risk of bias in included studies</h4> <section id="CD004879-sec-0069"> <h5 class="title">Experimental studies (trials)</h5> <p>The review authors independently assessed the methodological quality of the included studies using the criteria in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). In the case of disagreement in assigning quality criteria amongst the review authors (TOJ, EF, CDP, AR), VD carried out arbitration. </p> <p>We assessed risk of bias of the studies according to the following key domains (<a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <section id="CD004879-sec-0070"> <h6 class="title">Generation of the allocation sequence</h6> <p> <ul id="CD004879-list-0011"> <li> <p>Low risk of bias: e.g. use of a table of random numbers or computer‐generated random numbers. </p> </li> <li> <p>High risk of bias: e.g. use of alternation, date of birth, day of the week, or case record number. </p> </li> <li> <p>Unclear risk of bias: if insufficient information was provided.</p> </li> </ul> </p> </section> <section id="CD004879-sec-0071"> <h6 class="title">Allocation concealment</h6> <p> <ul id="CD004879-list-0012"> <li> <p>Low risk of bias: e.g. numbered or coded identical containers administered sequentially, on‐site computer system that can only be accessed after entering the characteristics of an enrolled participant, or serially numbered, opaque, sealed envelopes were used, or sealed envelopes that were not sequentially numbered were used. </p> </li> <li> <p>High risk of bias: e.g. use of an open table of random numbers.</p> </li> <li> <p>Unclear risk of bias: if insufficient information was provided.</p> </li> </ul> </p> </section> <section id="CD004879-sec-0072"> <h6 class="title">Blinding</h6> <p> <ul id="CD004879-list-0013"> <li> <p>Low risk of bias: if adequate double‐blinding, e.g. placebo vaccine, or single‐blinding, i.e. blinded outcome assessment, was used. </p> </li> <li> <p>High risk of bias: if no blinding was used.</p> </li> <li> <p>Unclear risk of bias: if insufficient information was provided.</p> </li> </ul> </p> </section> <section id="CD004879-sec-0073"> <h6 class="title">Incomplete outcome data</h6> <p>Number of losses to follow‐up.</p> <p> <ul id="CD004879-list-0014"> <li> <p>Low risk of bias: no missing data, or the proportion of missing data compared with observed event risk was not enough to have a clinically relevant impact on the intervention effect estimate. </p> </li> <li> <p>High risk of bias: the proportion of missing data compared with observed event risk was enough to induce clinically relevant bias in the intervention effect estimate. </p> </li> <li> <p>Unclear risk of bias: if insufficient information was provided.</p> </li> </ul> </p> </section> </section> <section id="CD004879-sec-0074"> <h5 class="title">Non‐experimental studies</h5> <p>We assessed the quality of non‐randomised studies in relation to the presence of potential confounders, which could make interpretation of the results difficult. We evaluated the quality of case‐control (prospective and retrospective) and cohort studies using the appropriate Newcastle‐Ottawa Scales (<a href="./appendices#CD004879-sec-0134">Appendix 9</a>). </p> <p>Using quality at the analysis stage as a means of interpretation of the results, we assigned 'Risk of bias' categories as (<a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>): </p> <p> <ol id="CD004879-list-0015"> <li> <p>low risk of bias: plausible bias unlikely to seriously alter the results;</p> </li> <li> <p>unclear risk of bias: plausible bias that raises some doubt about the results; and</p> </li> <li> <p>high risk of bias: plausible bias that seriously weakens confidence in the results.</p> </li> </ol> </p> </section> </section> <section id="CD004879-sec-0075"> <h4 class="title">Measures of treatment effect</h4> <p>We used the risk ratio (RR) and its 95% confidence interval (CI) as the summary measure. We calculated vaccine efficacy (or effectiveness) as VE = 1 ‐ RR expressed as a percentage, for cohort and RCT/CCT studies. For case‐control studies we adopted the odds ratio (OR) with 95% CIs. </p> <p>To enhance relevance to everyday practice, we also expressed the summary measure of the most reliable and significant comparisons (those from RCTs with influenza cases as an outcome by age group) as a risk difference (RD). This is a measure of absolute efficacy of the vaccines that incorporates significant information such as the incidence in the control arm and allows the calculation of its reciprocal, the number needed to treat for an additional beneficial outcome (in this case, vaccinate or NNV). Number needed to vaccinate expresses the number of children needed to be vaccinated to prevent one case of influenza. Evidence was insufficient to calculate meaningful RDs for rarer outcomes (such as hospitalisations or pneumonia), or the evidence was of poor quality (as in the case of cohorts). </p> <p>The NNV expresses the number of children needed to be vaccinated to prevent one case of influenza. The NNV can be computed as 1/RD. Since meta‐analysis estimates from RD are affected by spurious heterogeneity, we preferred to compute the NNV as CER*RR, where CER (control event rate) is the proportion of events in the control group. Given substantial variation in the control group rates across the studies for influenza and ILI outcomes, we have based NNVs on low, median, and high control group rates. This is a departure from the approach used in the previous version of this review (see <a href="#CD004879-sec-0157">Differences between protocol and review</a>). </p> </section> <section id="CD004879-sec-0076"> <h4 class="title">Unit of analysis issues</h4> <p>For cluster‐randomised trials we did not compute effective sample size as described by <a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a> because the information supplied by papers was insufficient to compute intracluster correlation coefficient (ICC), and additional information was not available. However, for studies with a known cluster design (<a href="./references#CD004879-bbs2-0001" title="AlexandrovaGI , BudilovskyGN , KovalTA , PolezhaevFI , GarmashovaLM , GhendonYuZ , et al. Study of live recombinant cold‐adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine1986;4(2):114‐8. ">aa Alexandrova 1986</a>; <a href="./references#CD004879-bbs2-0019" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993a</a>; <a href="./references#CD004879-bbs2-0020" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993b</a>), we conducted sensitivity analyses with effective sample size calculated from an assumed ICC of 0.004 (see <a href="#CD004879-sec-0083">Sensitivity analysis</a>) (<a href="./references#CD004879-bbs2-0227" title="LoebM , RussellML , MossL , FonsecaK , FoxJ , EarnDJD , et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA2010;303(10):943–50. ">Loeb 2010</a>). Information about ICC was unavailable for <a href="./references#CD004879-bbs2-0009" title="CloverRD , CrawfordS , GlezenWP , TaberLH , MatsonCC , CouchRB . Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83‐like viruses. Journal of Infectious Diseases1991;163(2):300‐4. ">aa Clover 1991</a> and <a href="./references#CD004879-bbs2-0013" title="GruberWC , TaberLH , GlezenWP , CloverRD , AbellTD , DemmlerRW , et al. Live attenuated and inactivated influenza vaccine in school‐age children. American Journal of Diseases in Children1990;144(5):595‐600. ">aa Gruber 1990</a>. Nevertheless, even if we suppose for these studies an ICC different from zero, we have to take into account that average cluster size is small and that we expect a design effect close to 1. Because of the small sample size of each arm, we can suppose that the reduction to effective sample size was negligible. </p> <p>We summarised evidence from non‐randomised studies (cohort and case‐control) in our review according to <a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>. </p> </section> <section id="CD004879-sec-0077"> <h4 class="title">Dealing with missing data</h4> <p>Our analysis relied on existing data. Whenever possible, we used the intention‐to‐treat (ITT) population. </p> </section> <section id="CD004879-sec-0078"> <h4 class="title">Assessment of heterogeneity</h4> <p>We calculated the I<sup>2</sup> statistic for each pooled estimate to assess the impact on statistical heterogeneity. The I<sup>2</sup> statistic may be interpreted as the proportion of total variation among effect estimates that is due to heterogeneity rather than sampling error, and it is intrinsically independent of the number of studies. When the I<sup>2</sup> is less than 30% there is little concern about statistical heterogeneity (<a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We used random‐effects models throughout to take into account the between‐study variance in our findings (<a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). Variance is to be expected in influenza vaccine trials as there are unpredictable systematic differences between trials regarding the circulating strains, degree of antigenic matching of the vaccine, type of vaccine, and the levels of immunity presented by different populations in different settings. Not all studies reported sufficient details to enable a full analysis of the sources of heterogeneity, but we were able to take into account age group and number of doses. </p> </section> <section id="CD004879-sec-0079"> <h4 class="title">Assessment of reporting biases</h4> <p>Due to the limited number of studies in each comparison, assessment of publication bias was not applicable. </p> <p>The overall quality of retrieved studies was poor and was affected by poor reporting or limited descriptions of the design of the studies. </p> <p>A detailed description is provided in the <a href="#CD004879-sec-0117">Quality of the evidence</a> section of the review. </p> </section> <section id="CD004879-sec-0080"> <h4 class="title">Data synthesis</h4> <p>We carried out data synthesis separately for live and inactivated vaccines. We grouped studies for analysis according to study design: trials, cohort studies, and case‐controlled studies. </p> <p>Between‐trial variability is to be expected in influenza vaccine studies as there are unpredictable differences between effect estimates. We incorporated heterogeneity into the pooled estimates using the DerSimonian‐Laird random‐effects model. </p> <p>We used RRs of events for the comparisons of vaccine with placebo/control groups for RCTs and cohort studies and ORs for the single case‐controlled study. </p> <section id="CD004879-sec-0081"> <h5 class="title">GRADE and 'Summary of findings' table</h5> <p>We created a 'Summary of findings' table using the following outcomes: influenza, ILI, absence from school, parental leave from work, acute otitis media, hospitalisation, and nausea<i>.</i> We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to the studies that contributed data to the meta‐analyses for the prespecified outcomes (<a href="./references#CD004879-bbs2-0201" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">Atkins 2004</a>). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004879-bbs2-0218" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), employing GRADEpro GDT software (<a href="./references#CD004879-bbs2-0216" title="GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2014. ">GRADEpro GDT 2014</a>). We justified all decisions to downgrade the quality of studies using footnotes, and made comments to aid readers’ understanding of the review where necessary. </p> </section> </section> <section id="CD004879-sec-0082"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We carried out subgroup analyses by age group for trials and cohort and case‐control studies as follows: under 2 years (from 0 to 23 months); under 6 years (from 24 months to 6 years), and over 6 years of age. We selected the under‐2‐years‐of‐age group, as the CDC recommends vaccination for healthy children aged 6 to 23 months (<a href="./references#CD004879-bbs2-0206" title="Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Report2011;60(33):1128‐32. ">CDC 2011</a>; <a href="./references#CD004879-bbs2-0213" title="FioreAE , UyekiTM , BroderK , FinelliL , EulerGL , SingletonJA , et al. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report2010;59(RR‐8):1‐62. ">Fiore 2011</a>; <a href="./references#CD004879-bbs2-0217" title="HarperSA , FukudaK , UyekiTM , CoxNJ , BridgesCB , Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report2004;53(RR‐6):1‐40. ">Harper 2004</a>). The under 6 years and over 6 years categories reflected the most frequent stratification in primary studies. One comparison (Analysis 8), which includes rare outcomes, included both vaccine types (live and inactivated). However, we only considered the subgroup analyses. </p> </section> <section id="CD004879-sec-0083"> <h4 class="title">Sensitivity analysis</h4> <p>We performed three sensitivity analyses:</p> <p> <ul id="CD004879-list-0016"> <li> <p>excluding studies translated from Russian (<a href="#CD004879-tbl-0004">Table 2</a>); </p> </li> <li> <p>excluding studies with high risk of bias (<a href="#CD004879-tbl-0005">Table 3</a>); </p> </li> <li> <p>estimating effective sample sizes for cluster‐randomised studies contributing data to influenza and ILI outcomes where adjustment could be made for the effect of clustering. </p> </li> </ul> </p> <div class="table" id="CD004879-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analysis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Vaccine type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Study type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Age group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Without Russian studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Data sets</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Data sets</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio (random) (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio (random) (95% CI)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>01.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 (0.10 to 0.23)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 (0.10 to 0.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.47 (0.23 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.47 (0.23 to 0.97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18 (0.11 to 0.29)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18 (0.11 to 0.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>01.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.54 (0.12 to 2.42)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (0.57 to 0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12 (0.01 to 2.11)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (0.60 to 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 (0.10 to 1.48)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (0.62 to 0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>02.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.18 to 1.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.18 to 1.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.61 (0.34 to 1.08)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.61 (0.34 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.31 (0.22 to 0.45)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.31 (0.22 to 0.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.41 (0.29 to 0.59)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.41 (0.29 to 0.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>02.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 (0.21 to 0.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 (0.21 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.24 (0.08 to 0.70)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (0.66 to 0.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 (0.24 to 0.50)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (0.54 to 0.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>03.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56 (0.35 to 0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56 (0.35 to 0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>03.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>04.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.27 to 1.47)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.27 to 1.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 (0.13 to 0.89)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 (0.13 to 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.10 to 0.39)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36 (0.12 to 1.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36 (0.19 to 0.66)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (0.25 to 0.73)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>04.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40 (0.13 to 1.20)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (0.65 to 1.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.10 (0.05 to 0.21)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.44 (0.29 to 0.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26 (0.07 to 0.92)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.42 to 0.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval<br/> ILI: influenza‐like illness<br/> RCTs: randomised controlled trials<br/> *: significance change<br/> +: possible decision‐making significant change </p> </div> </div> <div class="table" id="CD004879-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">'Risk of bias' sensitivity analysis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Effect measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b>All data sets</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b>Excluding studies at high risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>VE absolute change</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Change effect measure direction</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Change in statistical significance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of data sets</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effect estimate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>UL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Statistical significance</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of data sets</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effect estimate*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>UL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Statistical significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 1.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 1.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.44</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.68</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐5%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 2.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.54</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 4.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.09</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media (all episodes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Working days lost (number of events, parents)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug prescriptions (number of events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients attendance for pneumonia and influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 6.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 6.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vs ILI (crude data)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged below 23 months ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 24 to 59 months ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6 to 59 months ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged below 14 years old ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.06</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.06</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness vs no symptoms</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary cases</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>School absenteeism</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower respiratory tract disease</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.54</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.08</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐32%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.17</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐3%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospitalisation due to acute otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.7.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated vaccine (2 doses)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Consequences of acute otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.8.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated vaccine, 2 doses (the arm of the trial) visits (the outcome measure)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.8.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated vaccine (2 doses; courses of antibiotics</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients attendance for pneumonia and influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.75</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Working days lost (number of events, parents of children 6 to 36 months of age)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.71</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐14%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug prescriptions (number of events, 6 to 36 months of age)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval<br/> ILI: influenza‐like illness<br/> LL: lower limit<br/> NA: not applicable<br/> RR: risk ratio<br/> UL: upper limit<br/> VE: vaccine efficacy/effectiveness<br/> VE absolute change = (1 ‐ RR*) ‐ (1 ‐ RR)<br/> *: effect estimate excluding data sets at high risk of bias </p> </div> </div> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004879-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004879-sec-0084"></div> <section id="CD004879-sec-0085"> <h3 class="title">Description of studies</h3> <section id="CD004879-sec-0086"> <h4 class="title">Results of the search</h4> <p>Past searches identified 8340 records, corresponding to 8814 citations (after removal of duplicates). We screened 8814 records and excluded 8620 records based on the title and abstract. We retrieved the full text of 195 papers and excluded 107 papers (reasons are summarised in the <a href="#CD004879-sec-0092">Excluded studies</a> section and the <a href="./references#CD004879-sec-0160" title="">Characteristics of excluded studies</a> tables). We finally included 77 papers. Eleven papers are in Studies awaiting classification, as some data are not presented in the papers (<a href="#CD004879-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD004879-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD004879-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We updated the searches in December 2016, identifying 2295 records (after removal of duplicates). After screening of title and abstracts, we retrieved the full text of seven citations for evaluation. We excluded five new trials (see <a href="./references#CD004879-sec-0160" title="">Characteristics of excluded studies</a>) and included two new trials. The updated version of the review includes 41 clinical trials with over 200,000 observations. </p> <p>Trial register searches identified 18 completed trials with one or more corresponding publications, reporting methods, and study design. All 18 trials had been identified and dealt with appropriately in our searches of journal publication databases. </p> <p>In this 2016 updated review we included only new RCTs. We are no longer updating searches for observational comparative studies, which were included previously. </p> </section> <section id="CD004879-sec-0087"> <h4 class="title">Included studies</h4> <p>We have coded each trial on the basis of study design and type of data contributed to the review as follows. </p> <p>The first letter before the study represents study design: 'a' denotes RCT, 'b' denotes case‐control study, and 'c' denotes cohort study. The second letter indicates the contribution to the evidence in the efficacy/effectiveness data set (letter a) or harms (letter b). So, for example, a case‐control study contributing safety or harms data is coded as bb, and a trial contributing efficacy/effectiveness data is coded as aa. </p> <p>This review consists of 41 RCTs/CCTs (48 data sets), 12 case‐control studies (16 data sets), and 21 cohort studies (25 data sets). Eight trials (<a href="./references#CD004879-bbs2-0012" title="Grigor'evaEP , DeshevaI , DoninaSA , NaikhinAN , RekstinAR , BarantsevaIB , et al. The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7‐14 years. Voprosy Virusologii2002;47(4):24‐7. ">aa Grigor'eva 2002</a>; <a href="./references#CD004879-bbs2-0022" title="RudenkoLG , Vasil'evaRI , IsmagulovAT , KaragodinaVI , SlepushkinAN , DoroshenkoEM , et al. Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3‐14 years. Voprosy Virusologii1996;41:37‐9. ">aa Rudenko 1996b</a>; <a href="./references#CD004879-bbs2-0029" title="DeshevaI , DaniniGV , Grigor'evaEP , DoninaSA , KiselevaIV , RekstinAR , et al. The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3‐6 year old children. Voprosy Virusologii2002;47(4):21‐4. ">ab Desheva 2002</a>; <a href="./references#CD004879-bbs2-0030" title="Grigor'evaEP , RekstinAR , RudenkoLG , RamirezA , BarroM , LisovskaiaKV , et al. The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old. Voprosy Virusologii1994;39(1):26‐9. ">ab Grigor'eva 1994</a>; <a href="./references#CD004879-bbs2-0039" title="RudenkoLG , RamirezA , BarroM , GushchinaMI , ArmandaRE , ErmachenkoTA , et al. The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14. Voprosy Virusologii1991;36(6):472‐4. ">ab Rudenko 1991</a>; <a href="./references#CD004879-bbs2-0040" title="SlepushkinAN , DukovaVS , KalegaevaVA , KaganAN , TemriukEE . Results of studying the effectiveness of a live influenza vaccine for peroral use on preschool and schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1974;12:24‐9. ">ab Slepushkin 1974</a>; <a href="./references#CD004879-bbs2-0042" title="SlepushkinAN , Obrosova‐SerovaNP , BurtsevaEI , GovorkovaEA , RudenkoLG , VartanianRV , et al. A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):372‐4. ">ab Slepushkin 1991</a>; <a href="./references#CD004879-bbs2-0046" title="Vasil'evaRI , Merkur'evaLA , LatsenkoVG , Vasil'evaAM , ShvagerMM . Characteristics of the clinical and immunologic safety of inactivated influenza vaccines in children undergoing multiple immunizations. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;11:65‐9. ">ab Vasil'eva 1988a</a>), eight cohort studies (<a href="./references#CD004879-bbs2-0018" title="RudenkoLG , Grigor'evaEP , DrinevskiiVP , Koval'TA , DoroshenkoEM . Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;5:41‐6. ">aa Rudenko 1988</a>; <a href="./references#CD004879-bbs2-0047" title="Vasil'evaRI , SmirnovaLA , RudenkoLG , DrinevskiiVP , TsaritsinaIM . The results of state trials of inactivated influenza vaccines for children. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;3:49‐54. ">ab Vasil'eva 1988b</a>; <a href="./references#CD004879-bbs2-0067" title="BurtsevaEI , Obrosova‐SerovaNP , GovorkovaEA , RudenkoLG , VartanianRV , BeliaevAL , et al. A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):375‐7. ">ca Burtseva 1991</a>; <a href="./references#CD004879-bbs2-0068" title="BashliaevaZA , SumarokovAA , NefedovaLA , IaroshevskaiaII , OzeretskovskaiaNA . Basic results of a committee trial of the new vaccine Grippovac SE‐AZh. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1986;2:49‐54. ChumakovMP , BoikoVM , MalyshkinaLP , Mel'nikovaSK , RodinVI . Results of coded trials of the activity of the trivalent subunit influenza vaccine Grippovak in Moscow kindergartens in December 1983 through the 1st quarter of 1984. Voprosy Virusologii1987;32(2):175‐83. ">ca Chumakov 1987</a>; <a href="./references#CD004879-bbs2-0069" title="El'shinaGA , GorbunovMA , BektimirovTA , LonskaiaNI , PavlovaLI , Nikul'shinAA , et al. The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer‐subunit influenza vaccine administered to schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2000;2:50‐4. ">ca El'shina 2000</a>; <a href="./references#CD004879-bbs2-0081" title="SlobodniukAV , RomanenkoVV , UtnitskaiaOS , MotusTM , PereverzevAV . Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2002;4:36‐9. ">ca Slobodniuk 2002a</a>; <a href="./references#CD004879-bbs2-0084" title="Vasil'evaRI , OsidakLV , BichurinaMA , MukhinaLP , ChudinaLV . Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1982;4:96‐8. ">ca Vasil'eva 1982</a>; <a href="./references#CD004879-bbs2-0090" title="SlepushkinAN , RudenkoLG , KendalAP , MontoAS , BeliaevAL , BurtsevaEI , et al. A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity. Voprosy Virusologii1994;39:129‐31. ">cb Slepushkin 1994</a>), and one CCT were translated from the Russian (<a href="./references#CD004879-bbs2-0027" title="AksenovVA , SelidovkinDA , SorokinaLV , BurnosAS , SorokinaAG . The effectiveness of influenza prevention with a special variation of live influenza vaccine for children in the 1969 epidemic. Voprosy Virusologii1971;16:81‐6. ">ab Aksenov 1971</a>). We sent six requests to trial authors for further data (split by age); two trial authors provided the requested data. In this 2016 update, we included two new trials (<a href="./references#CD004879-bbs2-0008" title="BrooksWA , ZamanK , LewisKD , OrtizJR , GoswamiD , FeserJ , et al. Efficacy of a Russian‐backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double‐blind, placebo‐controlled trial. Lancet Global Health2016;4(12):e946‐54. ">aa Brooks 2016</a>; <a href="./references#CD004879-bbs2-0011" title="CowlingBJ , NgS , MaES , FangVJ , SoHC , WaiW , et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clinical Infectious Diseases2012;55(5):695‐702. ">aa Cowling 2012</a>). The <a href="./references#CD004879-bbs2-0011" title="CowlingBJ , NgS , MaES , FangVJ , SoHC , WaiW , et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clinical Infectious Diseases2012;55(5):695‐702. ">aa Cowling 2012</a> trial is included in <a href="#CD004879-tbl-0006">Table 4</a> because its design and reporting prevented us from including its results in our meta‐analysis. </p> <div class="table" id="CD004879-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Efficacy and effectiveness data from intra‐epidemic and non‐typical studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study reference</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exclusion reason</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RCT/cohort</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vaccine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>n treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>n control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nicholls 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort from community not representative of local population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nicholls 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort from community not representative of local population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 4 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nicholls 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort from community not representative of local population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 to 14 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Slepushkin 1974</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study of orally administered vaccine as emergency prophylaxis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live (oral) H2N2+B</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 3 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza or ARI &gt;= 10 days after vaccination</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>508</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>271</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>492</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ritzwoller 2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 23 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1129</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1615</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aksenov 1971</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live, H2N2+B, 3 doses 5 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 7 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza and ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>760</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>594</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aksenov 1971</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live, H2N2+B, 3 doses 8 to 10 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 7 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza and ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>728</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>674</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aksenov 1971</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live, H2N2+B, 3 doses 5 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 15 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza and ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1358</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>776</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cowling 2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TIV or saline placebo during the 2009–10 pandemic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 17 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>479</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ARI: acute respiratory infection<br/> ILI: influenza‐like illness<br/> RCT: randomised controlled trial<br/> TIV: trivalent influenza vaccine </p> </div> </div> <p>Included studies are classified below on the basis of the evidence provided. We included studies listed under 'Effectiveness and safety' and 'Effectiveness only' in our quantitative analysis. We included studies listed under 'Effectiveness and safety' and 'Safety only' in our qualitative analysis of vaccine safety only (see Adverse events section). </p> <section id="CD004879-sec-0088"> <h5 class="title">Effectiveness and safety</h5> <p> <ul id="CD004879-list-0017"> <li> <p><b>RCTs</b> (16 studies/22 data sets): </p> <ul id="CD004879-list-0018"> <li> <p><b>RCT‐cluster randomisation</b><i>:</i><a href="./references#CD004879-bbs2-0001" title="AlexandrovaGI , BudilovskyGN , KovalTA , PolezhaevFI , GarmashovaLM , GhendonYuZ , et al. Study of live recombinant cold‐adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine1986;4(2):114‐8. ">aa Alexandrova 1986</a>; <a href="./references#CD004879-bbs2-0009" title="CloverRD , CrawfordS , GlezenWP , TaberLH , MatsonCC , CouchRB . Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83‐like viruses. Journal of Infectious Diseases1991;163(2):300‐4. ">aa Clover 1991</a>; <a href="./references#CD004879-bbs2-0013" title="GruberWC , TaberLH , GlezenWP , CloverRD , AbellTD , DemmlerRW , et al. Live attenuated and inactivated influenza vaccine in school‐age children. American Journal of Diseases in Children1990;144(5):595‐600. ">aa Gruber 1990</a>; <a href="./references#CD004879-bbs2-0019" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993a</a>; <a href="./references#CD004879-bbs2-0020" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993b</a>; <a href="./references#CD004879-bbs2-0021" title="RudenkoLG , LonskayaNI , KlimovAI , VasilievaRI , RamirezA . Clinical and epidemiological evaluation of a live, cold‐adapted influenza vaccine for 3‐14‐year‐olds. Bulletin of the World Health Organization1996;74(1):77‐84. ">aa Rudenko 1996a</a>; <a href="./references#CD004879-bbs2-0022" title="RudenkoLG , Vasil'evaRI , IsmagulovAT , KaragodinaVI , SlepushkinAN , DoroshenkoEM , et al. Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3‐14 years. Voprosy Virusologii1996;41:37‐9. ">aa Rudenko 1996b</a>. </p> </li> <li> <p><b>RCT‐individual randomisation</b>: <a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>; <a href="./references#CD004879-bbs2-0003" title="BelsheRB , GruberWC , MendelmanPM , ChoI , ReisingerK , BlockSL , et al. Efficacy of vaccination with live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. Journal of Pediatrics2000;136(2):168‐75. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 2000a</a>; <a href="./references#CD004879-bbs2-0004" title="BeutnerKR , ChowT , RubiE , StrussenbergJ , ClementJ , OgraPL . Evaluation of a neuraminidase‐specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. Journal of Infectious Diseases1979;140(6):844‐50. ">aa Beutner 1979a</a>; <a href="./references#CD004879-bbs2-0005" title="BeutnerKR , ChowT , RubiE , StrussenbergJ , ClementJ , OgraPL . Evaluation of a neuraminidase‐specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. Journal of Infectious Diseases1979;140(6):844‐50. ">aa Beutner 1979b</a>; <a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>; <a href="./references#CD004879-bbs2-0007" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009b</a>; <a href="./references#CD004879-bbs2-0008" title="BrooksWA , ZamanK , LewisKD , OrtizJR , GoswamiD , FeserJ , et al. Efficacy of a Russian‐backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double‐blind, placebo‐controlled trial. Lancet Global Health2016;4(12):e946‐54. ">aa Brooks 2016</a>; <a href="./references#CD004879-bbs2-0010" title="ColomboC , ArgiolasL , LaVecchiaC , NegriE , MeloniG , MeloniT . Influenza vaccine in healthy preschool children. Revue d'Epidémiologie et de Santé Publique2001;49(2):157‐62. ">aa Colombo 2001</a>; <a href="./references#CD004879-bbs2-0012" title="Grigor'evaEP , DeshevaI , DoninaSA , NaikhinAN , RekstinAR , BarantsevaIB , et al. The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7‐14 years. Voprosy Virusologii2002;47(4):24‐7. ">aa Grigor'eva 2002</a>; <a href="./references#CD004879-bbs2-0016" title="KhanAS , PolezhaevF , VasiljevaR , DrinevskyV , BuffingtonJ , GaryH , et al. Comparison of US inactivated split‐virus and Russian live attenuated, cold‐adapted trivalent influenza vaccines in Russian schoolchildren. Journal of Infectious Diseases1996;173(2):453‐6. ">aa Khan 1996</a>; <a href="./references#CD004879-bbs2-0018" title="RudenkoLG , Grigor'evaEP , DrinevskiiVP , Koval'TA , DoroshenkoEM . Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;5:41‐6. ">aa Rudenko 1988</a>; <a href="./references#CD004879-bbs2-0023" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. ">aa Tam 2007a</a>; <a href="./references#CD004879-bbs2-0024" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. ">aa Tam 2007b</a>; <a href="./references#CD004879-bbs2-0025" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006a</a>; <a href="./references#CD004879-bbs2-0026" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006b</a>. </p> </li> </ul> </li> <li> <p><b>Prospective cohort</b> (5 studies/5 data sets): <a href="./references#CD004879-bbs2-0067" title="BurtsevaEI , Obrosova‐SerovaNP , GovorkovaEA , RudenkoLG , VartanianRV , BeliaevAL , et al. A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):375‐7. ">ca Burtseva 1991</a>; <a href="./references#CD004879-bbs2-0069" title="El'shinaGA , GorbunovMA , BektimirovTA , LonskaiaNI , PavlovaLI , Nikul'shinAA , et al. The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer‐subunit influenza vaccine administered to schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2000;2:50‐4. ">ca El'shina 2000</a>; <a href="./references#CD004879-bbs2-0072" title="KawaiN , IkematsuH , IwakiN , SatohI , KawashimaT , TsuchimotoT , et al. A prospective, Internet‐based study of the effectiveness and safety of influenza vaccination in the 2001‐2002 influenza season. Vaccine2003;21(31):4507‐13. ">ca Kawai 2003</a>; <a href="./references#CD004879-bbs2-0073" title="KingJCJr , StoddardJJ , GaglaniMJ , MooreKA , MagderL , McClureE , et al. Effectiveness of school‐based influenza vaccination. New England Journal of Medicine2006;355:2523‐32. ">ca King 2006</a>; <a href="./references#CD004879-bbs2-0084" title="Vasil'evaRI , OsidakLV , BichurinaMA , MukhinaLP , ChudinaLV . Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1982;4:96‐8. ">ca Vasil'eva 1982</a>. </p> </li> </ul> </p> </section> <section id="CD004879-sec-0089"> <h5 class="title">Effectiveness only</h5> <p> <ul id="CD004879-list-0019"> <li> <p><b>RCT</b> (2 studies/3 data sets): <a href="./references#CD004879-bbs2-0014" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA2003;290(12):1608‐16. ">aa Hoberman 2003a</a>; <a href="./references#CD004879-bbs2-0015" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA2003;290(12):1608‐16. ">aa Hoberman 2003b</a>; <a href="./references#CD004879-bbs2-0017" title="PrincipiN , EspositoS , MarchisioP , GaspariniR , CrovariP . Socioeconomic impact of influenza on healthy children and their families. Pediatric Infectious Disease Journal2003;22(Suppl 10):207‐10. ">aa Principi 2003</a>. </p> </li> <li> <p><b>Prospective cohort</b> (9 studies/11 data sets): <a href="./references#CD004879-bbs2-0068" title="BashliaevaZA , SumarokovAA , NefedovaLA , IaroshevskaiaII , OzeretskovskaiaNA . Basic results of a committee trial of the new vaccine Grippovac SE‐AZh. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1986;2:49‐54. ChumakovMP , BoikoVM , MalyshkinaLP , Mel'nikovaSK , RodinVI . Results of coded trials of the activity of the trivalent subunit influenza vaccine Grippovak in Moscow kindergartens in December 1983 through the 1st quarter of 1984. Voprosy Virusologii1987;32(2):175‐83. ">ca Chumakov 1987</a>; <a href="./references#CD004879-bbs2-0070" title="FujiedaM , MaedaA , KondoK , KajiM , HirotaY . Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002‐2003 season. Vaccine2006;24(7):957‐63. ">ca Fujieda 2006</a>; <a href="./references#CD004879-bbs2-0071" title="JianpingH , XinF , ChangshunL , BoZ , LinxiuG , WeiX , et al. Assessment of effectiveness of Vaxigrip. Vaccine1999;17(Suppl 1):57‐8. ">ca Jianping 1999</a>; <a href="./references#CD004879-bbs2-0074" title="MaedaT , ShintaniY , MiyamotoH , KawagoeH , NakanoK , NishiyamaA , et al. Prophylactic effect of inactivated influenza vaccine on young children. Pediatrics International2002;44(1):43‐6. ">ca Maeda 2002</a>; <a href="./references#CD004879-bbs2-0075" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. ">ca Maeda 2004a</a>; <a href="./references#CD004879-bbs2-0076" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. ">ca Maeda 2004b</a>; <a href="./references#CD004879-bbs2-0077" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. ">ca Maeda 2004c</a>; <a href="./references#CD004879-bbs2-0079" title="OzgurSK , BeyazovaU , KemalogluYK , MaralI , SahinF , CamurdanAD , et al. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children. Pediatric Infectious Disease Journal2006;25(5):401‐4. ">ca Ozgur 2006</a>; <a href="./references#CD004879-bbs2-0080" title="SallerasL , DominguezA , PumarolaT , PratA , MarcosMA , GarridoP , et al. Effectiveness of virosomal subunit influenza vaccine in preventing influenza‐related illnesses and its social and economic consequences in children aged 3‐14 years: a prospective cohort study. Vaccine2006;24(44‐6):6638‐42. ">ca Salleras 2006</a>; <a href="./references#CD004879-bbs2-0085" title="Wiggs‐StaynerKS , PurdyTR , GoGN , McLaughlinNC , TryzynkaPS , SinesJR , et al. The impact of mass school immunization on school attendance. Journal of School of Nursing2006;22(4):219‐22. ">ca Wiggs‐Stayner 2006</a>; <a href="./references#CD004879-bbs2-0086" title="YinJK , LahraMM , IskanderM , LambertSB , HeronL , NissenMD , et al. Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare. Journal of Paediatrics and Child Health2011;47(12):857‐62. ">ca Yin 2011</a>. </p> </li> <li> <p><b>Pandemic prospective cohort</b> (1 study/1 data set): <a href="./references#CD004879-bbs2-0078" title="OrtqvistA , BerggrenI , InsulanderM , DeJongB , SvenungssonB . Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A (H1N1)v, in Stockholm County, Sweden. Clinical Infectious Diseases2011;52(10):1203‐11. ">ca Ortqvist 2011</a>. </p> </li> <li> <p><b>Retrospective cohort</b> (2 studies/4 data sets): <a href="./references#CD004879-bbs2-0066" title="AllisonMA , DaleyMF , CraneLA , BarrowJ , BeatyBL , AllredN , et al. Influenza vaccine effectiveness in healthy 6‐ to 21‐month‐old children during the 2003‐2004 season. Journal of Pediatrics2006;149(6):755‐62. ">ca Allison 2006</a>; <a href="./references#CD004879-bbs2-0081" title="SlobodniukAV , RomanenkoVV , UtnitskaiaOS , MotusTM , PereverzevAV . Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2002;4:36‐9. ">ca Slobodniuk 2002a</a>; <a href="./references#CD004879-bbs2-0082" title="SlobodniukAV , RomanenkoVV , UtnitskaiaOS , MotusTM , PereverzevAV . Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2002;4:36‐9. ">ca Slobodniuk 2002b</a>; <a href="./references#CD004879-bbs2-0083" title="SlobodniukAV , RomanenkoVV , UtnitskaiaOS , MotusTM , PereverzevAV . Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2002;4:36‐9. ">ca Slobodniuk 2002c</a>. </p> </li> <li> <p><b>Case‐contro</b>l (7 studies/11 data sets): <a href="./references#CD004879-bbs2-0050" title="Effectiveness of vaccine against medical consultation due to laboratory‐confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004‐2005. Canada Communicable Disease Report2005;31(18):181‐91. ">ba Anonymous 2005</a>; <a href="./references#CD004879-bbs2-0051" title="CochranLW , BlackS , KleinNP , DekkerCL , LewisE , ReingoldAL . Vaccine effectiveness against laboratory‐confirmed influenza in infants: a matched case control study. Human Vaccines2010;6(9):729‐35. ">ba Cochran 2010a</a>; <a href="./references#CD004879-bbs2-0052" title="CochranLW , BlackS , KleinNP , DekkerCL , LewisE , ReingoldAL . Vaccine effectiveness against laboratory‐confirmed influenza in infants: a matched case control study. Human Vaccines2010;23(6):729‐35. ">ba Cochran 2010b</a>; <a href="./references#CD004879-bbs2-0053" title="CochranLW , BlackS , KleinNP , DekkerCL , LewisE , ReingoldAL . Vaccine effectiveness against laboratory‐confirmed influenza in infants: a matched case control study. Human Vaccines2010;23(6):729‐35. ">ba Cochran 2010c</a>; <a href="./references#CD004879-bbs2-0054" title="EisenbergKW , SzilagyiPG , FairbrotherG , GriffinMR , StaatM , ShoneLP , et al. Vaccine effectiveness against laboratory‐confirmed influenza in children 6 to 59 months of age during the 2003‐2004 and 2004‐2005 influenza seasons. Pediatrics2008;122(5):911‐9. ">ba Eisenberg 2008a</a>; <a href="./references#CD004879-bbs2-0055" title="EisenbergKW , SzilagyiPG , FairbrotherG , GriffinMR , StaatM , ShoneLP , et al. Vaccine effectiveness against laboratory‐confirmed influenza in children 6 to 59 months of age during the 2003‐2004 and 2004‐2005 influenza seasons. Pediatrics2008;122(5):911‐9. ">ba Eisenberg 2008b</a>; <a href="./references#CD004879-bbs2-0057" title="HirotaY , TakeshitaS , IdeS , KataokaK , OhkuboA , FukuyoshiS , et al. Various factors associated with the manifestation of influenza‐like illness. International Journal of Epidemiology1992;21(3):574‐82. ">ba Hirota 1992</a>; <a href="./references#CD004879-bbs2-0058" title="KellyH , JacobyP , DixonGA , CarcioneD , WilliamsS , MooreHC , et al. Vaccine effectiveness against laboratory‐confirmed influenza in healthy young children: a case‐control study. Pediatric Infectious Disease Journal2011;30(2):107‐11. ">ba Kelly 2011</a>; <a href="./references#CD004879-bbs2-0059" title="KisslingE , ValencianoM , CohenJM , OrosziB , BarretAS , RizzoC , et al. I‐MOVE multi‐centre case control study 2010‐11: overall and stratified estimates of influenza vaccine effectiveness in Europe. Eurosurveillance2011;6(11):19818. ">ba Kissling 2011</a>; <a href="./references#CD004879-bbs2-0061" title="StaatMA , GriffinMR , DonauerS , EdwardsKM , SzilagyiPG , WeinbergGA , et al. Vaccine effectiveness for laboratory‐confirmed influenza in children 6‐59 months of age, 2005‐2007. Vaccine2011;29(48):9005‐11. ">ba Staat 2011a</a>; <a href="./references#CD004879-bbs2-0062" title="StaatMA , GriffinMR , DonauerS , EdwardsKM , SzilagyiPG , WeinbergGA , et al. Vaccine effectiveness for laboratory‐confirmed influenza in children 6‐59 months of age, 2005‐2007. Vaccine2011;29(48):9005‐11. ">ba Staat 2011b</a>. </p> </li> <li> <p><b>Pandemic case‐control</b> (4 studies/4 data sets): <a href="./references#CD004879-bbs2-0056" title="GilcaR , DeceuninckG , DeSerresG , BoulianneN , SauvageauC , QuachC , et al. Effectiveness of pandemic H1N1 vaccine against influenza‐related hospitalization in children. Pediatrics2011;128(5):e1084‐91. ">ba Gilca 2011</a>; <a href="./references#CD004879-bbs2-0060" title="MahmudS , HammondG , ElliottL , HildermanT , KurbisC , CaetanoP , et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory‐confirmed H1N1 infections: population‐based case‐control study. Vaccine2011;29(45):7975‐81. ">ba Mahmud 2011</a>; <a href="./references#CD004879-bbs2-0063" title="ValencianoM , KisslingE , CohenJM , OrosziB , BarretAS , RizzoC , et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009‐2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I‐MOVE) multicentre case‐control study. PLoS Medicine2011;8(1):e1000388. ">ba Valenciano 2011</a>; <a href="./references#CD004879-bbs2-0064" title="VanBuynderPG , DhaliwalJK , VanBuynderJL , CouturierC , Minville‐LeblancM , GarceauR , et al. Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children. Influenza and Other Respiratory Viruses2010;4(4):171‐8. ">ba Van Buynder 2010</a>. </p> </li> </ul> </p> </section> <section id="CD004879-sec-0090"> <h5 class="title">Safety only</h5> <p> <ul id="CD004879-list-0020"> <li> <p><b>RCT</b> (21 studies/21 data sets): <a href="./references#CD004879-bbs2-0028" title="BelsheRB , SwierkoszEM , AndersonEL , NewmanFK , NugentSL , MaassabHF . Immunization of infants and young children with live attenuated trivalent cold‐recombinant influenza A H1N1, H3N2, and B vaccine. Journal of Infectious Diseases1992;165(4):727‐32. ">ab Belshe 1992</a>; <a href="./references#CD004879-bbs2-0029" title="DeshevaI , DaniniGV , Grigor'evaEP , DoninaSA , KiselevaIV , RekstinAR , et al. The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3‐6 year old children. Voprosy Virusologii2002;47(4):21‐4. ">ab Desheva 2002</a>; <a href="./references#CD004879-bbs2-0030" title="Grigor'evaEP , RekstinAR , RudenkoLG , RamirezA , BarroM , LisovskaiaKV , et al. The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old. Voprosy Virusologii1994;39(1):26‐9. ">ab Grigor'eva 1994</a>; <a href="./references#CD004879-bbs2-0031" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth‐Ayerst ca Influenza Vaccine Investigators Group. Journal of Infectious Diseases1996;173(6):1313‐9. ">ab Gruber 1996</a>; <a href="./references#CD004879-bbs2-0032" title="GruberWC , DardenPM , StillJG , LohrJ , ReedG , WrightPF . Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose‐response. Vaccine1997;15(12‐3):1379‐84. ">ab Gruber 1997</a>; <a href="./references#CD004879-bbs2-0033" title="GutmanLT , WilfertCM , IdrissZH , SchmidtE , AndrewsS , KatzSL . Single‐dose trials of monovalent A/New Jersey/76 (Hsw1N1) influenza virus vaccine in children in Durham, North Carolina. Journal of Infectious Diseases1977;136(Suppl):575‐8. ">ab Gutman 1977</a>; <a href="./references#CD004879-bbs2-0034" title="KingJCJr , LagosR , BernsteinDI , PiedraPA , KotloffK , BryantM , et al. Safety and immunogenicity of low and high doses of trivalent live cold‐adapted influenza vaccine administered intranasally as drops or spray to healthy children. Journal of Infectious Diseases1998;17(5):1394‐7. ">ab King 1998</a>; <a href="./references#CD004879-bbs2-0035" title="LevineMM , HughesTP , SimonP , O'DonnellS , GrauelS , LevineSG . Monovalent inactivated A/New Jersey/8/76 (Hsw1N1) vaccine in healthy children aged three to five years. Journal of Infectious Diseases1977;136(Suppl):571‐4. ">ab Levine 1977</a>; <a href="./references#CD004879-bbs2-0036" title="MalloryRM , MalkinE , AmbroseCS , BellamyT , ShiL , YiT , et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE2010;5(10):e13755. ">ab Mallory 2010</a>; <a href="./references#CD004879-bbs2-0037" title="Obrosova‐SerovaNP , SlepushkinAN , KendalAP , HarmonMW , BurtsevaEI , BebeshevaNI , et al. Evaluation in children of cold‐adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild‐type B/Ann Arbor/1/86 and cold‐adapted B/Leningrad/14/55 viruses. Vaccine1990;8(1):57‐60. ">ab Obrosova‐Serova 1990</a>; <a href="./references#CD004879-bbs2-0038" title="PlennevauxE , BlatterM , CornishMJ , GoK , KirbyD , WaliM , et al. Influenza A (H1N1) 2009 two‐dose immunization of US children: an observer‐blinded, randomized, placebo‐controlled trial. Vaccine2011;29(8):1569‐75. ">ab Plennevaux 2011</a>; <a href="./references#CD004879-bbs2-0039" title="RudenkoLG , RamirezA , BarroM , GushchinaMI , ArmandaRE , ErmachenkoTA , et al. The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14. Voprosy Virusologii1991;36(6):472‐4. ">ab Rudenko 1991</a>; <a href="./references#CD004879-bbs2-0041" title="SlepushkinAN , PatriarcaPA , Obrosova‐SerovaNP , HarmonMW , KupryashinaLN , CheshikSG , et al. Class‐specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)‐like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold‐adapted donor strain. Vaccine1988;6(1):25‐8. ">ab Slepushkin 1988</a>; <a href="./references#CD004879-bbs2-0042" title="SlepushkinAN , Obrosova‐SerovaNP , BurtsevaEI , GovorkovaEA , RudenkoLG , VartanianRV , et al. A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):372‐4. ">ab Slepushkin 1991</a>; <a href="./references#CD004879-bbs2-0043" title="SteinhoffMC , HalseyNA , WilsonMH , BurnsBA , SamorodinRK , FriesLF , et al. Comparison of live attenuated cold‐adapted and avian‐human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. Journal of Infectious Diseases1990;162(2):394‐401. ">ab Steinhoff 1990</a>; <a href="./references#CD004879-bbs2-0044" title="SteinhoffMC , HalseyNA , FriesLF , WilsonMH , KingJ , BurnsBA , et al. The A/Mallard/6750/78 avian‐human, but not the A/Ann Arbor/6/60 cold‐adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. Journal of Infectious Diseases1991;163(5):1023‐8. ">ab Steinhoff 1991</a>; <a href="./references#CD004879-bbs2-0045" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. ">ab Swierkosz 1994</a>; <a href="./references#CD004879-bbs2-0046" title="Vasil'evaRI , Merkur'evaLA , LatsenkoVG , Vasil'evaAM , ShvagerMM . Characteristics of the clinical and immunologic safety of inactivated influenza vaccines in children undergoing multiple immunizations. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;11:65‐9. ">ab Vasil'eva 1988a</a>; <a href="./references#CD004879-bbs2-0047" title="Vasil'evaRI , SmirnovaLA , RudenkoLG , DrinevskiiVP , TsaritsinaIM . The results of state trials of inactivated influenza vaccines for children. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;3:49‐54. ">ab Vasil'eva 1988b</a>; <a href="./references#CD004879-bbs2-0048" title="WrightPF , SellSH , ThompsonJ , KarzonDT . Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. Journal of Pediatrics1976;88(1):31‐5. ">ab Wright 1976a</a>; <a href="./references#CD004879-bbs2-0049" title="ZangwillKM , DrogeJ , MendelmanP , MarcySM , PartridgeS , ChiuCY , et al. Prospective, randomized, placebo‐controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Pediatic Infectious Disease Journal2001;20(8):740‐6. ">ab Zangwill 2001</a>. </p> </li> <li> <p><b>Prospective cohort</b> (1 study/1 data set): <a href="./references#CD004879-bbs2-0090" title="SlepushkinAN , RudenkoLG , KendalAP , MontoAS , BeliaevAL , BurtsevaEI , et al. A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity. Voprosy Virusologii1994;39:129‐31. ">cb Slepushkin 1994</a>. </p> </li> <li> <p><b>Pandemic prospective cohort</b> (1 study/1 data set): <a href="./references#CD004879-bbs2-0087" title="MPA . Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations – results of a case inventory study by the MPA in Sweden during 2009–2010. www.lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport pandermrix 110630.pdf (accessed 10 January 2012). ">cb MPA 2011</a>. </p> </li> <li> <p><b>Case‐control</b> (1 study/1 data set): <a href="./references#CD004879-bbs2-0065" title="GoodmanMJ , NordinJD , HarperP , DeforT , ZhouX . The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age. Pediatrics2006;117(5):821‐6. ">bb Goodman 2006</a>. </p> </li> </ul> </p> </section> <section id="CD004879-sec-0091"> <h5 class="title">Interepidemic studies</h5> <p> <ul id="CD004879-list-0021"> <li> <p><b>RCT</b> (2 studies/2 data sets): <a href="./references#CD004879-bbs2-0011" title="CowlingBJ , NgS , MaES , FangVJ , SoHC , WaiW , et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clinical Infectious Diseases2012;55(5):695‐702. ">aa Cowling 2012</a>; <a href="./references#CD004879-bbs2-0040" title="SlepushkinAN , DukovaVS , KalegaevaVA , KaganAN , TemriukEE . Results of studying the effectiveness of a live influenza vaccine for peroral use on preschool and schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1974;12:24‐9. ">ab Slepushkin 1974</a>. </p> </li> <li> <p><b>CCT</b> (1 study/1 data set): <a href="./references#CD004879-bbs2-0027" title="AksenovVA , SelidovkinDA , SorokinaLV , BurnosAS , SorokinaAG . The effectiveness of influenza prevention with a special variation of live influenza vaccine for children in the 1969 epidemic. Voprosy Virusologii1971;16:81‐6. ">ab Aksenov 1971</a>. </p> </li> <li> <p><b>Retrospective cohort</b> (2 studies/2 data sets): <a href="./references#CD004879-bbs2-0088" title="NichollsS , CarrollK , CroftsJ , Ben‐EliezerE , PaulJ , ZambonM , et al. Outbreak of influenza A (H3N2) in a highly‐vaccinated religious community: a retrospective cohort study. Communicable Disease and Public Health2004;7:272‐7. ">cb Nicholls 2004</a>; <a href="./references#CD004879-bbs2-0089" title="RitzwollerDP , BridgesCB , ShetterlyS , YamasakiK , KolczakM , FranceEK . Effectiveness of the 2003‐2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics2005;116(1):153‐9. ">cb Ritzwoller 2005</a>. </p> </li> </ul> </p> <p>Readers are reminded that one study may provide multiple data sets (e.g. <a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>; <a href="./references#CD004879-bbs2-0007" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009b</a>). </p> </section> </section> <section id="CD004879-sec-0092"> <h4 class="title">Excluded studies</h4> <p>We excluded 107 studies mainly because they were non‐comparative; had not been carried out in healthy children; had assessed the impact of vaccinating children to prevent influenza in the elderly; or presented only serological outcome or data published in studies already included in this review (See <a href="./references#CD004879-sec-0160" title="">Characteristics of excluded studies</a> tables). </p> </section> </section> <section id="CD004879-sec-0093"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD004879-sec-0094"> <h4 class="title">Randomised controlled trials/comparative controlled trials</h4> <p>We included 18 trials (corresponding to 25 data sets) in the vaccine efficacy or effectiveness analyses. We classified six RCTs (nine data sets) as having low risk of bias (<a href="./references#CD004879-bbs2-0001" title="AlexandrovaGI , BudilovskyGN , KovalTA , PolezhaevFI , GarmashovaLM , GhendonYuZ , et al. Study of live recombinant cold‐adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine1986;4(2):114‐8. ">aa Alexandrova 1986</a>; <a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>; (<a href="./references#CD004879-bbs2-0004" title="BeutnerKR , ChowT , RubiE , StrussenbergJ , ClementJ , OgraPL . Evaluation of a neuraminidase‐specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. Journal of Infectious Diseases1979;140(6):844‐50. ">aa Beutner 1979a</a>; <a href="./references#CD004879-bbs2-0005" title="BeutnerKR , ChowT , RubiE , StrussenbergJ , ClementJ , OgraPL . Evaluation of a neuraminidase‐specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. Journal of Infectious Diseases1979;140(6):844‐50. ">aa Beutner 1979b</a>); <a href="./references#CD004879-bbs2-0008" title="BrooksWA , ZamanK , LewisKD , OrtizJR , GoswamiD , FeserJ , et al. Efficacy of a Russian‐backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double‐blind, placebo‐controlled trial. Lancet Global Health2016;4(12):e946‐54. ">aa Brooks 2016</a>; (<a href="./references#CD004879-bbs2-0014" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA2003;290(12):1608‐16. ">aa Hoberman 2003a</a>; <a href="./references#CD004879-bbs2-0015" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA2003;290(12):1608‐16. ">aa Hoberman 2003b</a>); (<a href="./references#CD004879-bbs2-0023" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. ">aa Tam 2007a</a>; <a href="./references#CD004879-bbs2-0024" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. ">aa Tam 2007b</a>)). Two RCTs reported data from two influenza seasons. In both cases we classified the first season as at low risk of bias (two data sets) (<a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>; <a href="./references#CD004879-bbs2-0025" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006a</a>), whereas we classified the second season for both studies (two data sets) as at high risk of bias (<a href="./references#CD004879-bbs2-0007" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009b</a>; <a href="./references#CD004879-bbs2-0026" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006b</a>). We assessed five RCTs (five data sets) as at unclear risk of bias for one or more key domains, there being plausible bias raising some doubts about the results (<a href="./references#CD004879-bbs2-0009" title="CloverRD , CrawfordS , GlezenWP , TaberLH , MatsonCC , CouchRB . Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83‐like viruses. Journal of Infectious Diseases1991;163(2):300‐4. ">aa Clover 1991</a>; <a href="./references#CD004879-bbs2-0012" title="Grigor'evaEP , DeshevaI , DoninaSA , NaikhinAN , RekstinAR , BarantsevaIB , et al. The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7‐14 years. Voprosy Virusologii2002;47(4):24‐7. ">aa Grigor'eva 2002</a>; <a href="./references#CD004879-bbs2-0013" title="GruberWC , TaberLH , GlezenWP , CloverRD , AbellTD , DemmlerRW , et al. Live attenuated and inactivated influenza vaccine in school‐age children. American Journal of Diseases in Children1990;144(5):595‐600. ">aa Gruber 1990</a>; <a href="./references#CD004879-bbs2-0016" title="KhanAS , PolezhaevF , VasiljevaR , DrinevskyV , BuffingtonJ , GaryH , et al. Comparison of US inactivated split‐virus and Russian live attenuated, cold‐adapted trivalent influenza vaccines in Russian schoolchildren. Journal of Infectious Diseases1996;173(2):453‐6. ">aa Khan 1996</a>; <a href="./references#CD004879-bbs2-0017" title="PrincipiN , EspositoS , MarchisioP , GaspariniR , CrovariP . Socioeconomic impact of influenza on healthy children and their families. Pediatric Infectious Disease Journal2003;22(Suppl 10):207‐10. ">aa Principi 2003</a>). Finally, we considered five RCTs (seven data sets) to be at high risk of bias (<a href="./references#CD004879-bbs2-0003" title="BelsheRB , GruberWC , MendelmanPM , ChoI , ReisingerK , BlockSL , et al. Efficacy of vaccination with live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. Journal of Pediatrics2000;136(2):168‐75. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 2000a</a>; <a href="./references#CD004879-bbs2-0010" title="ColomboC , ArgiolasL , LaVecchiaC , NegriE , MeloniG , MeloniT . Influenza vaccine in healthy preschool children. Revue d'Epidémiologie et de Santé Publique2001;49(2):157‐62. ">aa Colombo 2001</a>; <a href="./references#CD004879-bbs2-0018" title="RudenkoLG , Grigor'evaEP , DrinevskiiVP , Koval'TA , DoroshenkoEM . Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;5:41‐6. ">aa Rudenko 1988</a>; (<a href="./references#CD004879-bbs2-0019" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993a</a>; <a href="./references#CD004879-bbs2-0020" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993b</a>); (<a href="./references#CD004879-bbs2-0021" title="RudenkoLG , LonskayaNI , KlimovAI , VasilievaRI , RamirezA . Clinical and epidemiological evaluation of a live, cold‐adapted influenza vaccine for 3‐14‐year‐olds. Bulletin of the World Health Organization1996;74(1):77‐84. ">aa Rudenko 1996a</a>; <a href="./references#CD004879-bbs2-0022" title="RudenkoLG , Vasil'evaRI , IsmagulovAT , KaragodinaVI , SlepushkinAN , DoroshenkoEM , et al. Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3‐14 years. Voprosy Virusologii1996;41:37‐9. ">aa Rudenko 1996b</a>)). Overall, out of 25 data sets providing evidence of efficacy and effectiveness, 44% (11/25) were at low risk of bias; 20% (5/25) had an unclear risk of bias; and 36% (9/25) were at high risk of bias (<a href="#CD004879-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD004879-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004879-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>We included 23 RCTs/CCTs (corresponding to 23 data sets) reporting vaccine safety outcome only. We assessed five RCTs as at low risk of bias (<a href="./references#CD004879-bbs2-0029" title="DeshevaI , DaniniGV , Grigor'evaEP , DoninaSA , KiselevaIV , RekstinAR , et al. The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3‐6 year old children. Voprosy Virusologii2002;47(4):21‐4. ">ab Desheva 2002</a>; <a href="./references#CD004879-bbs2-0035" title="LevineMM , HughesTP , SimonP , O'DonnellS , GrauelS , LevineSG . Monovalent inactivated A/New Jersey/8/76 (Hsw1N1) vaccine in healthy children aged three to five years. Journal of Infectious Diseases1977;136(Suppl):571‐4. ">ab Levine 1977</a>; <a href="./references#CD004879-bbs2-0036" title="MalloryRM , MalkinE , AmbroseCS , BellamyT , ShiL , YiT , et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE2010;5(10):e13755. ">ab Mallory 2010</a>; <a href="./references#CD004879-bbs2-0038" title="PlennevauxE , BlatterM , CornishMJ , GoK , KirbyD , WaliM , et al. Influenza A (H1N1) 2009 two‐dose immunization of US children: an observer‐blinded, randomized, placebo‐controlled trial. Vaccine2011;29(8):1569‐75. ">ab Plennevaux 2011</a>; <a href="./references#CD004879-bbs2-0049" title="ZangwillKM , DrogeJ , MendelmanP , MarcySM , PartridgeS , ChiuCY , et al. Prospective, randomized, placebo‐controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Pediatic Infectious Disease Journal2001;20(8):740‐6. ">ab Zangwill 2001</a>). Nine RCTs (corresponding to nine data sets) had an unclear risk of bias (<a href="./references#CD004879-bbs2-0027" title="AksenovVA , SelidovkinDA , SorokinaLV , BurnosAS , SorokinaAG . The effectiveness of influenza prevention with a special variation of live influenza vaccine for children in the 1969 epidemic. Voprosy Virusologii1971;16:81‐6. ">ab Aksenov 1971</a>; <a href="./references#CD004879-bbs2-0030" title="Grigor'evaEP , RekstinAR , RudenkoLG , RamirezA , BarroM , LisovskaiaKV , et al. The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old. Voprosy Virusologii1994;39(1):26‐9. ">ab Grigor'eva 1994</a>; <a href="./references#CD004879-bbs2-0031" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth‐Ayerst ca Influenza Vaccine Investigators Group. Journal of Infectious Diseases1996;173(6):1313‐9. ">ab Gruber 1996</a>; <a href="./references#CD004879-bbs2-0033" title="GutmanLT , WilfertCM , IdrissZH , SchmidtE , AndrewsS , KatzSL . Single‐dose trials of monovalent A/New Jersey/76 (Hsw1N1) influenza virus vaccine in children in Durham, North Carolina. Journal of Infectious Diseases1977;136(Suppl):575‐8. ">ab Gutman 1977</a>; <a href="./references#CD004879-bbs2-0034" title="KingJCJr , LagosR , BernsteinDI , PiedraPA , KotloffK , BryantM , et al. Safety and immunogenicity of low and high doses of trivalent live cold‐adapted influenza vaccine administered intranasally as drops or spray to healthy children. Journal of Infectious Diseases1998;17(5):1394‐7. ">ab King 1998</a>; <a href="./references#CD004879-bbs2-0042" title="SlepushkinAN , Obrosova‐SerovaNP , BurtsevaEI , GovorkovaEA , RudenkoLG , VartanianRV , et al. A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):372‐4. ">ab Slepushkin 1991</a>; <a href="./references#CD004879-bbs2-0043" title="SteinhoffMC , HalseyNA , WilsonMH , BurnsBA , SamorodinRK , FriesLF , et al. Comparison of live attenuated cold‐adapted and avian‐human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. Journal of Infectious Diseases1990;162(2):394‐401. ">ab Steinhoff 1990</a>; <a href="./references#CD004879-bbs2-0044" title="SteinhoffMC , HalseyNA , FriesLF , WilsonMH , KingJ , BurnsBA , et al. The A/Mallard/6750/78 avian‐human, but not the A/Ann Arbor/6/60 cold‐adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. Journal of Infectious Diseases1991;163(5):1023‐8. ">ab Steinhoff 1991</a>; <a href="./references#CD004879-bbs2-0045" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. ">ab Swierkosz 1994</a>). Finally, we assessed nine RCTs (nine data sets) as at high risk of bias (<a href="./references#CD004879-bbs2-0028" title="BelsheRB , SwierkoszEM , AndersonEL , NewmanFK , NugentSL , MaassabHF . Immunization of infants and young children with live attenuated trivalent cold‐recombinant influenza A H1N1, H3N2, and B vaccine. Journal of Infectious Diseases1992;165(4):727‐32. ">ab Belshe 1992</a>; <a href="./references#CD004879-bbs2-0032" title="GruberWC , DardenPM , StillJG , LohrJ , ReedG , WrightPF . Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose‐response. Vaccine1997;15(12‐3):1379‐84. ">ab Gruber 1997</a>; <a href="./references#CD004879-bbs2-0037" title="Obrosova‐SerovaNP , SlepushkinAN , KendalAP , HarmonMW , BurtsevaEI , BebeshevaNI , et al. Evaluation in children of cold‐adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild‐type B/Ann Arbor/1/86 and cold‐adapted B/Leningrad/14/55 viruses. Vaccine1990;8(1):57‐60. ">ab Obrosova‐Serova 1990</a>; <a href="./references#CD004879-bbs2-0039" title="RudenkoLG , RamirezA , BarroM , GushchinaMI , ArmandaRE , ErmachenkoTA , et al. The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14. Voprosy Virusologii1991;36(6):472‐4. ">ab Rudenko 1991</a>; <a href="./references#CD004879-bbs2-0040" title="SlepushkinAN , DukovaVS , KalegaevaVA , KaganAN , TemriukEE . Results of studying the effectiveness of a live influenza vaccine for peroral use on preschool and schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1974;12:24‐9. ">ab Slepushkin 1974</a>; <a href="./references#CD004879-bbs2-0041" title="SlepushkinAN , PatriarcaPA , Obrosova‐SerovaNP , HarmonMW , KupryashinaLN , CheshikSG , et al. Class‐specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)‐like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold‐adapted donor strain. Vaccine1988;6(1):25‐8. ">ab Slepushkin 1988</a>; (<a href="./references#CD004879-bbs2-0046" title="Vasil'evaRI , Merkur'evaLA , LatsenkoVG , Vasil'evaAM , ShvagerMM . Characteristics of the clinical and immunologic safety of inactivated influenza vaccines in children undergoing multiple immunizations. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;11:65‐9. ">ab Vasil'eva 1988a</a>; <a href="./references#CD004879-bbs2-0047" title="Vasil'evaRI , SmirnovaLA , RudenkoLG , DrinevskiiVP , TsaritsinaIM . The results of state trials of inactivated influenza vaccines for children. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1988;3:49‐54. ">ab Vasil'eva 1988b</a>); <a href="./references#CD004879-bbs2-0048" title="WrightPF , SellSH , ThompsonJ , KarzonDT . Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. Journal of Pediatrics1976;88(1):31‐5. ">ab Wright 1976a</a>). Overall, out of 23 data sets providing evidence of vaccine safety only, 22% (5/23 ) were at low risk of bias; 39% (9/23) had an unclear risk of bias; and 39% (9/23) were at high risk of bias (<a href="#CD004879-fig-0002">Figure 2</a>). </p> </section> <section id="CD004879-sec-0095"> <h4 class="title">Case‐control studies</h4> <p>We included 11 case‐control studies (corresponding to 15 data sets) in vaccine efficacy analyses. Four studies (five data sets) were at low risk of bias ((<a href="./references#CD004879-bbs2-0054" title="EisenbergKW , SzilagyiPG , FairbrotherG , GriffinMR , StaatM , ShoneLP , et al. Vaccine effectiveness against laboratory‐confirmed influenza in children 6 to 59 months of age during the 2003‐2004 and 2004‐2005 influenza seasons. Pediatrics2008;122(5):911‐9. ">ba Eisenberg 2008a</a>; <a href="./references#CD004879-bbs2-0055" title="EisenbergKW , SzilagyiPG , FairbrotherG , GriffinMR , StaatM , ShoneLP , et al. Vaccine effectiveness against laboratory‐confirmed influenza in children 6 to 59 months of age during the 2003‐2004 and 2004‐2005 influenza seasons. Pediatrics2008;122(5):911‐9. ">ba Eisenberg 2008b</a>); <a href="./references#CD004879-bbs2-0059" title="KisslingE , ValencianoM , CohenJM , OrosziB , BarretAS , RizzoC , et al. I‐MOVE multi‐centre case control study 2010‐11: overall and stratified estimates of influenza vaccine effectiveness in Europe. Eurosurveillance2011;6(11):19818. ">ba Kissling 2011</a>; <a href="./references#CD004879-bbs2-0060" title="MahmudS , HammondG , ElliottL , HildermanT , KurbisC , CaetanoP , et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory‐confirmed H1N1 infections: population‐based case‐control study. Vaccine2011;29(45):7975‐81. ">ba Mahmud 2011</a>; <a href="./references#CD004879-bbs2-0063" title="ValencianoM , KisslingE , CohenJM , OrosziB , BarretAS , RizzoC , et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009‐2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I‐MOVE) multicentre case‐control study. PLoS Medicine2011;8(1):e1000388. ">ba Valenciano 2011</a>). Four studies (five data sets) had an unclear risk of bias for one or more key domains (<a href="./references#CD004879-bbs2-0050" title="Effectiveness of vaccine against medical consultation due to laboratory‐confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004‐2005. Canada Communicable Disease Report2005;31(18):181‐91. ">ba Anonymous 2005</a>; <a href="./references#CD004879-bbs2-0056" title="GilcaR , DeceuninckG , DeSerresG , BoulianneN , SauvageauC , QuachC , et al. Effectiveness of pandemic H1N1 vaccine against influenza‐related hospitalization in children. Pediatrics2011;128(5):e1084‐91. ">ba Gilca 2011</a>; <a href="./references#CD004879-bbs2-0058" title="KellyH , JacobyP , DixonGA , CarcioneD , WilliamsS , MooreHC , et al. Vaccine effectiveness against laboratory‐confirmed influenza in healthy young children: a case‐control study. Pediatric Infectious Disease Journal2011;30(2):107‐11. ">ba Kelly 2011</a>; (<a href="./references#CD004879-bbs2-0061" title="StaatMA , GriffinMR , DonauerS , EdwardsKM , SzilagyiPG , WeinbergGA , et al. Vaccine effectiveness for laboratory‐confirmed influenza in children 6‐59 months of age, 2005‐2007. Vaccine2011;29(48):9005‐11. ">ba Staat 2011a</a>; <a href="./references#CD004879-bbs2-0062" title="StaatMA , GriffinMR , DonauerS , EdwardsKM , SzilagyiPG , WeinbergGA , et al. Vaccine effectiveness for laboratory‐confirmed influenza in children 6‐59 months of age, 2005‐2007. Vaccine2011;29(48):9005‐11. ">ba Staat 2011b</a>)). Three studies (five data sets) were at high risk of bias ((<a href="./references#CD004879-bbs2-0051" title="CochranLW , BlackS , KleinNP , DekkerCL , LewisE , ReingoldAL . Vaccine effectiveness against laboratory‐confirmed influenza in infants: a matched case control study. Human Vaccines2010;6(9):729‐35. ">ba Cochran 2010a</a>; <a href="./references#CD004879-bbs2-0052" title="CochranLW , BlackS , KleinNP , DekkerCL , LewisE , ReingoldAL . Vaccine effectiveness against laboratory‐confirmed influenza in infants: a matched case control study. Human Vaccines2010;23(6):729‐35. ">ba Cochran 2010b</a>; <a href="./references#CD004879-bbs2-0053" title="CochranLW , BlackS , KleinNP , DekkerCL , LewisE , ReingoldAL . Vaccine effectiveness against laboratory‐confirmed influenza in infants: a matched case control study. Human Vaccines2010;23(6):729‐35. ">ba Cochran 2010c</a>); <a href="./references#CD004879-bbs2-0057" title="HirotaY , TakeshitaS , IdeS , KataokaK , OhkuboA , FukuyoshiS , et al. Various factors associated with the manifestation of influenza‐like illness. International Journal of Epidemiology1992;21(3):574‐82. ">ba Hirota 1992</a>; <a href="./references#CD004879-bbs2-0064" title="VanBuynderPG , DhaliwalJK , VanBuynderJL , CouturierC , Minville‐LeblancM , GarceauR , et al. Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children. Influenza and Other Respiratory Viruses2010;4(4):171‐8. ">ba Van Buynder 2010</a>). Overall, out of 15 data sets providing evidence of vaccine efficacy, 33.3% (5/15) were at low risk of bias; 33.3% (5/15) had an unclear risk of bias; and 33.3% (5/15) were at high risk of bias (<a href="#CD004879-fig-0002">Figure 2</a>).<br/> <br/> We assessed the only case‐control study with a safety outcome, <a href="./references#CD004879-bbs2-0065" title="GoodmanMJ , NordinJD , HarperP , DeforT , ZhouX . The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age. Pediatrics2006;117(5):821‐6. ">bb Goodman 2006</a>, as at high risk of bias. </p> </section> <section id="CD004879-sec-0096"> <h4 class="title">Cohort studies</h4> <p>We included 17 cohort studies (corresponding to 21 data sets) in vaccine efficacy or effectiveness analyses. Two studies (two data sets) had an unclear risk of bias (<a href="./references#CD004879-bbs2-0066" title="AllisonMA , DaleyMF , CraneLA , BarrowJ , BeatyBL , AllredN , et al. Influenza vaccine effectiveness in healthy 6‐ to 21‐month‐old children during the 2003‐2004 season. Journal of Pediatrics2006;149(6):755‐62. ">ca Allison 2006</a>; <a href="./references#CD004879-bbs2-0068" title="BashliaevaZA , SumarokovAA , NefedovaLA , IaroshevskaiaII , OzeretskovskaiaNA . Basic results of a committee trial of the new vaccine Grippovac SE‐AZh. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1986;2:49‐54. ChumakovMP , BoikoVM , MalyshkinaLP , Mel'nikovaSK , RodinVI . Results of coded trials of the activity of the trivalent subunit influenza vaccine Grippovak in Moscow kindergartens in December 1983 through the 1st quarter of 1984. Voprosy Virusologii1987;32(2):175‐83. ">ca Chumakov 1987</a>). Fifteen studies (19 data sets) were at high risk of bias (<a href="./references#CD004879-bbs2-0067" title="BurtsevaEI , Obrosova‐SerovaNP , GovorkovaEA , RudenkoLG , VartanianRV , BeliaevAL , et al. A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):375‐7. ">ca Burtseva 1991</a>; <a href="./references#CD004879-bbs2-0069" title="El'shinaGA , GorbunovMA , BektimirovTA , LonskaiaNI , PavlovaLI , Nikul'shinAA , et al. The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer‐subunit influenza vaccine administered to schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2000;2:50‐4. ">ca El'shina 2000</a>; <a href="./references#CD004879-bbs2-0070" title="FujiedaM , MaedaA , KondoK , KajiM , HirotaY . Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002‐2003 season. Vaccine2006;24(7):957‐63. ">ca Fujieda 2006</a>; <a href="./references#CD004879-bbs2-0071" title="JianpingH , XinF , ChangshunL , BoZ , LinxiuG , WeiX , et al. Assessment of effectiveness of Vaxigrip. Vaccine1999;17(Suppl 1):57‐8. ">ca Jianping 1999</a>; <a href="./references#CD004879-bbs2-0072" title="KawaiN , IkematsuH , IwakiN , SatohI , KawashimaT , TsuchimotoT , et al. A prospective, Internet‐based study of the effectiveness and safety of influenza vaccination in the 2001‐2002 influenza season. Vaccine2003;21(31):4507‐13. ">ca Kawai 2003</a>; <a href="./references#CD004879-bbs2-0073" title="KingJCJr , StoddardJJ , GaglaniMJ , MooreKA , MagderL , McClureE , et al. Effectiveness of school‐based influenza vaccination. New England Journal of Medicine2006;355:2523‐32. ">ca King 2006</a>; <a href="./references#CD004879-bbs2-0074" title="MaedaT , ShintaniY , MiyamotoH , KawagoeH , NakanoK , NishiyamaA , et al. Prophylactic effect of inactivated influenza vaccine on young children. Pediatrics International2002;44(1):43‐6. ">ca Maeda 2002</a>; (<a href="./references#CD004879-bbs2-0075" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. ">ca Maeda 2004a</a>; <a href="./references#CD004879-bbs2-0076" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. ">ca Maeda 2004b</a>; <a href="./references#CD004879-bbs2-0077" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. ">ca Maeda 2004c</a>); <a href="./references#CD004879-bbs2-0078" title="OrtqvistA , BerggrenI , InsulanderM , DeJongB , SvenungssonB . Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A (H1N1)v, in Stockholm County, Sweden. Clinical Infectious Diseases2011;52(10):1203‐11. ">ca Ortqvist 2011</a>; <a href="./references#CD004879-bbs2-0079" title="OzgurSK , BeyazovaU , KemalogluYK , MaralI , SahinF , CamurdanAD , et al. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children. Pediatric Infectious Disease Journal2006;25(5):401‐4. ">ca Ozgur 2006</a>; <a href="./references#CD004879-bbs2-0080" title="SallerasL , DominguezA , PumarolaT , PratA , MarcosMA , GarridoP , et al. Effectiveness of virosomal subunit influenza vaccine in preventing influenza‐related illnesses and its social and economic consequences in children aged 3‐14 years: a prospective cohort study. Vaccine2006;24(44‐6):6638‐42. ">ca Salleras 2006</a>; (<a href="./references#CD004879-bbs2-0081" title="SlobodniukAV , RomanenkoVV , UtnitskaiaOS , MotusTM , PereverzevAV . Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2002;4:36‐9. ">ca Slobodniuk 2002a</a>; <a href="./references#CD004879-bbs2-0082" title="SlobodniukAV , RomanenkoVV , UtnitskaiaOS , MotusTM , PereverzevAV . Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2002;4:36‐9. ">ca Slobodniuk 2002b</a>; <a href="./references#CD004879-bbs2-0083" title="SlobodniukAV , RomanenkoVV , UtnitskaiaOS , MotusTM , PereverzevAV . Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2002;4:36‐9. ">ca Slobodniuk 2002c</a>); <a href="./references#CD004879-bbs2-0084" title="Vasil'evaRI , OsidakLV , BichurinaMA , MukhinaLP , ChudinaLV . Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1982;4:96‐8. ">ca Vasil'eva 1982</a>; <a href="./references#CD004879-bbs2-0085" title="Wiggs‐StaynerKS , PurdyTR , GoGN , McLaughlinNC , TryzynkaPS , SinesJR , et al. The impact of mass school immunization on school attendance. Journal of School of Nursing2006;22(4):219‐22. ">ca Wiggs‐Stayner 2006</a>; <a href="./references#CD004879-bbs2-0086" title="YinJK , LahraMM , IskanderM , LambertSB , HeronL , NissenMD , et al. Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare. Journal of Paediatrics and Child Health2011;47(12):857‐62. ">ca Yin 2011</a>). Overall, out of 21 data sets, 9.5% (2/21) had an unclear risk of bias, and 90.5% (19/21) were at high risk of bias (<a href="#CD004879-fig-0002">Figure 2</a>). </p> <p>Of the four cohort studies (corresponding to four data sets) included in vaccine safety only, only one (one data set) was at low risk of bias (<a href="./references#CD004879-bbs2-0087" title="MPA . Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations – results of a case inventory study by the MPA in Sweden during 2009–2010. www.lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport pandermrix 110630.pdf (accessed 10 January 2012). ">cb MPA 2011</a>), and three studies (three data sets) were at high risk of bias (<a href="./references#CD004879-bbs2-0088" title="NichollsS , CarrollK , CroftsJ , Ben‐EliezerE , PaulJ , ZambonM , et al. Outbreak of influenza A (H3N2) in a highly‐vaccinated religious community: a retrospective cohort study. Communicable Disease and Public Health2004;7:272‐7. ">cb Nicholls 2004</a>; <a href="./references#CD004879-bbs2-0089" title="RitzwollerDP , BridgesCB , ShetterlyS , YamasakiK , KolczakM , FranceEK . Effectiveness of the 2003‐2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics2005;116(1):153‐9. ">cb Ritzwoller 2005</a>; <a href="./references#CD004879-bbs2-0090" title="SlepushkinAN , RudenkoLG , KendalAP , MontoAS , BeliaevAL , BurtsevaEI , et al. A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity. Voprosy Virusologii1994;39:129‐31. ">cb Slepushkin 1994</a>). </p> </section> <section id="CD004879-sec-0097"> <h4 class="title">Allocation</h4> <p>Of the 19 included RCTs (26 data sets), nine studies (12 data sets) reported adequate allocation concealment. We assessed allocation concealment as satisfactory only for the first season of the two‐season trials by <a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>, <a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>, and <a href="./references#CD004879-bbs2-0025" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006a</a>. </p> </section> <section id="CD004879-sec-0098"> <h4 class="title">Blinding</h4> <p>We considered the blinding to be satisfactory in 29 data sets out of 49 (59%). Nineteen data sets showed unclear blinding, and one was not blinded. </p> </section> <section id="CD004879-sec-0099"> <h4 class="title">Incomplete outcome data</h4> <p>Few studies reported information on influenza circulation in the surrounding community, making interpretation of the results and assessment of their generalisability difficult. </p> </section> <section id="CD004879-sec-0100"> <h4 class="title">Selective reporting</h4> <p>There is evidence of sizeable reporting bias of all types in influenza vaccines studies in general (<a href="./references#CD004879-bbs2-0222" title="JeffersonT , DiPietrantonjC , DebaliniMG , RivettiA , DemicheliV . Study quality, concordance, take home message, funding and impact: their relationship in influenza vaccines studies. BMJ2009;338:b354. ">Jefferson 2009</a>), in the publication of 2009 H1N1 pandemic vaccines studies (<a href="./references#CD004879-bbs2-0219" title="IoannidisJPA , ManzoliL , DeVitoC , D’AddarioM , VillariP . Publication delay of randomized trials on 2009 Influenza A (H1N1) vaccination. PLoS ONE2011;6(12):e28346. [DOI: 10.1371/journal.pone.0028346] ">Ioannidis 2011</a>), and in the harms in children (<a href="./references#CD004879-bbs2-0221" title="JeffersonT , SmithS , DemicheliV , HarndenA , RivettiA . Safety of influenza vaccines in children. Lancet2005;366(9488):803‐4. ">Jefferson 2005a</a>). Other studies failed to report sufficient data for inclusion in meta‐analysis (<a href="./references#CD004879-bbs2-0011" title="CowlingBJ , NgS , MaES , FangVJ , SoHC , WaiW , et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clinical Infectious Diseases2012;55(5):695‐702. ">aa Cowling 2012</a>). </p> </section> <section id="CD004879-sec-0101"> <h4 class="title">Other potential sources of bias</h4> <p>Twenty‐five studies reported that written consent had been obtained from the parents of study participants (<a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>; <a href="./references#CD004879-bbs2-0003" title="BelsheRB , GruberWC , MendelmanPM , ChoI , ReisingerK , BlockSL , et al. Efficacy of vaccination with live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. Journal of Pediatrics2000;136(2):168‐75. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 2000a</a>; <a href="./references#CD004879-bbs2-0004" title="BeutnerKR , ChowT , RubiE , StrussenbergJ , ClementJ , OgraPL . Evaluation of a neuraminidase‐specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. Journal of Infectious Diseases1979;140(6):844‐50. ">aa Beutner 1979a</a>; <a href="./references#CD004879-bbs2-0009" title="CloverRD , CrawfordS , GlezenWP , TaberLH , MatsonCC , CouchRB . Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83‐like viruses. Journal of Infectious Diseases1991;163(2):300‐4. ">aa Clover 1991</a>; <a href="./references#CD004879-bbs2-0010" title="ColomboC , ArgiolasL , LaVecchiaC , NegriE , MeloniG , MeloniT . Influenza vaccine in healthy preschool children. Revue d'Epidémiologie et de Santé Publique2001;49(2):157‐62. ">aa Colombo 2001</a>; <a href="./references#CD004879-bbs2-0013" title="GruberWC , TaberLH , GlezenWP , CloverRD , AbellTD , DemmlerRW , et al. Live attenuated and inactivated influenza vaccine in school‐age children. American Journal of Diseases in Children1990;144(5):595‐600. ">aa Gruber 1990</a>; <a href="./references#CD004879-bbs2-0014" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA2003;290(12):1608‐16. ">aa Hoberman 2003a</a>; <a href="./references#CD004879-bbs2-0016" title="KhanAS , PolezhaevF , VasiljevaR , DrinevskyV , BuffingtonJ , GaryH , et al. Comparison of US inactivated split‐virus and Russian live attenuated, cold‐adapted trivalent influenza vaccines in Russian schoolchildren. Journal of Infectious Diseases1996;173(2):453‐6. ">aa Khan 1996</a>; <a href="./references#CD004879-bbs2-0019" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993a</a>; <a href="./references#CD004879-bbs2-0021" title="RudenkoLG , LonskayaNI , KlimovAI , VasilievaRI , RamirezA . Clinical and epidemiological evaluation of a live, cold‐adapted influenza vaccine for 3‐14‐year‐olds. Bulletin of the World Health Organization1996;74(1):77‐84. ">aa Rudenko 1996a</a>; <a href="./references#CD004879-bbs2-0028" title="BelsheRB , SwierkoszEM , AndersonEL , NewmanFK , NugentSL , MaassabHF . Immunization of infants and young children with live attenuated trivalent cold‐recombinant influenza A H1N1, H3N2, and B vaccine. Journal of Infectious Diseases1992;165(4):727‐32. ">ab Belshe 1992</a>; <a href="./references#CD004879-bbs2-0031" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth‐Ayerst ca Influenza Vaccine Investigators Group. Journal of Infectious Diseases1996;173(6):1313‐9. ">ab Gruber 1996</a>; <a href="./references#CD004879-bbs2-0032" title="GruberWC , DardenPM , StillJG , LohrJ , ReedG , WrightPF . Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose‐response. Vaccine1997;15(12‐3):1379‐84. ">ab Gruber 1997</a>; <a href="./references#CD004879-bbs2-0033" title="GutmanLT , WilfertCM , IdrissZH , SchmidtE , AndrewsS , KatzSL . Single‐dose trials of monovalent A/New Jersey/76 (Hsw1N1) influenza virus vaccine in children in Durham, North Carolina. Journal of Infectious Diseases1977;136(Suppl):575‐8. ">ab Gutman 1977</a>; <a href="./references#CD004879-bbs2-0034" title="KingJCJr , LagosR , BernsteinDI , PiedraPA , KotloffK , BryantM , et al. Safety and immunogenicity of low and high doses of trivalent live cold‐adapted influenza vaccine administered intranasally as drops or spray to healthy children. Journal of Infectious Diseases1998;17(5):1394‐7. ">ab King 1998</a>; <a href="./references#CD004879-bbs2-0035" title="LevineMM , HughesTP , SimonP , O'DonnellS , GrauelS , LevineSG . Monovalent inactivated A/New Jersey/8/76 (Hsw1N1) vaccine in healthy children aged three to five years. Journal of Infectious Diseases1977;136(Suppl):571‐4. ">ab Levine 1977</a>; <a href="./references#CD004879-bbs2-0041" title="SlepushkinAN , PatriarcaPA , Obrosova‐SerovaNP , HarmonMW , KupryashinaLN , CheshikSG , et al. Class‐specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)‐like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold‐adapted donor strain. Vaccine1988;6(1):25‐8. ">ab Slepushkin 1988</a>; <a href="./references#CD004879-bbs2-0043" title="SteinhoffMC , HalseyNA , WilsonMH , BurnsBA , SamorodinRK , FriesLF , et al. Comparison of live attenuated cold‐adapted and avian‐human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. Journal of Infectious Diseases1990;162(2):394‐401. ">ab Steinhoff 1990</a>; <a href="./references#CD004879-bbs2-0044" title="SteinhoffMC , HalseyNA , FriesLF , WilsonMH , KingJ , BurnsBA , et al. The A/Mallard/6750/78 avian‐human, but not the A/Ann Arbor/6/60 cold‐adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. Journal of Infectious Diseases1991;163(5):1023‐8. ">ab Steinhoff 1991</a>; <a href="./references#CD004879-bbs2-0045" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. ">ab Swierkosz 1994</a>; <a href="./references#CD004879-bbs2-0048" title="WrightPF , SellSH , ThompsonJ , KarzonDT . Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. Journal of Pediatrics1976;88(1):31‐5. ">ab Wright 1976a</a>; <a href="./references#CD004879-bbs2-0057" title="HirotaY , TakeshitaS , IdeS , KataokaK , OhkuboA , FukuyoshiS , et al. Various factors associated with the manifestation of influenza‐like illness. International Journal of Epidemiology1992;21(3):574‐82. ">ba Hirota 1992</a>; <a href="./references#CD004879-bbs2-0072" title="KawaiN , IkematsuH , IwakiN , SatohI , KawashimaT , TsuchimotoT , et al. A prospective, Internet‐based study of the effectiveness and safety of influenza vaccination in the 2001‐2002 influenza season. Vaccine2003;21(31):4507‐13. ">ca Kawai 2003</a>; <a href="./references#CD004879-bbs2-0074" title="MaedaT , ShintaniY , MiyamotoH , KawagoeH , NakanoK , NishiyamaA , et al. Prophylactic effect of inactivated influenza vaccine on young children. Pediatrics International2002;44(1):43‐6. ">ca Maeda 2002</a>; <a href="./references#CD004879-bbs2-0075" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. ">ca Maeda 2004a</a>); another two studies refer to parental permission being granted (<a href="./references#CD004879-bbs2-0029" title="DeshevaI , DaniniGV , Grigor'evaEP , DoninaSA , KiselevaIV , RekstinAR , et al. The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3‐6 year old children. Voprosy Virusologii2002;47(4):21‐4. ">ab Desheva 2002</a>; <a href="./references#CD004879-bbs2-0069" title="El'shinaGA , GorbunovMA , BektimirovTA , LonskaiaNI , PavlovaLI , Nikul'shinAA , et al. The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer‐subunit influenza vaccine administered to schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii2000;2:50‐4. ">ca El'shina 2000</a>); and one study refers to voluntary participation (<a href="./references#CD004879-bbs2-0090" title="SlepushkinAN , RudenkoLG , KendalAP , MontoAS , BeliaevAL , BurtsevaEI , et al. A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity. Voprosy Virusologii1994;39:129‐31. ">cb Slepushkin 1994</a>). Seven studies reported that the trial had received approval from a local review body (<a href="./references#CD004879-bbs2-0004" title="BeutnerKR , ChowT , RubiE , StrussenbergJ , ClementJ , OgraPL . Evaluation of a neuraminidase‐specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. Journal of Infectious Diseases1979;140(6):844‐50. ">aa Beutner 1979a</a>; <a href="./references#CD004879-bbs2-0009" title="CloverRD , CrawfordS , GlezenWP , TaberLH , MatsonCC , CouchRB . Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83‐like viruses. Journal of Infectious Diseases1991;163(2):300‐4. ">aa Clover 1991</a>; <a href="./references#CD004879-bbs2-0013" title="GruberWC , TaberLH , GlezenWP , CloverRD , AbellTD , DemmlerRW , et al. Live attenuated and inactivated influenza vaccine in school‐age children. American Journal of Diseases in Children1990;144(5):595‐600. ">aa Gruber 1990</a>; <a href="./references#CD004879-bbs2-0014" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA2003;290(12):1608‐16. ">aa Hoberman 2003a</a>; <a href="./references#CD004879-bbs2-0019" title="RudenkoLG , SlepushkinAN , MontoAS , KendalAP , GrigorievaEP , BurtsevaEP , et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Journal of Infectious Diseases1993;168(4):881‐7. ">aa Rudenko 1993a</a>; <a href="./references#CD004879-bbs2-0042" title="SlepushkinAN , Obrosova‐SerovaNP , BurtsevaEI , GovorkovaEA , RudenkoLG , VartanianRV , et al. A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):372‐4. ">ab Slepushkin 1991</a>; <a href="./references#CD004879-bbs2-0090" title="SlepushkinAN , RudenkoLG , KendalAP , MontoAS , BeliaevAL , BurtsevaEI , et al. A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity. Voprosy Virusologii1994;39:129‐31. ">cb Slepushkin 1994</a>). </p> <p>The main problem we encountered in interpreting studies included in the 2007 update was that of high risk of bias: all included studies were poorly reported and contained either contradictions between data in figures, tables, and text, or reported implausible events or showed evidence of reporting bias of one sort or another. The two placebo‐controlled trials of cold‐adapted influenza vaccine (CAIV) reported only partial safety data, with data missing for up to a third of participants. The reporting format of both trials (which had the same sponsors) was similar and so were the inconsistencies, which suggests either a pre‐set format from the same sponsor or the presence of one or more ghost authors, or both. </p> <p>We encountered similar problems in the 2011 update, especially in cohort studies and a specific type of case‐control study. </p> </section> </section> <section id="CD004879-sec-0102"> <h3 class="title" id="CD004879-sec-0102">Effects of interventions</h3> <p>See: <a href="./full#CD004879-tbl-0001"><b>Summary of findings for the main comparison</b> Live attenuated influenza vaccine compared to placebo or do nothing for preventing influenza in children</a>; <a href="./full#CD004879-tbl-0002"><b>Summary of findings 2</b> Inactivated influenza vaccine compared to placebo or do nothing for preventing influenza in children</a> </p> <section id="CD004879-sec-0103"> <h4 class="title">Quantitative data synthesis</h4> <p>We constructed the following eight comparisons for our meta‐analysis.</p> <p> <ul id="CD004879-list-0022"> <li> <p>Four comparisons included evidence from RCTs subgrouped by dose: live vaccines (<b>comparison 01</b> (<a href="./references#CD004879-fig-0003" title="">Analysis 1.1</a>, <a href="./references#CD004879-fig-0004" title="">Analysis 1.2</a>, <a href="./references#CD004879-fig-0005" title="">Analysis 1.3</a>, <a href="./references#CD004879-fig-0007" title="">Analysis 1.5</a>, <a href="./references#CD004879-fig-0008" title="">Analysis 1.6</a>, <a href="./references#CD004879-fig-0009" title="">Analysis 1.7</a>)) and inactivated vaccines (<b>comparison 02</b> (<a href="./references#CD004879-fig-0011" title="">Analysis 2.1</a>, <a href="./references#CD004879-fig-0012" title="">Analysis 2.2</a>)). We subgrouped these same studies by age in <b>comparison 03</b> (<a href="./references#CD004879-fig-0016" title="">Analysis 3.1</a>, <a href="./references#CD004879-fig-0017" title="">Analysis 3.2</a>) and <b>comparison 04</b> (<a href="./references#CD004879-fig-0018" title="">Analysis 4.1</a>, <a href="./references#CD004879-fig-0019" title="">Analysis 4.2</a>). </p> </li> <li> <p>One comparison was constructed for all outcomes for all vaccine types versus placebo: <b>comparison 05</b> (<a href="./references#CD004879-fig-0020" title="">Analysis 5.1</a>, <a href="./references#CD004879-fig-0021" title="">Analysis 5.2</a>, <a href="./references#CD004879-fig-0022" title="">Analysis 5.3</a>, <a href="./references#CD004879-fig-0023" title="">Analysis 5.4</a>, <a href="./references#CD004879-fig-0024" title="">Analysis 5.5</a>, <a href="./references#CD004879-fig-0025" title="">Analysis 5.6</a>, <a href="./references#CD004879-fig-0026" title="">Analysis 5.7</a>, <a href="./references#CD004879-fig-0027" title="">Analysis 5.8</a>, <a href="./references#CD004879-fig-0028" title="">Analysis 5.9</a>, <a href="./references#CD004879-fig-0029" title="">Analysis 5.10</a>, <a href="./references#CD004879-fig-0030" title="">Analysis 5.11</a>). </p> </li> <li> <p>Data from non‐randomised studies have been retained but not updated since 2011, as follows: case‐control studies in <b>comparison 6</b> (<a href="./references#CD004879-fig-0031" title="">Analysis 6.1</a>, <a href="./references#CD004879-fig-0032" title="">Analysis 6.2</a>, <a href="./references#CD004879-fig-0033" title="">Analysis 6.3</a>); cohort studies for live attenuated vaccines in <b>comparison 07</b> (<a href="./references#CD004879-fig-0034" title="">Analysis 7.1</a>, <a href="./references#CD004879-fig-0035" title="">Analysis 7.2</a>); and inactivated vaccines in <b>comparison 08</b> (<a href="./references#CD004879-fig-0036" title="">Analysis 8.1</a>, <a href="./references#CD004879-fig-0037" title="">Analysis 8.2</a>, <a href="./references#CD004879-fig-0038" title="">Analysis 8.3</a>). </p> </li> </ul> </p> <p>All comparators were placebo or do nothing, and <b>comparisons 03</b> ,<b>04</b> ,<b>06</b> , and <b>07</b> were stratified by available age groups, that is under two years, under six years, and over six years, and by type of outcome. </p> <p>The comparisons with influenza as an outcome (<a href="./references#CD004879-fig-0003" title="">Analysis 1.1</a> and <a href="./references#CD004879-fig-0034" title="">Analysis 7.1</a> for live vaccines; <a href="./references#CD004879-fig-0011" title="">Analysis 2.1</a> and <a href="./references#CD004879-fig-0036" title="">Analysis 8.1</a> for inactivated vaccines) therefore summarise the evidence of vaccine efficacy. The comparisons with ILI as an outcome (<a href="./references#CD004879-fig-0017" title="">Analysis 3.2</a> and <a href="./references#CD004879-fig-0035" title="">Analysis 7.2</a> for live vaccines; <a href="./references#CD004879-fig-0019" title="">Analysis 4.2</a> and <a href="./references#CD004879-fig-0037" title="">Analysis 8.2</a> for inactivated vaccines) summarise vaccine effectiveness. </p> <p><b>Comparison 05</b> (<a href="./references#CD004879-fig-0022" title="">Analysis 5.3</a> to <a href="./references#CD004879-fig-0027" title="">Analysis 5.8</a>) (for placebo‐controlled trials) included data for rare outcomes (secondary cases, school absences, lower respiratory tract infection, acute otitis media and other consequences and socioeconomic impact). Due to scarcity of data (most outcomes were reported by one or two studies only), no age stratification was possible for these outcomes. </p> </section> <section id="CD004879-sec-0104"> <h4 class="title">Comparisons showing vaccine efficacy (protection against influenza)</h4> <p><b>Comparison 01</b> (<a href="./references#CD004879-fig-0003" title="">Analysis 1.1</a>, evidence from RCTs) shows that live attenuated vaccines probably have 78% overall efficacy (risk ratio (RR) 0.22, 95% confidence interval (CI) 0.11 to 0.41; 7718 children; moderate‐certainty evidence). One study on 1632 children aged 15 to 71 months did report differences in incidence of influenza in 1‐year‐olds of 17% and 86% and for 2‐year‐olds of 24% and 96% for placebo and vaccination arms, respectively (<a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>). We have presented these figures in the <a href="#CD004879-sec-0114">Discussion</a> section, but in the absence of an age breakdown, could not include these data in the meta‐analysis. One study recruiting 3200 children aged between 6 to 36 months reported vaccine efficacy data that were consistent with those from our own analyses (73.5% in <a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>). </p> <p>Based on the median control group risk of 18% in children aged 3 to 16 years, live attenuated vaccination reduces the proportion of children with influenza to 4% (risk difference (RD) ‐14%, 95% CI ‐16% to ‐12%). At least seven children over the age of two need to be vaccinated to avoid one case of influenza (i.e. one set of symptoms with one infection). Risk differences for low and high control group risks yield numbers needed to vaccinate (NNVs) of 9 and 3, respectively. See <a href="./full#CD004879-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p><b>Comparison 02</b> (<a href="./references#CD004879-fig-0011" title="">Analysis 2.1</a>, evidence from RCTs) shows that inactivated vaccines have a vaccine efficacy (VE) of 64% (RR 0.36, 95% CI 0.28 to 0.48; 1628 children; high‐certainty evidence). In one small study in children aged two or younger, there was not enough information about the vaccines to determine efficacy of vaccination (RR 0.55, 95% CI 0.18 to 1.69). The findings are consistent with results from other studies, but the 95% CI is wide and includes meaningful differences with either strategy. </p> <p>Based on the median control group risk of 30% in children aged 2 to 16 years, inactivated vaccination reduces the proportion of children with influenza to 11% (RD ‐19%, 95% CI ‐21% to ‐15%). At least five children over the age of two need to be vaccinated to avoid one case of influenza (i.e. one set of symptoms with one infection). Risk differences for low and high control group risks yield NNVs of 50 and 3, respectively. See <a href="./full#CD004879-tbl-0002">summary of findings Table 2</a>. </p> <p><b>Comparison 07</b> (<a href="./references#CD004879-fig-0034" title="">Analysis 7.1</a>, evidence from cohort studies) shows that live attenuated vaccines have 44% VE (RR 0.56, 95% CI 0.35 to 0.91), although this observation is based on a single, small study in children aged over six years (<a href="./references#CD004879-bbs2-0067" title="BurtsevaEI , Obrosova‐SerovaNP , GovorkovaEA , RudenkoLG , VartanianRV , BeliaevAL , et al. A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8‐ to 15‐year‐old children. Voprosy Virusologii1991;36(5):375‐7. ">ca Burtseva 1991</a>). </p> <p><b>Comparison 08</b> (<a href="./references#CD004879-fig-0036" title="">Analysis 8.1</a>, evidence from cohort studies) shows that inactivated vaccines have 64% VE (RR 0.36, 95% CI 0.12 to 1.11) in the over‐six‐years age group; 66% VE (RR 0.34, 95% CI 0.13 to 0.89) in children up to six years of age; and are no better than placebo in children aged below two years (RR 0.63, 95% CI 0.27 to 1.47). </p> </section> <section id="CD004879-sec-0105"> <h4 class="title">Comparisons showing vaccines' effectiveness</h4> <p><b>Comparison 01</b> (<a href="./references#CD004879-fig-0004" title="">Analysis 1.2</a>, evidence from RCTs) shows that live attenuated vaccines may have 31% overall effectiveness (RR 0.69, 95% CI 0.6 to 0.80; 124,606 children; low‐certainty evidence), but we could find no evidence for children aged two years or younger. </p> <p>Compared with the median control group risk of 17% in children aged 3 to 16 years, live attenuated vaccination reduces the proportion of children with ILI to 12% (RD ‐5%, 95% CI ‐7% to ‐4%). At least 20 children over the age of three need to be vaccinated to avoid one case of ILI (i.e. one set of symptoms). Risk differences for low and high control group risks yield NNVs of 25 and 10, respectively. See <a href="./full#CD004879-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p><b>Comparison 02</b> (<a href="./references#CD004879-fig-0012" title="">Analysis 2.2</a>, evidence from RCTs) shows that inactivated vaccines probably have 28% overall effectiveness (RR 0.72, 95% CI 0.65 to 0.79; 19,044 children; moderate‐certainty evidence). We could find no evidence for children aged two years or younger. </p> <p>Compared with the median control group risk of 28% in children aged 3 to 16 years, inactivated vaccination reduces the proportion of children with ILI to 20% (RD ‐8%, 95% CI ‐10% to ‐6%). At least 12 children over the age of three need to be vaccinated to avoid one case of ILI (i.e. one set of symptoms). Risk differences for low and high control group risks yield NNVs of 25 and 11, respectively. See <a href="./full#CD004879-tbl-0002">summary of findings Table 2</a>. </p> <p><b>Comparison 07</b> (<a href="./references#CD004879-fig-0035" title="">Analysis 7.2</a>, evidence from cohort studies) shows that live attenuated vaccines are 37% effective in the over‐five‐years age group (RR 0.63, 95% CI 0.57 to 0.69). </p> <p><b>Comparison 08</b> (<a href="./references#CD004879-fig-0037" title="">Analysis 8.2</a>, evidence from cohort studies) shows that inactivated vaccines have overall 47% effectiveness (RR 0.53, 95% CI 0.42 to 0.67). Data from a very small single study report an effectiveness of 53% in children under the age of two (<a href="./references#CD004879-bbs2-0086" title="YinJK , LahraMM , IskanderM , LambertSB , HeronL , NissenMD , et al. Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare. Journal of Paediatrics and Child Health2011;47(12):857‐62. ">ca Yin 2011</a>). Effectiveness in children aged up to six years (RR 0.74, 95% CI 0.59 to 0.93) is just statistically significant. However, this must be interpreted with caution because the sizeable decrease in RR since the 2005 version of our review is due to the inclusion of a large cohort study at high risk of bias (<a href="./references#CD004879-bbs2-0070" title="FujiedaM , MaedaA , KondoK , KajiM , HirotaY . Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002‐2003 season. Vaccine2006;24(7):957‐63. ">ca Fujieda 2006</a>). Inactivated vaccines were more effective (VE = 56%) (RR 0.44, 95% CI 0.29 to 0.68) in children aged six years or older. </p> </section> <section id="CD004879-sec-0106"> <h4 class="title">Evidence on rarer outcomes</h4> <p>There are uncertain effects of live attenuated vaccines on the number of children who were absent from school (RR 0.51, 0.22 to 1.19; <a href="./references#CD004879-fig-0006" title="">Analysis 1.4</a>) and the number of parents taking leave to care for their children (RR 0.69, 95% CI 0.46 to 1.03; 2874 children; 2 studies; <a href="./references#CD004879-fig-0007" title="">Analysis 1.5</a>), the evidence for both outcomes of low certainty. </p> <p><b>Comparison 05</b> (<a href="./references#CD004879-fig-0022" title="">Analysis 5.3</a> to <a href="./references#CD004879-fig-0030" title="">Analysis 5.11</a>) assessed evidence from RCTs on rare outcomes. Vaccines reduced school absence compared with placebo (RR 0.49, 95% CI 0.26 to 0.92) or standard care (RR 0.14, 95% CI 0.07 to 0.27). Both observations are based on single studies (<a href="./references#CD004879-bbs2-0010" title="ColomboC , ArgiolasL , LaVecchiaC , NegriE , MeloniG , MeloniT . Influenza vaccine in healthy preschool children. Revue d'Epidémiologie et de Santé Publique2001;49(2):157‐62. ">aa Colombo 2001</a>; <a href="./references#CD004879-bbs2-0016" title="KhanAS , PolezhaevF , VasiljevaR , DrinevskyV , BuffingtonJ , GaryH , et al. Comparison of US inactivated split‐virus and Russian live attenuated, cold‐adapted trivalent influenza vaccines in Russian schoolchildren. Journal of Infectious Diseases1996;173(2):453‐6. ">aa Khan 1996</a>). A third trial reported lower average school days missed by vaccinated children (mean difference ‐4.23, 95% CI ‐6.81 to ‐1.65) (<a href="./references#CD004879-bbs2-0017" title="PrincipiN , EspositoS , MarchisioP , GaspariniR , CrovariP . Socioeconomic impact of influenza on healthy children and their families. Pediatric Infectious Disease Journal2003;22(Suppl 10):207‐10. ">aa Principi 2003</a>). A trial showed a significant effect of trivalent, cold‐adapted influenza vaccine against outpatients' attendance for pneumonia and influenza (odds ratio (OR) 0.60, 95% CI 0.43 to 0.82) and parents' working days lost (OR 0.62, 95% CI 0.39 to 1.00) (<a href="./references#CD004879-bbs2-0025" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006a</a>). The effects on all other outcomes (secondary cases, lower respiratory tract disease, drug prescriptions, acute otitis media and other consequences and socioeconomic impact) were not significantly different from those of placebo or standard care. According to one possible cohort study at high risk of bias (<a href="./references#CD004879-bbs2-0079" title="OzgurSK , BeyazovaU , KemalogluYK , MaralI , SahinF , CamurdanAD , et al. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children. Pediatric Infectious Disease Journal2006;25(5):401‐4. ">ca Ozgur 2006</a>), inactivated vaccines do not reduce the risk of acute otitis media (although this may be due to the small denominator of 119). Virosomal vaccines (engineered to resemble the antigenic structure of the influenza virus) reduce antibiotic consumption (OR 0.77, 95% CI 0.61 to 0.98), school absenteeism (OR 0.42, 95% CI 0.34 to 0.51), and work absenteeism (OR 0.69, 95% CI 0.51 to 0.93). These observations must be interpreted with caution as they are based on a single cohort study at high risk of bias (<a href="./references#CD004879-bbs2-0080" title="SallerasL , DominguezA , PumarolaT , PratA , MarcosMA , GarridoP , et al. Effectiveness of virosomal subunit influenza vaccine in preventing influenza‐related illnesses and its social and economic consequences in children aged 3‐14 years: a prospective cohort study. Vaccine2006;24(44‐6):6638‐42. ">ca Salleras 2006</a>). </p> <p>For completeness we have summarised the available evidence of efficacy and effectiveness from intra‐epidemic and non‐typical studies in <a href="#CD004879-tbl-0006">Table 4</a>. </p> <p>In the case‐control study testing the effectiveness against ILI of an inactivated vaccine during an outbreak in 803 children aged 6 to 12 years (<b>comparison 06</b>, <a href="./references#CD004879-fig-0033" title="">Analysis 6.3</a>) (<a href="./references#CD004879-bbs2-0057" title="HirotaY , TakeshitaS , IdeS , KataokaK , OhkuboA , FukuyoshiS , et al. Various factors associated with the manifestation of influenza‐like illness. International Journal of Epidemiology1992;21(3):574‐82. ">ba Hirota 1992</a>), the vaccine was well matched antigenically to the circulating strain. Its administration was inversely associated with risk of severe ILI but not with mild ILI (no ORs are reported). </p> <p>The case‐control study testing the effect against laboratory‐confirmed influenza of inactivated influenza vaccine in children aged below six years showed OR 0.59, 95% CI 0.45 to 0.77, 41% VE, 95% CI (23% to 55%) in <b>comparison 06</b> (<a href="./references#CD004879-fig-0031" title="">Analysis 6.1</a>), performed with crude data. </p> <p>In <b>comparison 06</b> (<a href="./references#CD004879-fig-0032" title="">Analysis 6.2</a>), which was performed with adjusted estimates, the OR in children below 23 months was 0.60, 95% CI 0.39 to 0.94, 40% VE; in children between 24 and 59 months (OR 0.40, 95% CI 0.22 to 0.70), 60% VE; in children 6 to 59 months (OR 0.45, 95% CI 0.32 to 0.62), 55% VE; and in children below 14 years (OR 0.23, 95% CI 0.06 to 0.84), 77% VE. </p> </section> <section id="CD004879-sec-0107"> <h4 class="title">Evidence on number of doses</h4> <p>There was no evidence of a subgroup effect between studies efficacy of one‐ and two‐dose schedules of live attenuated vaccines versus placebo. Results appear to favour the two‐dose schedule: 77% efficacy (RR 0.33, 95% CI 0.18 to 0.62) (<a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>; <a href="./references#CD004879-bbs2-0003" title="BelsheRB , GruberWC , MendelmanPM , ChoI , ReisingerK , BlockSL , et al. Efficacy of vaccination with live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. Journal of Pediatrics2000;136(2):168‐75. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 2000a</a>; <a href="./references#CD004879-bbs2-0008" title="BrooksWA , ZamanK , LewisKD , OrtizJR , GoswamiD , FeserJ , et al. Efficacy of a Russian‐backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double‐blind, placebo‐controlled trial. Lancet Global Health2016;4(12):e946‐54. ">aa Brooks 2016</a>; <a href="./references#CD004879-bbs2-0009" title="CloverRD , CrawfordS , GlezenWP , TaberLH , MatsonCC , CouchRB . Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83‐like viruses. Journal of Infectious Diseases1991;163(2):300‐4. ">aa Clover 1991</a>; <a href="./references#CD004879-bbs2-0013" title="GruberWC , TaberLH , GlezenWP , CloverRD , AbellTD , DemmlerRW , et al. Live attenuated and inactivated influenza vaccine in school‐age children. American Journal of Diseases in Children1990;144(5):595‐600. ">aa Gruber 1990</a>), compared with 89% efficacy (RR 0.11, 95% CI 0.04 to 0.26), although this estimate is based on two two‐dose studies only (<a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>; <a href="./references#CD004879-bbs2-0025" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006a</a>). All inactivated vaccine trials were conducted using a one‐dose schedule. The one‐dose virosomal vaccine was both efficacious and effective in children aged 3 to 14 years (RR 0.11, 95% CI 0.03 to 0.49) and (RR 0.26, 95% CI 0.17 to 0.60). However, these observations must be interpreted with caution, as they are based on a single cohort study at high risk of bias (<a href="./references#CD004879-bbs2-0080" title="SallerasL , DominguezA , PumarolaT , PratA , MarcosMA , GarridoP , et al. Effectiveness of virosomal subunit influenza vaccine in preventing influenza‐related illnesses and its social and economic consequences in children aged 3‐14 years: a prospective cohort study. Vaccine2006;24(44‐6):6638‐42. ">ca Salleras 2006</a>). </p> </section> <section id="CD004879-sec-0108"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analysis based on assumed intracluster correlation coefficients to recalculate effective sample sizes in cluster studies where schools were the unit of allocation did not change the direction, size, or precision of effect for either influenza or ILI (see <a href="./references#CD004879-fig-0010" title="">Analysis 1.8</a> and <a href="./references#CD004879-fig-0015" title="">Analysis 2.5</a>). </p> <p>Pooling all age data did not change our conclusions. Exclusion of evidence from Russian studies had the effect of making some of the comparisons not significant and depopulating single‐study comparisons, but did not materially affect our conclusions. However, we have no reason to believe that vaccines produced in Russia perform differently from vaccines produced elsewhere. The only study directly comparing the effectiveness of trivalent inactivated split‐virus vaccine (Wyeth‐Ayerst) with trivalent live attenuated, cold‐adapted influenza vaccine (Odessa Production Company for Biological Products; Odessa, Ukraine) with placebo on school absences failed to show any significant difference in performance (<a href="./references#CD004879-bbs2-0016" title="KhanAS , PolezhaevF , VasiljevaR , DrinevskyV , BuffingtonJ , GaryH , et al. Comparison of US inactivated split‐virus and Russian live attenuated, cold‐adapted trivalent influenza vaccines in Russian schoolchildren. Journal of Infectious Diseases1996;173(2):453‐6. ">aa Khan 1996</a>). </p> <p><a href="#CD004879-tbl-0004">Table 2</a> shows the results of the stepwise sensitivity analysis excluding Russian/USSR studies. All comparisons except <a href="./references#CD004879-fig-0016" title="">Analysis 3.1</a> and <a href="./references#CD004879-fig-0017" title="">Analysis 3.2</a> (influenza and ILI in live vaccine trials) were sensitive to the exclusion of evidence from Russian/USSR studies. For comparison <a href="./references#CD004879-fig-0017" title="">Analysis 3.2</a>, exclusion of seven independent data sets made the effectiveness estimate non‐significant in children older than six years but enhanced the total effectiveness from 33% to 88%. For comparison <a href="./references#CD004879-fig-0019" title="">Analysis 4.2</a>, effectiveness estimates for children older than six years were not significantly affected but were increased from 28% to 76%. Comparisons <a href="./references#CD004879-fig-0034" title="">Analysis 7.1</a> and <a href="./references#CD004879-fig-0035" title="">Analysis 7.2</a> were depopulated by the removal of the one data set in each group. For comparison <a href="./references#CD004879-fig-0036" title="">Analysis 8.1</a>, the non‐significant 64% estimate for children older than six years became significant (80%), whereas for comparison <a href="./references#CD004879-fig-0037" title="">Analysis 8.2</a>, the estimates for children older than six years (56%) remained significant but increased in size. </p> <p><a href="#CD004879-tbl-0005">Table 3</a> reports the results of the sensitivity analysis performed excluding studies (data sets) at high risk of bias. The results of <a href="./references#CD004879-fig-0016" title="">Analysis 3.1</a> and <a href="./references#CD004879-fig-0017" title="">Analysis 3.2</a> were sensitive to exclusion of the data sets at high risk of bias. However, these did not alter the results on vaccine efficacy or effectiveness described in the review. <a href="./references#CD004879-fig-0018" title="">Analysis 4.1</a> does not include evidence from studies at high risk of bias, and its results are unchanged. <a href="./references#CD004879-fig-0019" title="">Analysis 4.2</a> is sensitive to exclusion of evidence from studies at high risk of bias. Specifically, evidence of effectiveness in children under six years becomes not statistically significant with a VE reduction from 61% to 48%. In children over six years of age, exclusion of data sets at high risk of bias increased VE from 28% to 76%, and overall VE increased from 36% to 61%. <a href="./references#CD004879-fig-0034" title="">Analysis 7.1</a>, <a href="./references#CD004879-fig-0035" title="">Analysis 7.2</a>, <a href="./references#CD004879-fig-0036" title="">Analysis 8.1</a>, and <a href="./references#CD004879-fig-0037" title="">Analysis 8.2</a> are depopulated because data for this comparison came from studies at high risk of bias only. Evidence from <a href="./references#CD004879-fig-0003" title="">Analysis 1.1</a> to <a href="./references#CD004879-fig-0032" title="">Analysis 6.2</a> is sensitive to exclusion of studies at high risk of bias, but this did not alter the conclusions. Evidence from <a href="./references#CD004879-fig-0033" title="">Analysis 6.3</a> disappears. Evidence from <a href="./references#CD004879-fig-0020" title="">Analysis 5.1</a> to <a href="./references#CD004879-fig-0030" title="">Analysis 5.11</a> is sensitive to exclusion of studies at high risk of bias, but this did not alter the conclusions of the review. </p> </section> <section id="CD004879-sec-0109"> <h4 class="title">Safety studies</h4> <section id="CD004879-sec-0110"> <h5 class="title">Adverse events</h5> <p>In previous versions of the review we provided extensive documentation of the loss of evidence due to differing definitions and reporting formats of harms, chiefly local adverse events. For simplicity and to ease reading, we deleted the tables. </p> <section id="CD004879-sec-0111"> <h6 class="title">Randomised controlled trials</h6> <p>Twenty‐nine studies presented data on the safety of live influenza vaccines in children aged 2 months to 17 years old (<a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>; <a href="./references#CD004879-bbs2-0036" title="MalloryRM , MalkinE , AmbroseCS , BellamyT , ShiL , YiT , et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE2010;5(10):e13755. ">ab Mallory 2010</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Alexandrova-1986" target="_blank">Alexandrova 1986</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-1992" target="_blank">Belshe 1992</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-1998" target="_blank">Belshe 1998</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-2000a" target="_blank">Belshe 2000a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Beutner-1979a" target="_blank">Beutner 1979a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Desheva-2002" target="_blank">Desheva 2002</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Grigor_x0027_eva-1994" target="_blank">Grigor'eva 1994</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Grigor_x0027_eva-2002" target="_blank">Grigor'eva 2002</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1990" target="_blank">Gruber 1990</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1996" target="_blank">Gruber 1996</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1997" target="_blank">Gruber 1997</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Khan-1996" target="_blank">Khan 1996</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-King-1998" target="_blank">King 1998</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Obrosova_x002d_Serova-1990" target="_blank">Obrosova‐Serova 1990</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Piedra-2002a" target="_blank">Piedra 2002a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1988" target="_blank">Rudenko 1988</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1991" target="_blank">Rudenko 1991</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1993a" target="_blank">Rudenko 1993a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1996a" target="_blank">Rudenko 1996a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Slepushkin-1991" target="_blank">Slepushkin 1991</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Slepushkin-1994" target="_blank">Slepushkin 1994</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Steinhoff-1990" target="_blank">Steinhoff 1990</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Swierkosz-1994" target="_blank">Swierkosz 1994</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Tam-2007" target="_blank">Tam 2007</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vesikari-2006a" target="_blank">Vesikari 2006a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vesikari-2006b" target="_blank">Vesikari 2006b</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Zangwill-2001" target="_blank">Zangwill 2001</a>). </p> <p>Eight studies presented safety data for inactivated vaccines in children aged 6 months to 18 years old (<a href="./references#CD004879-bbs2-0038" title="PlennevauxE , BlatterM , CornishMJ , GoK , KirbyD , WaliM , et al. Influenza A (H1N1) 2009 two‐dose immunization of US children: an observer‐blinded, randomized, placebo‐controlled trial. Vaccine2011;29(8):1569‐75. ">ab Plennevaux 2011</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1990" target="_blank">Gruber 1990</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gutman-1977" target="_blank">Gutman 1977</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Khan-1996" target="_blank">Khan 1996</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Levine-1977" target="_blank">Levine 1977</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Slepushkin-1991" target="_blank">Slepushkin 1991</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vasil_x0027_eva-1988a" target="_blank">Vasil'eva 1988a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Wright-1976a" target="_blank">Wright 1976a</a>), and one paper, <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-El_x0027_shina-2000" target="_blank">El'shina 2000</a>, contained an RCT of short‐term safety data (≤ 5 days) and a cohort study of long‐term safety data (≤ 5 months). </p> <p>Most of the RCTs presented temperature rise as an outcome, with large differences among trials. Considering only studies reporting raw data on this outcome, the proportion of vaccinated children with fever ranged from 0.16%, in <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1993a" target="_blank">Rudenko 1993a</a>, to 15% (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-1998" target="_blank">Belshe 1998</a>), while in the placebo groups this proportion ranged from 0.71%, in <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1993a" target="_blank">Rudenko 1993a</a>, to 22% (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1996" target="_blank">Gruber 1996</a>).   </p> <p>Three studies reported raw data for nasal congestion (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-1998" target="_blank">Belshe 1998</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-2000a" target="_blank">Belshe 2000a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1996" target="_blank">Gruber 1996</a>). Studies conducted by Belshe assessed safety of cold‐adapted trivalent influenza vaccine, while the study by Gruber and colleagues assessed live attenuated vaccine. The proportion of vaccinated children with nasal congestion ranged from 19%, in <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-2000a" target="_blank">Belshe 2000a</a>, to 78% (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1996" target="_blank">Gruber 1996</a>), while in the control group this proportion ranged from 14%, in <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-2000a" target="_blank">Belshe 2000a</a>, to 68% (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1996" target="_blank">Gruber 1996</a>). </p> <p><a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-1992" target="_blank">Belshe 1992</a> reported data on upper respiratory tract infections: in the vaccinated arms the proportion of children affected ranged from 53% to 70%, while in the placebo group this outcome was reported in 47% of children. </p> <p><a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a> and <a href="./references#CD004879-bbs2-0007" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009b</a> (one study run over two seasons) reported a significant difference in the rate of bronchitis between live attenuated influenza vaccine (LAIV) and saline placebo recipients (3.1% and 1.6%, respectively; P = 0.046), while the incidence of bronchospasm was also similar between groups (1.8% and 1.5%, respectively). </p> <p><a href="./references#CD004879-bbs2-0036" title="MalloryRM , MalkinE , AmbroseCS , BellamyT , ShiL , YiT , et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE2010;5(10):e13755. ">ab Mallory 2010</a> reported headache as the most common solicited symptom in children receiving H1N1 LAIV through day 8 after dose one, which was reported by 16.6% and 15.4% of H1N1 LAIV and placebo recipients respectively, rate difference 1.2% (95% CI –10.2% to 10.2). </p> <p>Three RCTs included data on reactions to live vaccine within six weeks of inoculation (short‐term outcomes). <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-1998" target="_blank">Belshe 1998</a> included serious adverse events up to 42 days after vaccination. From the same trial, Piedra 2002a (see <a href="./references#CD004879-bbs2-0002" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. PiedraPA , YanL , KotloffK , ZangwillK , BernsteinDI , KingJ , et al. Safety of the trivalent, cold‐adapted influenza vaccine in preschool‐aged children. Pediatrics2002;110(4):662‐72. ">aa Belshe 1998</a>) included the following outcomes between 11 and 42 days after vaccination: afebrile illness, analgesic/antipyretic use, antihistamine/decongestant/antitussive use, febrile illness, febrile otitis media, lower respiratory tract infection, oral antibiotics use, and otitis media. In the <a href="./references#CD004879-bbs2-0038" title="PlennevauxE , BlatterM , CornishMJ , GoK , KirbyD , WaliM , et al. Influenza A (H1N1) 2009 two‐dose immunization of US children: an observer‐blinded, randomized, placebo‐controlled trial. Vaccine2011;29(8):1569‐75. ">ab Plennevaux 2011</a> study, within 21 days since the last of the two injections a range of 42% to 55% of children in each age and vaccine group experienced unsolicited adverse events, considered by the investigator to not be vaccine related in most cases. <a href="./references#CD004879-bbs2-0036" title="MalloryRM , MalkinE , AmbroseCS , BellamyT , ShiL , YiT , et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE2010;5(10):e13755. ">ab Mallory 2010</a> reported adverse events during days 1 to 15 after doses one and two. Adverse events after dose one were reported in 18.1% and 16.9% of H1N1 LAIV and placebo recipients respectively, and in 13.7% and 14.3% after dose two. The most common adverse events in children after dose one were nausea (1.9% versus 3.1%), vomiting (2.7% versus 1.5%), and diarrhoea (1.5% versus 1.5%). </p> <p>For longer‐term outcomes, <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Belshe-1998" target="_blank">Belshe 1998</a> included vaccine‐related serious adverse events within 102 days of inoculation. Three RCTs included safety outcome followed up for six months after inoculation. <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Desheva-2002" target="_blank">Desheva 2002</a> included three outcomes: allergies, infections (excluding influenza and acute respiratory infections), and other somatic illnesses. <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1988" target="_blank">Rudenko 1988</a> included only morbidity (excluding influenza and acute respiratory infections). <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Rudenko-1996a" target="_blank">Rudenko 1996a</a> evaluated 13 outcomes including allergies and five respiratory tract disease outcomes. </p> <p>Seven RCTs reported data on short‐term outcomes following inoculation with inactivated vaccines. In particular, two RCTs reported data on erythema, swelling, and induration (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Beutner-1979a" target="_blank">Beutner 1979a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Wright-1976a" target="_blank">Wright 1976a</a>); two other studies reported data on pain/tenderness (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Beutner-1979a" target="_blank">Beutner 1979a</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Gruber-1990" target="_blank">Gruber 1990</a>); and one study reported data on infiltration and hyperaemia (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vasil_x0027_eva-1988a" target="_blank">Vasil'eva 1988a</a>). </p> <p>One RCT presented safety outcomes data up to six months after inoculation of inactivated vaccine (15 outcomes) (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vasil_x0027_eva-1988a" target="_blank">Vasil'eva 1988a</a>). </p> </section> <section id="CD004879-sec-0112"> <h6 class="title">Observational studies</h6> <p>Three cohort studies presented safety data for inactivated vaccines in children aged 12 months to 18 years old (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Slepushkin-1994" target="_blank">Slepushkin 1994</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vasil_x0027_eva-1982" target="_blank">Vasil'eva 1982</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vasil_x0027_eva-1988b" target="_blank">Vasil'eva 1988b</a>), and 1 paper, <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-El_x0027_shina-2000" target="_blank">El'shina 2000</a>, contained an RCT of short‐term safety data (≤ 5 days) and a cohort study of long‐term safety data (≤ 5 months). </p> <p>One cohort study compared the reactogenicity and immunogenicity of live bivalent or trivalent vaccines and inactivated bivalent and trivalent vaccines in 1817 children in 3 cohorts between 1989 and 1991 (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Slepushkin-1994" target="_blank">Slepushkin 1994</a>). Reactions to the vaccines were studied for five days after vaccination. A temperature of 37.5 °C was considered a weak reaction, and from 37.6 to 38.5 °C a severe reaction. When a trivalent vaccine was administered subcutaneously to children aged 11 to 14 years in 1990, temperature reactions were recorded in 2.6% of participants, moderate local reactions in 3.2%, and severe local reaction in 0.7%. Consequently, the intramuscular route was used for the 7‐to‐10‐years age group where a lower frequency of reactions was recorded. In 1991, the inactive vaccine caused moderate temperature reactions (37.6 °C to 38.5 °C) in 1.3% of the participants and moderate local reactions (26 to 50 mm hyperaemia) in 4.4% of the participants. </p> <p><a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vasil_x0027_eva-1982" target="_blank">Vasil'eva 1982</a> reported safety data of 335 children aged 7 to 15 years vaccinated with inactivated influenza vaccine. The children were monitored for reactions by daily physical examination for five days following inoculation. The outcomes of temperature, headache or malaise, sore throat, and local reactions (hyperaemia or cutaneous wheal) were recorded. Mild fever (37.0 °C to 37.5 °C) was observed in 20% to 25% of children aged 7 to 10 years and in 8% to 12% of children aged 11 to 15 years. Isolated cases of moderate and severe fever, that is above 37.6 °C, were recorded in all groups. There were no statistical differences in systemic reactions between vaccine and placebo, between age groups, or for method of administration. Local reactions were most frequent in children aged 11 to 15 years vaccinated with a syringe; 26.5% of children from this subgroup showed moderate reactions (26 to 50 mm hyperaemia). </p> <p><a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-El_x0027_shina-2000" target="_blank">El'shina 2000</a> reported long‐term safety data. The outcomes of cardiovascular illnesses, upper respiratory tract infection, illnesses of the stomach and intestines, skin diseases, allergies, and infectious illnesses were presented. There were no statistically significant differences between groups for the above safety outcomes. Incidences were rare, and there was no difference between vaccinated and unvaccinated groups. </p> <p><a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Vasil_x0027_eva-1988b" target="_blank">Vasil'eva 1988b</a> assessed the safety of multiple immunisations of an inactivated bivalent influenza A vaccine in 12,643 children aged 11 to 14 years. All children were followed up for 30 days after inoculation to determine the frequency of requests for urgent medical attention and of hospitalisation. The safety outcomes presented were increase in temperature, local reactions, and intoxication/catarrh in the nasopharynx. The frequency of weak temperature reactions (&lt; 37.5 °C) varied from 6.6% to 37.9% in vaccinated groups and 2.9% to 29.0% in placebo groups. Moderate temperature reactions occurred in isolated cases; the maximum frequency was 1.9% in children vaccinated four times, who also showed the highest frequency of headaches and catarrh (11.1%). However, there were no statistically significant differences between vaccine and placebo groups. There was some increase in local reactions with an increase in number of inoculations (the percentage rising from 0.9% after one inoculation, 1.1% after three inoculations, and 1.9% after four inoculations), but these were not significantly different from responses in the placebo groups. No severe general or local reactions were observed in any child. </p> </section> </section> <section id="CD004879-sec-0113"> <h5 class="title">Serious adverse events</h5> <p>Three RCTs, <a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>, <a href="./references#CD004879-bbs2-0036" title="MalloryRM , MalkinE , AmbroseCS , BellamyT , ShiL , YiT , et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE2010;5(10):e13755. ">ab Mallory 2010</a>, and <a href="./references#CD004879-bbs2-0038" title="PlennevauxE , BlatterM , CornishMJ , GoK , KirbyD , WaliM , et al. Influenza A (H1N1) 2009 two‐dose immunization of US children: an observer‐blinded, randomized, placebo‐controlled trial. Vaccine2011;29(8):1569‐75. ">ab Plennevaux 2011</a>, and one case‐control study, <a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Goodman-2006" target="_blank">Goodman 2006</a>, reported safety data on serious adverse events. </p> <p><a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a> reported in the first year of the study one or more serious adverse events in 5.0% of LAIV‐LAIV recipients, 3.8% of LAIV‐placebo recipients, 3.4% of excipient placebo recipients, and 4.1% of saline placebo recipients. During the second year of the study, 1.6% and 2.4% of LAIV and placebo recipients, respectively, reported one or more serious adverse event(s). Most of the events were respiratory. Twenty‐nine children experienced serious adverse events considered to be related to study product, the most frequent of which were pneumonia, bronchopneumonia, bronchiolitis, and bronchitis. Three deaths were reported: one was the result of <i>Escherichia coli</i> septicaemia diagnosed 18 days after receipt of the second dose of LAIV in year one, and 2 deaths were accidental. None of these cases was judged by the investigators to be related to the study product. </p> <p><a href="./references#CD004879-bbs2-0038" title="PlennevauxE , BlatterM , CornishMJ , GoK , KirbyD , WaliM , et al. Influenza A (H1N1) 2009 two‐dose immunization of US children: an observer‐blinded, randomized, placebo‐controlled trial. Vaccine2011;29(8):1569‐75. ">ab Plennevaux 2011</a> reported a maximum rate of 8% severe unsolicited events. In particular, for the age group 6 to 35 months, the proportion of children vaccinated with 7.5 µg haemagglutinin and 15 µg haemagglutinin vaccines who experienced severe adverse events was 5% and 6%, respectively, while no events occurred in the placebo group. </p> <p><a href="./references#CD004879-bbs2-0036" title="MalloryRM , MalkinE , AmbroseCS , BellamyT , ShiL , YiT , et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE2010;5(10):e13755. ">ab Mallory 2010</a> reported three serious adverse events in children during the study: hospitalisation for depression and osteomyelitis in vaccine recipients, and cellulitis in a placebo recipient; all were considered by the investigators to be unrelated to the study vaccine. One new onset chronic disease, attention deficit hyperactivity disorder, was reported in a placebo recipient.  </p> <p>The case‐control study assessing the safety of trivalent influenza vaccine (TIV) in 6‐ to 23‐months‐old children included in the 2007 update reported a series of outcomes identified by physicians combing the exposed population for possible outcomes of interest and then clustering the diagnosis by International Classification of Diseases (ICD) categories and then using Vaccine Safety Datalink (VSD) categories (<a href="http://archie.cochrane.org/sections/documents/view?document=710403051508190005%26format=REVMAN#STD-Goodman-2006" target="_blank">Goodman 2006</a>). This kind of data mining is not likely to clarify the safety profile of TIV. </p> <p>The monovalent pandemic influenza vaccine Pandemrix (GSK) appears to be associated with the onset of narcolepsy and cataplexy in children. Current evidence does not support either a country‐specific spread or a lot‐related problem (<a href="./references#CD004879-bbs2-0087" title="MPA . Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations – results of a case inventory study by the MPA in Sweden during 2009–2010. www.lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport pandermrix 110630.pdf (accessed 10 January 2012). ">cb MPA 2011</a>; <a href="./references#CD004879-bbs2-0245" title="National Institute for Health and Welfare (THL). National Narcolepsy Task Force Interim Report. www.thl.fi/thl‐client/pdfs/dce182fb‐651e‐48a1‐b018‐3f774d6d1875 (accessed 2 January 2012). ">THL 2012</a>). </p> <p>Elsewere in the literature there were sparse reports of harms associated with particular brands of inactivated influenza vaccines. This was the case of the 2010 TIV by CSL Limited, which was used mainly in Australia. One child in every 110 aged below five who was vaccinated with the CSL vaccine had a febrile seizure. Australia consequently suspended its use. These episodes highlight the insufficient regulatory attention to potential harms from influenza vaccines in children, as the registration trials for the CSL vaccine had been carried out on 162 children aged up to three years (<a href="./references#CD004879-bbs2-0207" title="CollignonP , DoshiP , JeffersonT . Ramifications of adverse events in children in Australia (letter to the Editor). BMJ2010;340:c2994. ">Collignon 2010</a>). </p> <p>This degree of scrutiny to identify all global cases of missed potential harms is beyond the resources of this review. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004879-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004879-sec-0114"></div> <section id="CD004879-sec-0115"> <h3 class="title" id="CD004879-sec-0115">Summary of main results</h3> <p>Our review shows that LAIVs have good relative efficacy (up to 80%), but lower relative effectiveness (around 33%) in children aged under 16 years and older than two years. Live attenuated influenza vaccines may be effective in controlling a school outbreak, although this observation is based on an old, poorly reported Russian study (<a href="./references#CD004879-bbs2-0040" title="SlepushkinAN , DukovaVS , KalegaevaVA , KaganAN , TemriukEE . Results of studying the effectiveness of a live influenza vaccine for peroral use on preschool and schoolchildren. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii1974;12:24‐9. ">ab Slepushkin 1974</a>). </p> <p>Inactivated vaccines have a lower relative efficacy (59%) than live attenuated vaccines. In children aged two years or younger, there is very limited evidence to determine their effects compared with placebo. This observation is based on a single small study (<a href="./references#CD004879-bbs2-0014" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA2003;290(12):1608‐16. ">aa Hoberman 2003a</a>). Under the age of six, TIV does not provide significant protection against influenza (has no significant efficacy). Below two years of age there is no evidence of effect of either LAIV or TIV. </p> <p>Inactivated vaccines may reduce ILI by around 36% for children aged older than two years, but we could find no evidence for children aged two years or younger. Our conclusions on inactivated vaccines are based on almost 20,000 children from randomised studies. </p> <p>Evidence from cohort studies (11,000 observations) yields higher estimates, suggesting that inactivated vaccines have higher (up to 64%) efficacy and effectiveness (56%) in the over‐six‐years age group; in children younger than two years of age, their efficacy is no better than that of a control arm, and there is evidence from a single study of 53% effectiveness. However, readers should bear in mind the very low quality of the cohort data sets. </p> <p>The differences between efficacy and effectiveness of the vaccines are not surprising, as influenza vaccines are specifically targeted at influenza viruses and are not meant to prevent other causes of ILI. </p> <p>We found little evidence for other outcomes. A trial at high risk of bias shows a significant effect of trivalent, cold‐adapted influenza vaccine against outpatients' attendance for pneumonia and influenza and parents' working days lost (<a href="./references#CD004879-bbs2-0025" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy, and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118:2298‐312. ">aa Vesikari 2006a</a>). Evidence for other outcomes (secondary cases, lower respiratory tract disease, drug prescriptions, acute otitis media and other consequences and socioeconomic impact) suggests no difference from placebo or standard care. However, these conclusions are based on single studies lacking statistical power, except for acute otitis media. Virosomal vaccines reduce antibiotic consumption and school and work absenteeism, but these observations are based on a single cohort study at high risk of bias (<a href="./references#CD004879-bbs2-0080" title="SallerasL , DominguezA , PumarolaT , PratA , MarcosMA , GarridoP , et al. Effectiveness of virosomal subunit influenza vaccine in preventing influenza‐related illnesses and its social and economic consequences in children aged 3‐14 years: a prospective cohort study. Vaccine2006;24(44‐6):6638‐42. ">ca Salleras 2006</a>). </p> </section> <section id="CD004879-sec-0116"> <h3 class="title" id="CD004879-sec-0116">Overall completeness and applicability of evidence</h3> <p>The studies included in our review assess the effects of vaccines over several decades. Our review has several potential limitations. We found insufficient data to allow us to draw firm conclusions on vaccination routes (intramuscular or intranasal) or one‐ or two‐dose schedules in inactivated vaccines. The evidence base for children younger than two years remains limited. We were unable to obtain dichotomous data from 1 study in 3200 children mainly younger than 2 years (mean age 20 months). <a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a> reports similar vaccine efficacy to our summary estimate. Most eligible studies report influenza and ILI outcomes, but the measurement and reporting of data for other key outcomes, notably otitis media, hospitalisation, and adverse effects, remain inconsistent or incomplete. </p> <p>The small number of included studies in each comparison prevents a sufficiently powerful test to assess empirical evidence of publication bias. The only method to mitigate publication bias is to include published and (if retrievable) unpublished literature, regardless of language or country. </p> <p>Decision‐makers looking to inform local or national policies with evidence summarised in this review should be aware of the wide variation in the NNVs we have calculated from the same risk ratios. Even where our results have shown consistent protective effects of vaccination, wide variation in control group risks point to additional sources of variation between settings that could explain why the absolute effects differ. This could be due to differences in between‐study follow‐up periods (the longer the follow‐up period, the more the potential for identification of cases with vaccine effectiveness dilution as viral circulation declines), differences in ILI case definitions (our sensitivity analysis failed to show significant differences in case definition specificity), differences in performance of different live vaccines (we have no reason to believe this is so), differences in case‐finding and in study quality, and differences in viral circulation levels. The included studies provided insufficient data to stratify for viral circulation or duration of follow‐up. Irrespective of the variation in absolute effects, our estimates point to high vaccine efficacy but lower effectiveness. </p> </section> <section id="CD004879-sec-0117"> <h3 class="title" id="CD004879-sec-0117">Quality of the evidence</h3> <p>We have made different downgrading decisions for influenza and ILI outcomes across the two vaccine types (<a href="./full#CD004879-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD004879-tbl-0002">summary of findings Table 2</a>). We downgraded the evidence for live attenuated vaccine to moderate quality for influenza due to inconsistency and for ILI to low quality due to risk of bias and inconsistency. For ILI, the direction of effect was discordant across the studies. For influenza, we made the decision to downgrade for inconsistency despite the similar direction of effect across the studies. High between‐study variation of effect could not be explained by age or dose (<a href="./references#CD004879-fig-0003" title="">Analysis 1.1</a>; <a href="./references#CD004879-fig-0011" title="">Analysis 2.1</a>). The absence of an obvious relationship between control group risk and relative effect across the studies makes the variation in the absolute reduction a source of uncertainty. We downgraded the results for both absence from school and parental leave due to risk of bias. We further downgraded absence from school due to imprecision, and the discordant nature of the results for parental leave prompted us to downgrade further due to inconsistency. No data were available for hospitalisation or nausea. Variability in the reporting of fever prevented us from combining data. When taken together with risk of bias, we arrived at a rating of very low quality. The evidence for inactivated vaccines was high and moderate for influenza and ILI, respectively. The stability of the risk ratio for influenza gave us more confidence in its application to the variable control group risk across the studies. We considered bias a limitation only for ILI. Data for other outcomes were not available. </p> <p>The general methodological quality of the included studies was poor. We found that description of vaccine content was variable, and no preservatives or excipients were reported. We could find no comment on the degree of matching between virus strains used in the studies, circulating strains, and composition of yearly World Health Organization (WHO) recommended vaccines. In healthy adults, antigenic composition is an important predictor of vaccine efficacy, as our Cochrane Review of influenza vaccines has shown (<a href="./references#CD004879-bbs2-0223" title="JeffersonT , DiPietrantonjC , RivettiA , BawazeerGA , Al‐AnsaryLA , FerroniE . Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews2010, Issue 7. [DOI: 10.1002/14651858.CD001269.pub4] ">Jefferson 2010</a>). The relative paucity of head‐to‐head comparisons of vaccines hinders meaningful comments on their relative performance and points to an absolute requirement for more direct‐comparison trials. Our 2005 decision to include non‐randomised evidence in the evaluation of efficacy/effectiveness resulted in the inclusion of a large number of studies of dubious quality. This is best observed in cohort studies. The majority of these are at high risk of bias, as are case‐control studies. We found several case‐control studies of similar design that claimed to be testing the effectiveness of inactivated influenza vaccines in a "real world setting" (e.g. <a href="./references#CD004879-bbs2-0051" title="CochranLW , BlackS , KleinNP , DekkerCL , LewisE , ReingoldAL . Vaccine effectiveness against laboratory‐confirmed influenza in infants: a matched case control study. Human Vaccines2010;6(9):729‐35. ">ba Cochran 2010a</a>; <a href="./references#CD004879-bbs2-0054" title="EisenbergKW , SzilagyiPG , FairbrotherG , GriffinMR , StaatM , ShoneLP , et al. Vaccine effectiveness against laboratory‐confirmed influenza in children 6 to 59 months of age during the 2003‐2004 and 2004‐2005 influenza seasons. Pediatrics2008;122(5):911‐9. ">ba Eisenberg 2008a</a>; <a href="./references#CD004879-bbs2-0058" title="KellyH , JacobyP , DixonGA , CarcioneD , WilliamsS , MooreHC , et al. Vaccine effectiveness against laboratory‐confirmed influenza in healthy young children: a case‐control study. Pediatric Infectious Disease Journal2011;30(2):107‐11. ">ba Kelly 2011</a>; <a href="./references#CD004879-bbs2-0059" title="KisslingE , ValencianoM , CohenJM , OrosziB , BarretAS , RizzoC , et al. I‐MOVE multi‐centre case control study 2010‐11: overall and stratified estimates of influenza vaccine effectiveness in Europe. Eurosurveillance2011;6(11):19818. ">ba Kissling 2011</a>; <a href="./references#CD004879-bbs2-0060" title="MahmudS , HammondG , ElliottL , HildermanT , KurbisC , CaetanoP , et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory‐confirmed H1N1 infections: population‐based case‐control study. Vaccine2011;29(45):7975‐81. ">ba Mahmud 2011</a>; <a href="./references#CD004879-bbs2-0061" title="StaatMA , GriffinMR , DonauerS , EdwardsKM , SzilagyiPG , WeinbergGA , et al. Vaccine effectiveness for laboratory‐confirmed influenza in children 6‐59 months of age, 2005‐2007. Vaccine2011;29(48):9005‐11. ">ba Staat 2011a</a>; <a href="./references#CD004879-bbs2-0063" title="ValencianoM , KisslingE , CohenJM , OrosziB , BarretAS , RizzoC , et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009‐2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I‐MOVE) multicentre case‐control study. PLoS Medicine2011;8(1):e1000388. ">ba Valenciano 2011</a>; <a href="./references#CD004879-bbs2-0064" title="VanBuynderPG , DhaliwalJK , VanBuynderJL , CouturierC , Minville‐LeblancM , GarceauR , et al. Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children. Influenza and Other Respiratory Viruses2010;4(4):171‐8. ">ba Van Buynder 2010</a>). The case test‐negative design is described in detail elsewhere (<a href="./references#CD004879-bbs2-0214" title="FoppaIM , HaberM , FerdinandsJM , ShayDK . The case test‐negative design for studies of the effectiveness of influenza vaccine. Vaccine2013;31(30):3104‐9. ">Foppa 2013</a>; <a href="./references#CD004879-bbs2-0247" title="ValencianoM , CiancioBC , I‐MOVE study team. I‐MOVE: a European network to measure the effectiveness of influenza vaccine. Eurosurveillance2012;17(39):20281. ">Valenciano 2012</a>). Cases and controls were both selected on the basis of the presence of ILI symptoms. The discriminating variable between cases and controls was the positivity (for influenza) of a laboratory‐tested throat specimen. Consequently, this design does not test the effect of vaccine exposure on the onset of ILI. It tests the effect of the vaccines on microbiological specimens, which is of dubious public health significance. </p> <p>The data included in a case test‐negative design are sometimes harvested from an ongoing networked surveillance cohort. In this case, the case test‐negative design is described as “nested” within the cohort. The source cohort can include community and hospitalised cases and controls, allowing flexibility (<a href="./references#CD004879-bbs2-0226" title="KisslingE , RondyM , I‐MOVE/I‐MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I‐MOVE multicentre case control studies at primary care and hospital levels in Europe. Eurosurveillance2017;22(7):30464. [DOI: 10.2807/1560‐7917.ES.2017.22.7.30464] ">Kissling 2017</a>). In Europe the surveillance programme has a formal structure and is known as Influenza ‐ Monitoring Vaccine Effectiveness (I‐MOVE). I‐MOVE is partly funded and co‐ordinated by the European Centre for Disease Prevention and Control. </p> <p>Briefly, the study design that is similar to a case‐control design consists of selecting influenza cases (e.g. cases of ILI who have tested positive for influenza) and controls (cases of ILI who have tested negative) and calculating the relevant odds ratio (OR). Cases and controls are subsequently stratified by vaccination status. An estimate of vaccines' effectiveness (VE) is derived from the OR of influenza in vaccinated/unvaccinated participants using the standard formula VE = 1 ‐ OR%. The practice of using the OR estimate as an approximation of the risk ratio (RR) was first used in a 1980 study on pneumococcal vaccine (<a href="./references#CD004879-bbs2-0203" title="BroomeC , FacklamR , FraserD . Pneumococcal disease after pneumococcal vaccination ‐ an alternative method to estimate the efficacy of pneumococcal vaccine. New England Journal of Medicine1980;303(10):549‐52. ">Broome 1980</a>). </p> <p>The design does not test field effectiveness, but the capacity of the vaccines to generate a negative polymerase chain reaction (PCR) result (what we would call laboratory efficacy). Both cases and controls are symptomatic, so any prevention is solely focused on the negativity of laboratory tests. In addition, no useful public health absolute measures of effect can be derived (such as absolute risk reduction and its reciprocal NNV) by such designs, as the background rates of infection and viral circulation are not part of the calculation of the estimates of effect. The mathematical method first used by <a href="./references#CD004879-bbs2-0203" title="BroomeC , FacklamR , FraserD . Pneumococcal disease after pneumococcal vaccination ‐ an alternative method to estimate the efficacy of pneumococcal vaccine. New England Journal of Medicine1980;303(10):549‐52. ">Broome 1980</a> is correct if three key assumptions are met: </p> <p> <ul id="CD004879-list-0023"> <li> <p>the risk of non‐influenza ILI is the same in vaccinated and non‐vaccinated individuals (a factor called “k” by <a href="./references#CD004879-bbs2-0203" title="BroomeC , FacklamR , FraserD . Pneumococcal disease after pneumococcal vaccination ‐ an alternative method to estimate the efficacy of pneumococcal vaccine. New England Journal of Medicine1980;303(10):549‐52. ">Broome 1980</a>); </p> </li> <li> <p>the attack rate in the vaccinated population is low;</p> </li> <li> <p>the circulating serotypes are similar to those in the selected population within the case‐control test‐negative design. </p> </li> </ul> </p> <p>All assumptions are unlikely to be fulfilled at the same time, especially in multicentre/multi country surveillance cohorts with a non‐random sampling frame. For example, Cowling and colleagues reported an increased risk of non‐influenza respiratory virus infections associated with receipt of inactivated influenza vaccine. In addition, the OR will give falsely high VE if the attack rate in the vaccinated population is high (<a href="./references#CD004879-bbs2-0208" title="CowlingB , FangV , NishiuraH , ChanK‐H , NgS , IpDKM , et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clinical Infectious Diseases2012;54(12):1778‐83. ">Cowling 2012</a>; <a href="./references#CD004879-bbs2-0235" title="OrensteinW , BernierR , DonderoT , HinmanAR , MarksJS , BartKJ , et al. Field evaluation of vaccine efficacy. Bulletin of the World Health Organization1985;63(6):1055‐68. ">Orenstein 1985</a>). Apart from these fundamental design problems, case test‐negative studies are also affected by poor reporting. (See also <a href="./references#CD004879-bbs2-0238" title="PerencevichEN . Pondering vexing issues in infection prevention and control. haicontroversies.blogspot.com.au/2015/09/there‐is‐no‐such‐thing‐as‐patient‐safety.html#!/ (accessed 22 May 2017). ">Perencevich 2013a</a>; <a href="./references#CD004879-bbs2-0239" title="PerencevichEN . How should we calculate influenza vaccine effectiveness? ACP Internist Blog Archive. blog.acpinternist.org/2013/02/how‐should‐we‐calculate‐influenza_7.html (accessed 17 May 2017). ">Perencevich 2013b</a>). </p> </section> <section id="CD004879-sec-0118"> <h3 class="title" id="CD004879-sec-0118">Potential biases in the review process</h3> <p>We found a large data set showing variable quality evidence of vaccines' efficacy in children aged over three years. </p> <p>As we had already observed in our Cochrane Review of influenza vaccines in healthy adults (<a href="./references#CD004879-bbs2-0210" title="DemicheliV , JeffersonT , Al‐AnsaryLA , FerroniE , RivettiA , DiPietrantonjC . Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD001269.pub5] ">Demicheli 2014</a>), there is marked difference between the efficacy and effectiveness of the vaccines due to the large proportion of ILI ('the flu') caused by agents other than influenza viruses. This is an important point in the decision to vaccinate whole populations. In addition, we found limited evidence that vaccines reduce the burden of school absences. Decision‐makers' attention to the vaccination of very young children is not supported by the evidence summarised in our review. Although there is a growing body of evidence showing the impact of influenza on hospitalisations and deaths of children, at present we could find no convincing evidence that vaccines can reduce mortality, hospital admissions, serious complications, or community transmission of influenza. </p> <p>We were surprised to find only one safety study of inactivated vaccine in children under 2 years, carried out nearly 30 years ago in 35 children (<a href="./references#CD004879-bbs2-0048" title="WrightPF , SellSH , ThompsonJ , KarzonDT . Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. Journal of Pediatrics1976;88(1):31‐5. ">ab Wright 1976a</a>). The lack of safety data for inactive vaccines in younger children is particularly surprising given that the inactive vaccine is now recommended for healthy children six months and older in the USA and Canada (<a href="./references#CD004879-bbs2-0198" title="American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza immunization of children. Pediatrics2004;113:1441‐7. ">AAPCID 2004</a>; <a href="./references#CD004879-bbs2-0217" title="HarperSA , FukudaK , UyekiTM , CoxNJ , BridgesCB , Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report2004;53(RR‐6):1‐40. ">Harper 2004</a>; <a href="./references#CD004879-bbs2-0236" title="OrrP . Statement on influenza vaccination for the 2004‐2005 season. Canada Communicable Disease Report2004;30:1‐32. ">Orr 2004</a>). In contrast, while the live vaccine is only licenced for children aged 5 and older in the USA, we found 10 studies testing its safety in younger children. However, the manufacturers' refusal to release all safety outcome data from trials carried out in young children, together with obvious reporting bias and inconsistencies in the primary studies, does not bode well for a fair assessment of the safety of live attenuated vaccines. </p> <p>We found a notable range and diversity of safety outcomes and definitions (or lack thereof) in the included studies, leading to a loss of data. This clearly demonstrates the difficulty of attempting to meta‐analyse safety data for a review when the data are not presented in a standardised format. The Brighton Collaboration, set up to facilitate the development, evaluation, and dissemination of high‐quality information about the safety of human vaccines, has produced guidelines on the recording and presentation of temperature and induration. The results of this search and review clearly show the need for the existence of such guidelines and their adoption by researchers worldwide. </p> </section> <section id="CD004879-sec-0119"> <h3 class="title" id="CD004879-sec-0119">Agreements and disagreements with other studies or reviews</h3> <p>The effects of influenza vaccination in those aged 16 or younger have recently been the topic of a number of other reviews. On the basis of their methods and the inclusion criteria adopted, we have classified the reviews into the following broad categories. </p> <p>1) A first group of reviews that consider only studies with PCR‐confirmed or culture‐confirmed clinical cases as primary efficacy outcome (<a href="./references#CD004879-bbs2-0200" title="AmbroseCS , WuX , KnufM , WutzlerP . The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta‐analysis of 8 randomized controlled studies. Vaccine2012;30(5):886‐92. ">Ambrose 2012</a>; <a href="./references#CD004879-bbs2-0202" title="BelsheRB , TobackSL , YiT , AmbroseCS . Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age. Influenza and Other Respiratory Viruses2010;4(3):141‐5. ">Belshe 2010</a>; <a href="./references#CD004879-bbs2-0204" title="CarterNJ , CurranMP . Live attenuated influenza vaccine (FluMist; Fluenz): a review of its use in the prevention of seasonal influenza in children and adults. Drugs2011;71(12):1591‐622. ">Carter 2011</a>; <a href="./references#CD004879-bbs2-0237" title="OsterholmMT , KelleyNS , SommerA , BelongiaEA . Efficacy and effectiveness of influenza vaccines: a systematic review and meta‐analysis. Lancet2012;12(1):36‐44. ">Osterholm 2012</a>; <a href="./references#CD004879-bbs2-0243" title="RhorerJ , AmbroseCS , DickinsonS , HamiltonH , OlekaNA , MalinoskiFJ , et al. Efficacy of live attenuated influenza vaccine in children: a meta‐analysis of nine randomized clinical trials. Vaccine2009;27(7):1101‐10. ">Rhorer 2009</a>). All of these reviews are focused on LAIV administration, but also include studies comparing LAIV with TIV. </p> <p><a href="./references#CD004879-bbs2-0200" title="AmbroseCS , WuX , KnufM , WutzlerP . The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta‐analysis of 8 randomized controlled studies. Vaccine2012;30(5):886‐92. ">Ambrose 2012</a> and <a href="./references#CD004879-bbs2-0243" title="RhorerJ , AmbroseCS , DickinsonS , HamiltonH , OlekaNA , MalinoskiFJ , et al. Efficacy of live attenuated influenza vaccine in children: a meta‐analysis of nine randomized clinical trials. Vaccine2009;27(7):1101‐10. ">Rhorer 2009</a> are based on the same evidence, including trials performed on populations aged between 6 months and 17 years. <a href="./references#CD004879-bbs2-0243" title="RhorerJ , AmbroseCS , DickinsonS , HamiltonH , OlekaNA , MalinoskiFJ , et al. Efficacy of live attenuated influenza vaccine in children: a meta‐analysis of nine randomized clinical trials. Vaccine2009;27(7):1101‐10. ">Rhorer 2009</a> includes one more placebo‐controlled trial than <a href="./references#CD004879-bbs2-0200" title="AmbroseCS , WuX , KnufM , WutzlerP . The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta‐analysis of 8 randomized controlled studies. Vaccine2012;30(5):886‐92. ">Ambrose 2012</a>. In <a href="./references#CD004879-bbs2-0200" title="AmbroseCS , WuX , KnufM , WutzlerP . The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta‐analysis of 8 randomized controlled studies. Vaccine2012;30(5):886‐92. ">Ambrose 2012</a>, the analysis is limited to the paediatric age group for which the vaccine is licenced (24 months or more at immunisation). Out of the nine included RCTs, six were placebo controlled (corresponding to nine data sets), whereas controls were immunised with TIV in the remaining three included trials (three data sets). Both reviews show a high relative efficacy of a two‐dose LAIV course against similar viral strains (about 80%) and a significantly lower efficacy of TIV. </p> <p>The review by <a href="./references#CD004879-bbs2-0237" title="OsterholmMT , KelleyNS , SommerA , BelongiaEA . Efficacy and effectiveness of influenza vaccines: a systematic review and meta‐analysis. Lancet2012;12(1):36‐44. ">Osterholm 2012</a> includes evidence on both adult and paediatric populations. Included designs are either placebo‐controlled trials or case‐controlled studies. Considering only studies performed on paediatric populations, the placebo‐controlled RCTs are the same as those included in <a href="./references#CD004879-bbs2-0243" title="RhorerJ , AmbroseCS , DickinsonS , HamiltonH , OlekaNA , MalinoskiFJ , et al. Efficacy of live attenuated influenza vaccine in children: a meta‐analysis of nine randomized clinical trials. Vaccine2009;27(7):1101‐10. ">Rhorer 2009</a>. A pooled meta‐analysis was carried out on the same data sets (apart from one study: <a href="./references#CD004879-bbs2-0006" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009a</a>; <a href="./references#CD004879-bbs2-0007" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. ">aa Bracco Neto 2009b</a>). Evidence from case‐control studies is also discussed (against seasonal or H1N1 pandemic influenza), even if it is not included in the analysis. Relative efficacy estimates of LAIV against PCR‐ or culture‐confirmed influenza in children aged six months to seven years was around 80%. </p> <p><a href="./references#CD004879-bbs2-0204" title="CarterNJ , CurranMP . Live attenuated influenza vaccine (FluMist; Fluenz): a review of its use in the prevention of seasonal influenza in children and adults. Drugs2011;71(12):1591‐622. ">Carter 2011</a> reports results of studies on LAIV efficacy, reactogenicity, and immunogenicity in children and adult populations. Evidence of the vaccines’ efficacy in children (i.e. against influenza, as opposed to ILI) is the same as that included in <a href="./references#CD004879-bbs2-0243" title="RhorerJ , AmbroseCS , DickinsonS , HamiltonH , OlekaNA , MalinoskiFJ , et al. Efficacy of live attenuated influenza vaccine in children: a meta‐analysis of nine randomized clinical trials. Vaccine2009;27(7):1101‐10. ">Rhorer 2009</a> (with the exception of <a href="./references#CD004879-bbs2-0215" title="ForrestBD , PrideMW , DunningAJ , CapedingMR , ChotpitayasunondhT , TamJS , et al. Correlation of cellular immune responses with protection against culture‐confirmed influenza virus in young children. Clinical and Vaccine Immunology2008;15(7):1042‐53. ">Forrest 2008</a>). A meta‐analysis was not performed; only a descriptive review is presented. Estimates of LAIV efficacy in comparison with placebo or TIV are the same as that of the above mentioned studies. In contrast to the other reviews that included the study by <a href="./references#CD004879-bbs2-0228" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. ">Lum 2010</a> (<a href="./references#CD004879-bbs2-0237" title="OsterholmMT , KelleyNS , SommerA , BelongiaEA . Efficacy and effectiveness of influenza vaccines: a systematic review and meta‐analysis. Lancet2012;12(1):36‐44. ">Osterholm 2012</a>; <a href="./references#CD004879-bbs2-0243" title="RhorerJ , AmbroseCS , DickinsonS , HamiltonH , OlekaNA , MalinoskiFJ , et al. Efficacy of live attenuated influenza vaccine in children: a meta‐analysis of nine randomized clinical trials. Vaccine2009;27(7):1101‐10. ">Rhorer 2009</a>), <a href="./references#CD004879-bbs2-0204" title="CarterNJ , CurranMP . Live attenuated influenza vaccine (FluMist; Fluenz): a review of its use in the prevention of seasonal influenza in children and adults. Drugs2011;71(12):1591‐622. ">Carter 2011</a> assessed the effect of measles, mumps, and rubella (MMR) vaccine co‐administration, concluding that this did not affect LAIV efficacy. The review also considers evidence on local and systemic reactions observed a few days after LAIV immunisation: runny nose, headache, and tiredness are likely to occur more frequently among LAIV than among placebo recipients, especially after the first dose. Live attenuated influenza vaccine is more reactogenic than TIV, and its administration is associated with an increased risk of wheezing within 42 days after vaccination in children younger than five years of age in comparison with TIV. </p> <p>2) A second group of systematic reviews, <a href="./references#CD004879-bbs2-0229" title="ManzoliL , SchioppaF , BocciaA , VillariP . The efficacy of influenza vaccine for healthy children: a meta‐analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatric Infectious Disease Journal2007;26(2):97‐106. ">Manzoli 2007</a> and <a href="./references#CD004879-bbs2-0233" title="NegriE , ColomboC , GiordanoL , GrothN , ApoloneG , LaVecchiaC . Influenza vaccine in healthy children: a meta‐analysis. Vaccine2005;23(22):2851‐61. ">Negri 2005</a>, present several methodological analogies with our 2005 Cochrane Review; the exceptions are that only RCTs or CCTs are included; safety issues of the vaccines are not considered; and some included studies also had a vaccine control arm. The most recent review confirms that there are no significant differences between TIV and LAIV effects on the three assessed outcomes (influenza, ILI, and otitis media). A sensitivity analysis was performed excluding Russian studies (classified at a lower level of methodological quality) from a pooled analysis, which resulted in a higher estimate of effect against clinical disease (pooled estimates for LAIV and TIV). <a href="./references#CD004879-bbs2-0244" title="Rodrigo PendasJA , Alemany VilchesL , Moraga LlopFA . Systematic reviews of the efficacy and effectiveness of influenza vaccination in infants, children and teenagers [Revisiones sistematicas de la eficacia o efectividad de las vacunas antigripales en el lactante, el nino y el adolescente sano]. Vacunas2007;8(3):130‐42. ">Rodrigo Pendas 2007</a> includes studies (seven RCTs) evaluating the efficacy of both LAIV and TIV in preventing ILI, confirmed influenza, otitis media, and other respiratory illnesses. </p> <p>3) Only one review presented the effect of vaccination on the contacts of children (<a href="./references#CD004879-bbs2-0225" title="JordanR , ConnockM , AlbonE , Fry‐SmithA , OlowokureB , HawkerJ , et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine2006;24(8):1047‐62. ">Jordan 2006</a>). Results from this industry‐funded review including eight RCTs, three community studies, and three economic evaluations are discussed but a meta‐analysis is not performed. The authors conclude that child vaccination could produce significant health benefits and be cost‐saving to the community as a whole. </p> <p>4) Two other reviews evaluated the immunogenicity of monovalent H1N1 pandemic influenza vaccines (in both adjuvanted and non‐adjuvanted formulations) (<a href="./references#CD004879-bbs2-0230" title="ManzoliL , DeVitoC , SalantiG , D'AddarioM , VillariP , IoannidisJPA . Meta‐analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PLoS ONE2011;6(9):e24384. ">Manzoli 2011</a>; <a href="./references#CD004879-bbs2-0251" title="YinJK , KhandakerG , RashidH , HeronL , RiddaI , BooyR . Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta‐analysis. Influenza and Other Respiratory Viruses2011;5(5):299‐305. ">Yin 2011</a>). All tested split/subunit vaccines induced a satisfactory immunogenicity (over 70%) after only one dose in adolescents, while only non‐adjuvanted vaccines at high doses and oil‐in‐water adjuvanted vaccines showed acceptable results for children. Even if the rate of serious adverse events was low for all 2009 H1N1 vaccines (0.013% overall), the review does not allow a firm conclusion to be drawn for vaccine safety at the population level. Mild to moderate adverse reactions were more frequent for oil‐in‐water adjuvanted vaccines. <a href="./references#CD004879-bbs2-0248" title="WijnansL , DeBieS , DielemanJ , BonhoefferJ , SturkenboomM . Safety of pandemic H1N1 vaccines in children and adolescents. Vaccine2011;29(43):7559‐71. ">Wijnans 2011</a> reviews several studies (clinical trials, case reports, results of surveillance) reporting safety data of monovalent H1N1 pandemic vaccine. </p> <p>The key question of the relationship between a surrogate outcome (antibody production) and field outcomes (clinical illness) is left unaddressed, calling into question the rationale for applying results from the reviews in deciding vaccination policies. </p> <p>5) One other review is based on evidence available in the Cochrane Library only (11 Cochrane Reviews; one other review/meta‐analysis; 14 RCTs; 3 CCTs) (<a href="./references#CD004879-bbs2-0232" title="MichielsB , GovaertsF , RemmenR , VermeireE , CoenenS . A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine2011;29(49):9159‐70. ">Michiels 2011</a>). The review provides a critical approach to the opportunity to administer inactivated influenza vaccine to children, adults, and the elderly, but also to individuals affected by comorbidity conditions (diabetes, chronic lung disease, cardiovascular disease, kidney or liver disease, and immune suppression). Inactivated influenza vaccines appear to be effective in healthy adults and children over six years but not in children younger than two years and institutionalised elderly. Inconsistent results are found in studies in children younger than six years, individuals with chronic obstructive airways disease, institutionalised elderly, elderly with comorbidity, and healthcare workers in elderly homes. Vaccination of children might be protective in non‐recipients of all ages living in the same community. The vaccination of pregnant women might be beneficial for their newborns. </p> <p>Despite the great variations in methods, the reviews all reached similar conclusions to those of our 2005 Cochrane Review: TIV has few effects, and there is no evidence that it affects deaths, complications, or transmission of influenza. Live attenuated influenza vaccine performed a little better at the expense of safety. </p> <p>Most reviews present estimates of vaccine efficacy derived from studies in which principal outcome measures are 'confirmed' cases of influenza, that is with laboratory confirmation of infection. The reviews express results in relative terms (RR) (i.e. regardless of the level of influenza viruses circulating in the study population). The relative efficacy measure represents the capacity of the vaccine to prevent cases specifically due to virus strains contained in the vaccine compared to the control. When used in vaccination campaigns, the same vaccines are unlikely to prevent the same proportion of cases simply because most ILI cases are attributable to other viruses. To assess the real benefit produced by a campaign, it would be preferable to also look at the impact of the vaccines on ILI and to present results using absolute measure such as RDs and their reciprocal, the NNV. These take into account the level of influenza viral circulation in the population. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004879-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD004879-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004879-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 1 Influenza." data-id="CD004879-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 1 Influenza.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 2 Influenza‐like illness." data-id="CD004879-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 2 Influenza‐like illness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 3 Otitis media (all episodes)." data-id="CD004879-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 3 Otitis media (all episodes).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 4 School absenteeism." data-id="CD004879-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 4 School absenteeism.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 5 Working days lost (number of events, parents)." data-id="CD004879-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 5 Working days lost (number of events, parents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 6 Drug prescriptions (number of events)." data-id="CD004879-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 6 Drug prescriptions (number of events). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 7 Outpatients attendance for pneumonia and influenza." data-id="CD004879-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 7 Outpatients attendance for pneumonia and influenza. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Live vaccine versus placebo (RCTs), Outcome 8 Influenza‐like illness (clustering sensitivity analysis)." data-id="CD004879-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Live vaccine versus placebo (RCTs), Outcome 8 Influenza‐like illness (clustering sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 1 Influenza." data-id="CD004879-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 1 Influenza.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 2 Influenza‐like illness." data-id="CD004879-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 2 Influenza‐like illness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 3 Acute otitis media." data-id="CD004879-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 3 Acute otitis media.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 4 School absenteeism." data-id="CD004879-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 4 School absenteeism.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 5 Influenza‐like illness (clustering sensitivity analysis)." data-id="CD004879-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Inactivated vaccine versus placebo (RCTs), Outcome 5 Influenza‐like illness (clustering sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Live vaccine versus placebo or no intervention (RCTs by age group), Outcome 1 Influenza." data-id="CD004879-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Live vaccine versus placebo or no intervention (RCTs by age group), Outcome 1 Influenza. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Live vaccine versus placebo or no intervention (RCTs by age group), Outcome 2 Influenza‐like illness." data-id="CD004879-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Live vaccine versus placebo or no intervention (RCTs by age group), Outcome 2 Influenza‐like illness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inactivated vaccine versus placebo or no intervention (RCTs by age group), Outcome 1 Influenza." data-id="CD004879-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Inactivated vaccine versus placebo or no intervention (RCTs by age group), Outcome 1 Influenza. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inactivated vaccine versus placebo or no intervention (RCTs by age group), Outcome 2 Influenza‐like illness." data-id="CD004879-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Inactivated vaccine versus placebo or no intervention (RCTs by age group), Outcome 2 Influenza‐like illness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 1 Influenza." data-id="CD004879-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 1 Influenza.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 2 Influenza‐like illness." data-id="CD004879-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 2 Influenza‐like illness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 3 Secondary cases." data-id="CD004879-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 3 Secondary cases.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 4 School absenteeism." data-id="CD004879-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 4 School absenteeism.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 5 Lower respiratory tract disease." data-id="CD004879-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 5 Lower respiratory tract disease.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 6 Acute otitis media." data-id="CD004879-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 6 Acute otitis media.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 7 Hospitalisation due to acute otitis media." data-id="CD004879-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 7 Hospitalisation due to acute otitis media. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 8 Consequences of acute otitis media." data-id="CD004879-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 8 Consequences of acute otitis media. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 9 Outpatients attendance for pneumonia and influenza." data-id="CD004879-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 9 Outpatients attendance for pneumonia and influenza. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 10 Working days lost (number of events, parents of children 6 to 36 months of age)." data-id="CD004879-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 10 Working days lost (number of events, parents of children 6 to 36 months of age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All vaccine types versus placebo, Outcome 11 Drug prescriptions (number of events, 6 to 36 months of age)." data-id="CD004879-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 All vaccine types versus placebo, Outcome 11 Drug prescriptions (number of events, 6 to 36 months of age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Case‐control studies, Outcome 1 Influenza vs influenza‐like illness (crude data)." data-id="CD004879-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Case‐control studies, Outcome 1 Influenza vs influenza‐like illness (crude data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Case‐control studies, Outcome 2 Influenza vs influenza‐like illness (adj. estimates)." data-id="CD004879-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Case‐control studies, Outcome 2 Influenza vs influenza‐like illness (adj. estimates). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Case‐control studies, Outcome 3 Influenza‐like illness vs no symptoms." data-id="CD004879-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Case‐control studies, Outcome 3 Influenza‐like illness vs no symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Live attenuated vaccines (cohort studies by age group), Outcome 1 Influenza." data-id="CD004879-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Live attenuated vaccines (cohort studies by age group), Outcome 1 Influenza.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Live attenuated vaccines (cohort studies by age group), Outcome 2 Influenza‐like illness." data-id="CD004879-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Live attenuated vaccines (cohort studies by age group), Outcome 2 Influenza‐like illness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Inactivated vaccines (cohort studies by age group), Outcome 1 Influenza." data-id="CD004879-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Inactivated vaccines (cohort studies by age group), Outcome 1 Influenza.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Inactivated vaccines (cohort studies by age group), Outcome 2 Influenza‐like illness." data-id="CD004879-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Inactivated vaccines (cohort studies by age group), Outcome 2 Influenza‐like illness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004879-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/urn:x-wiley:14651858:media:CD004879:CD004879-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_t/tCD004879-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Inactivated vaccines (cohort studies by age group), Outcome 3 Otitis media." data-id="CD004879-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Inactivated vaccines (cohort studies by age group), Outcome 3 Otitis media. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/media/CDSR/CD004879/image_n/nCD004879-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004879-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Live attenuated influenza vaccine compared to placebo or do nothing for preventing influenza in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Influenza vaccine compared to placebo or do nothing for preventing influenza in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> healthy, community‐dwelling children younger than 16 years of age<br/> <b>Setting:</b> influenza seasons in the USA, Western Europe, Russia, and Bangladesh<br/> <b>Intervention:</b> live attenuated influenza vaccine<br/> <b>Comparison:</b> placebo or do nothing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or do nothing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with influenza vaccine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza assessed by laboratory confirmation</p> <p>Follow‐up over 1 or 2 influenza seasons</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.22<br/> (0.11 to 0.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>7718<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>130 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (14 to 53) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (20 to 74) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>480 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000<br/> (53 to 197) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza‐like illness assessed by subjective report</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.69<br/> (0.60 to 0.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>124,606<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>121 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000<br/> (73 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>172 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000<br/> (103 to 138) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>341 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>235 per 1000<br/> (205 to 273) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media assessed by clinical confirmation (inspection of ear and symptoms)</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>915 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>897 per 1000</p> <p>(869 to 924)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.98 (0.95 to 1.01)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1784</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with time off from school during follow‐up</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.51<br/> (0.22 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>296<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>7 8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (22 to 119) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of parents having to take off work during follow‐up</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69<br/> (0.46 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2874<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>9 1 0</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>262 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>181 per 1000<br/> (121 to 270) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospitalisation ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fever assessed as reported increase in temperature</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Temperature rise as an outcome was presented in most of the RCTs, with large differences among trials. Considering only studies reporting raw data for this outcome, the proportion of vaccinated children with fever ranged from 0.16% to 15%, while the proportion of children in the placebo groups with fever ranged from 0.71% to 22%. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20,561</p> <p>(4 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>11 12</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Control group risks stratified for low‐, moderate‐, and high‐risk groups due to wide variation in event rates across the studies.<br/> <sup>2</sup>Sensitivity analysis by risk of bias did not change the size or direction of effect.<br/> <sup>3</sup>Downgraded one level due to serious inconsistency. Although direction of effect across the studies is consistent, there is variation in the magnitude of effect (I<sup>2</sup> 94%). Statistical variation could not be explained by age or dose. The reasons for wide variation in control group risk could be due to variable viral circulation, but this is uncertain.<br/> <sup>4</sup>Downgraded one level due to serious risk of bias. Analysis dominated by studies at high or unclear risk of bias for multiple domains. We considered only one study as at low risk of bias.<br/> <sup>5</sup>Downgraded one level due to serious inconsistency. Direction and magnitude of effect varies between the studies, and there is a high level of statistical heterogeneity (96%).<br/> <sup>6</sup>Downgraded one level due to serious indirectness. Single study following children over a single influenza season with particularly high rates of otitis media. It is uncertain whether a rate of 92% would be expected over a similar time frame in other settings.<br/> <sup>7</sup>Downgraded one level due to serious risk of bias. Single study at unclear or high risk of bias for most domains.<br/> <sup>8</sup>Downgraded two levels due to serious imprecision. The number of events is low, and the confidence interval for the absolute effect is consistent with a small increase and small reduction in school absenteeism.<br/> <sup>9</sup>Downgraded one level due to serious risk of bias. Of two data sets used from the eligible study, we judged one to be at high risk of bias.<br/> <sup>10</sup>Downgraded due to serious inconsistency. Study results are discordant in terms of size of reduction in parental working days lost.<br/> <sup>11</sup>Downgraded due to very serious inconsistency. Proportion of children with fever differed substantially between studies.<br/> <sup>12</sup>Downgraded due to serious risk of bias. Studies at high or unclear risk of bias across several domains. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Live attenuated influenza vaccine compared to placebo or do nothing for preventing influenza in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004879-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inactivated influenza vaccine compared to placebo or do nothing for preventing influenza in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Inactivated influenza vaccine compared to placebo or do nothing for preventing influenza in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> healthy, community‐dwelling children older than 2 years of age<br/> <b>Setting:</b> influenza seasons in the USA<br/> <b>Intervention:</b> inactivated influenza vaccine<br/> <b>Comparison:</b> placebo or do nothing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or do nothing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with influenza vaccine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza assessed by laboratory confirmation</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.36<br/> (0.28 to 0.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1628<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (1 to 2) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>298 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000<br/> (83 to 143) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>481 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>173 per 1000<br/> (135 to 231) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Influenza‐like illness assessed by subjective report</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.72<br/> (0.65 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>19,044<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>134 per 1000<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000<br/> (87 to 106) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>282 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<br/> (183 to 223) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>328 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000<br/> (213 to 259) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media assessed by clinical confirmation (inspection of ear and symptoms)</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>271 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>312 per 1000</p> <p>(257 to 379)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.15</p> <p>(0.95 to 1.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>884</p> <p>(3 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absence from school</p> <p>Follow‐up over a single influenza season</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1000</p> <p>(16 to 112)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.46</p> <p>(0.17 to 1.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of parents having to take off work during follow‐up ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospitalisations ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fever ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Control group risks stratified by low, moderate, and high due to wide variation in event rates.<br/> <sup>2</sup>Downgraded one level due to serious risk of bias. Analysis based on studies at high or unclear risk of bias for multiple domains.<br/> <sup>3</sup>Downgraded one level due to serious imprecision. Confidence interval includes meaningful increase in otitis media with vaccination.<br/> <sup>4</sup>Downgraded one level due to serious risk of bias. Study contributing data had multiple domains at unclear risk of bias.<br/> <sup>5</sup>Downgraded two levels due to very serious imprecision. Low number of events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inactivated influenza vaccine compared to placebo or do nothing for preventing influenza in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004879-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Synthesis of results and conclusions from the previous versions of the present review</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Review version (searches date)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of included trials (RCT/CCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of included observational studies</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Estimates of effect (RCTs/CCTs only)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Conclusions from the Abstract</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 1</p> <p>(15 November 2005)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> <p>(12 cohorts and 1 case‐control study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = 33% (95% CI 28% to 38%)</p> <p>TIV = 36% (95% CI 24% to 46%)</p> <p><b>Influenza</b> </p> <p>LAIV = 79% (95% CI 48% to 92%)</p> <p>TIV = 59% (95% CI 41% to 71%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vaccines are efficacious in children older than two years, but little</p> <p>evidence is available for children under two. There was a marked difference between vaccine efficacy and effectiveness. That no safety comparisons could be carried out emphasises the need for standardisation of methods and presentation of vaccine </p> <p>safety data in future studies. It was surprising to find only one study of inactivated</p> <p>vaccine in children under two years, given recent recommendations to vaccinate</p> <p>healthy children from six months old in the USA and Canada. If immunisation in children is to be recommended as public health policy, large‐scale studies assessing important outcomes and directly comparing vaccine types are urgently required. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 2</p> <p>(20 February 2008)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> <p>(18 cohorts and 3 case‐control studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = 33% (95% CI 28% to 38%)</p> <p>TIV = 36% (95% CI 24% to 46%)</p> <p><b>Influenza</b> </p> <p>LAIV = 82% (95% CI 71% to 89%)</p> <p>TIV = 59% (95% CI 41% to 71%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vaccines are efficacious in children older than two, but little evidence is </p> <p>available for children under two. There was a marked difference between vaccine</p> <p>efficacy and effectiveness. No safety comparisons could be carried out, emphasising</p> <p>the need for standardisation of methods and presentation of vaccine safety data</p> <p>in future studies. It was surprising to find only one study of inactivated vaccine in </p> <p>children under two years, given current recommendations to vaccinate healthy children from six months old in the USA and Canada. If immunisation in children is to be recommended as a public health policy, large‐scale studies assessing important outcomes and directly comparing vaccine types are urgently required. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 3</p> <p>(9 July 2012)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(21 cohorts and 12 case‐control studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = 33% (95% CI 28% to 38%)</p> <p>TIV = 36% (95% CI 24% to 46%)</p> <p><b>Influenza</b> </p> <p>LAIV = 80% (95% CI 68% to 87%)</p> <p>TIV = 59% (95% CI 41% to 71%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vaccines are efficacious in preventing cases of influenza in children older</p> <p>than two years of age, but little evidence is available for children younger than two </p> <p>years of age. There was a difference between vaccine efficacy and effectiveness,</p> <p>partly due to differing data sets, settings, and viral circulation patterns. No safety</p> <p>comparisons could be carried out, emphasising the need for standardisation of</p> <p>methods and presentation of vaccine safety data in future studies. In specific cases,</p> <p>influenza vaccines were associated with serious harms such as narcolepsy and febrile</p> <p>convulsions. It was surprising to find only one study of inactivated vaccine in children</p> <p>under two years, given current recommendations to vaccinate healthy children from</p> <p>six months of age in the USA, Canada, parts of Europe, and Australia. If immunisation</p> <p>in children is to be recommended as a public health policy, large‐scale studies</p> <p>assessing important outcomes and directly comparing vaccine types are urgently required.</p> <p>The degree of scrutiny needed to identify all global cases of potential harms is beyond the resources of this review. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CCT: comparative controlled trial<br/> LAIV: live attenuated influenza vaccine<br/> RCT: randomised controlled trial<br/> TIV: trivalent inactivated influenza vaccine </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Synthesis of results and conclusions from the previous versions of the present review</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004879-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analysis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Vaccine type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Study type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Age group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Without Russian studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Data sets</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Data sets</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio (random) (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio (random) (95% CI)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>01.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 (0.10 to 0.23)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 (0.10 to 0.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.47 (0.23 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.47 (0.23 to 0.97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18 (0.11 to 0.29)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18 (0.11 to 0.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>01.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.54 (0.12 to 2.42)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (0.57 to 0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12 (0.01 to 2.11)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (0.60 to 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 (0.10 to 1.48)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (0.62 to 0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>02.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.18 to 1.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.18 to 1.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.61 (0.34 to 1.08)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.61 (0.34 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.31 (0.22 to 0.45)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.31 (0.22 to 0.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.41 (0.29 to 0.59)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.41 (0.29 to 0.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>02.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 (0.21 to 0.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 (0.21 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.24 (0.08 to 0.70)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (0.66 to 0.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 (0.24 to 0.50)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (0.54 to 0.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>03.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56 (0.35 to 0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56 (0.35 to 0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>03.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Live</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.57 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>04.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.27 to 1.47)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63 (0.27 to 1.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 (0.13 to 0.89)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 (0.13 to 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.10 to 0.39)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36 (0.12 to 1.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36 (0.19 to 0.66)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (0.25 to 0.73)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>04.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Inactivated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cohort studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt;/= 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40 (0.13 to 1.20)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (0.65 to 1.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.10 (0.05 to 0.21)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.44 (0.29 to 0.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26 (0.07 to 0.92)+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.42 to 0.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>CI: confidence interval<br/> ILI: influenza‐like illness<br/> RCTs: randomised controlled trials<br/> *: significance change<br/> +: possible decision‐making significant change </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004879-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">'Risk of bias' sensitivity analysis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Effect measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b>All data sets</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b>Excluding studies at high risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>VE absolute change</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Change effect measure direction</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Change in statistical significance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of data sets</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effect estimate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>UL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Statistical significance</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of data sets</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effect estimate*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>UL 95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Statistical significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 1.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 1.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.44</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.68</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐5%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 2.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.54</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 4.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.09</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media (all episodes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.01</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Working days lost (number of events, parents)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug prescriptions (number of events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients attendance for pneumonia and influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 6.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 6.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza vs ILI (crude data)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged below 23 months ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 24 to 59 months ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6 to 59 months ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.2.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged below 14 years old ‐ fully vaccinated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.06</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.06</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness vs no symptoms</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Odds ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza‐like illness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary cases</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>School absenteeism</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower respiratory tract disease</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.54</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.08</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐32%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.17</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐3%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospitalisation due to acute otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.7.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated vaccine (2 doses)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Consequences of acute otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> ‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.8.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated vaccine, 2 doses (the arm of the trial) visits (the outcome measure)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.8.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated vaccine (2 doses; courses of antibiotics</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients attendance for pneumonia and influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.75</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Working days lost (number of events, parents of children 6 to 36 months of age)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.71</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐14%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Changed</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 8.11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug prescriptions (number of events, 6 to 36 months of age)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk ratio</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unchanged</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="16"> <div class="table-footnote"> <p>CI: confidence interval<br/> ILI: influenza‐like illness<br/> LL: lower limit<br/> NA: not applicable<br/> RR: risk ratio<br/> UL: upper limit<br/> VE: vaccine efficacy/effectiveness<br/> VE absolute change = (1 ‐ RR*) ‐ (1 ‐ RR)<br/> *: effect estimate excluding data sets at high risk of bias </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">'Risk of bias' sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004879-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Efficacy and effectiveness data from intra‐epidemic and non‐typical studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study reference</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exclusion reason</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RCT/cohort</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vaccine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>n treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>n control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nicholls 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort from community not representative of local population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 2 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nicholls 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort from community not representative of local population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 4 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nicholls 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort from community not representative of local population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 to 14 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Slepushkin 1974</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study of orally administered vaccine as emergency prophylaxis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live (oral) H2N2+B</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 3 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza or ARI &gt;= 10 days after vaccination</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>508</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>271</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>492</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ritzwoller 2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactive, trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 23 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ILI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1129</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1615</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aksenov 1971</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live, H2N2+B, 3 doses 5 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 7 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza and ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>760</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>594</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aksenov 1971</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live, H2N2+B, 3 doses 8 to 10 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 7 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza and ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>728</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>674</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aksenov 1971</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live, H2N2+B, 3 doses 5 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 15 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza and ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1358</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>776</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cowling 2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐epidemic study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TIV or saline placebo during the 2009–10 pandemic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 17 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morbidity due to influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>479</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>ARI: acute respiratory infection<br/> ILI: influenza‐like illness<br/> RCT: randomised controlled trial<br/> TIV: trivalent influenza vaccine </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Efficacy and effectiveness data from intra‐epidemic and non‐typical studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/full#CD004879-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Live vaccine versus placebo (RCTs)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7718</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.11, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.14, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3043</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.04, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124606</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.60, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.18, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.57, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Otitis media (all episodes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2873</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.95, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 School absenteeism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Working days lost (number of events, parents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.46, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Drug prescriptions (number of events) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Outpatients attendance for pneumonia and influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.59, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Influenza‐like illness (clustering sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.59, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.18, 2.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47920</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.56, 0.76]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Live vaccine versus placebo (RCTs)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inactivated vaccine versus placebo (RCTs)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.28, 0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19044</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.65, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.15, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.69, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Acute otitis media <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>884</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.95, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.10, 23.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.95, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 School absenteeism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Influenza‐like illness (clustering sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.60, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.15, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5859</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.66, 0.79]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inactivated vaccine versus placebo (RCTs)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Live vaccine versus placebo or no intervention (RCTs by age group)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10812</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.14, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10752</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.12, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.62, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38646</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.57, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149772</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.60, 0.74]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Live vaccine versus placebo or no intervention (RCTs by age group)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Inactivated vaccine versus placebo or no intervention (RCTs by age group)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.29, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>786</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.18, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.34, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>710</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.22, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.54, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.21, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18912</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.66, 0.78]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Inactivated vaccine versus placebo or no intervention (RCTs by age group)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">All vaccine types versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.19, 0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3556</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.18, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3043</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.04, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.28, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.62, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.18, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.57, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.15, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.69, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Secondary cases <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.56, 4.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.56, 4.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 School absenteeism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.26, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.22, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.17, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Lower respiratory tract disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.03, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1496</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.01, 4.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.01, 6.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Acute otitis media <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.79, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Live attenuated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2585</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.05, 3.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Live attenuated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.95, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Inactivated vaccines (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.10, 23.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Inactivated vaccines (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.95, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Hospitalisation due to acute otitis media <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Inactivated vaccine (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.62, 3.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Consequences of acute otitis media <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Inactivated vaccine (2 (doses of the intervention) ‐ visits (outcome measure))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.27, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Inactivated vaccine (2 doses; courses of antibiotics)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.36, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Outpatients attendance for pneumonia and influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.59, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Live attenuated vaccine (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.49, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Live attenuated vaccine (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.75, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Working days lost (number of events, parents of children 6 to 36 months of age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.46, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Live attenuated vaccine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.46, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Drug prescriptions (number of events, 6 to 36 months of age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Live attenuated vaccine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">All vaccine types versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Case‐control studies</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza vs influenza‐like illness (crude data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Children aged below 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.45, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Children aged between 5 and 19 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.07, 8.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza vs influenza‐like illness (adj. estimates) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Children aged below 23 months ‐ fully vaccinated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.39, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Children aged between 24 and 59 months ‐ fully vaccinated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.22, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Children aged between 6 and 59 months ‐ fully vaccinated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.32, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Children aged below 14 years old ‐ fully vaccinated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.06, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Influenza‐like illness vs no symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.28, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Inactivated vaccine (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.26, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Inactivated vaccine (2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.18, 1.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Case‐control studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Live attenuated vaccines (cohort studies by age group)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.35, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.35, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.57, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.57, 0.69]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Live attenuated vaccines (cohort studies by age group)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004879-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Inactivated vaccines (cohort studies by age group)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1873</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.25, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.27, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.13, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.12, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.42, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 under 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 under 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7046</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.59, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 over 6 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4866</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.29, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Otitis media <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.22, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Children aged 6 months to 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.22, 1.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Inactivated vaccines (cohort studies by age group)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004879.pub5/references#CD004879-tbl-0014">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004879.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004879-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004879-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004879-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD004879-note-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD004879-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD004879-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD004879-note-0009">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD004879-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD004879-note-0003">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004879-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004879-note-0019">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004879\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004879\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004879\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004879\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004879\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004879.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004879.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004879.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004879.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004879.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740713989987"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004879.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740713989991"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004879.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d63b6f8f8937a',t:'MTc0MDcxMzk5NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 